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Conventional dendritic cells initiate Imiquimod-induced psoriasis via IL-23 and independent
of plasmacytoid dendritic cells or type-I interferons
C Wohn,1 JL Ober-Blöbaum,1 E Prens,2 C Cheong,3 S Haak,4 S Pantelyushin,5 B Reizis,4 B Becher,5
H Weighardt6 and BE Clausen1 1 Dept. Immunology, Erasmus MC, Rotterdam, Netherlands, 2
Dept. Dermatology, Erasmus MC, Rotterdam, Netherlands, 3 Lab. Cellular Physiology and
Immunology, Rockefeller University, NY, NY, 4 Dept. Microbiology and Immunology,
Columbia University, NY, NY, 5 Inst. Experimental Immunology, University of Zurich, Zurich,
Switzerland and 6 Inst. Umweltmedizinische Forschung, Heinrich-Heine-University,
Düsseldorf, Germany
Psoriasis is a common auto-inflammatory skin disease of unknown etiology. However, skin infil-
trating plasmacytoid dendritic cells (pDC) are believed to initiate psoriasis through IFNα produc-
tion. Topical application of the Toll-like receptor (TLR) 7 ligand Imiquimod (IMQ) onto mouse skin
induces pathology closely resembling the human disease, which depends on production of IL-17/22
by innate lymphocytes. On the other hand, the role of different DC subsets, in particular, conven-
tional DC (cDC) versus pDC/IFNα to mediate the disease remains elusive. To this aim, we gener-
ated mice deficient for the TLR adaptor molecule MyD88, in which TLR signaling was exclusively
switched on in all CD11c+ DC including pDC (DC-MyD88ind). As expected, MyD88-deficient mice
were resistant whereas selective activation of MyD88 signaling in DC was sufficient to mediate full-
blown IMQ-induced skin inflammation. Unexpectedly, antibody-mediated depletion of pDC in DC-
MyD88ind mice did not alter the course or severity of psoriasiform skin inflammation. These results
were confirmed in pDC-depleted hBDCA-2 DTR and pDC-less DC-E2-2-/- mice. Moreover, unaf-
fected IMQ-psoriasis in IFNAR-/- mice revealed that the type-I-IFN pathway was dispensable for
the development of local skin inflammation. Analysis of in vivo cytokine production after IMQ paint-
ing onto the skin of wild type mice demonstrated that IL23p19 was exclusively produced by the
Langerin- dermal DC subset. In conclusion, TLR7-activated Langerin- cDC trigger IMQ-induced pso-
riasis via IL-23 and independently of pDC or IFNα. These findings may have important implications
for treatment of the human disease.
072
Langerhans cells suppress Th1-mediated autoimmunity against Desmoglein3
D Kitashima,1 DH Kaplan,2 M Amagai1 and K Nagao1 1 Dermatology, Keio University, Tokyo,
Japan and 2 Dermatology, University of Minnesota, Minneapolis, MN
Epidermal Langerhans cells induce Th2 and Th17 responses against microbial antigens in vivo. LC’s
role(s) in regulating responses to physiological self-antigens remains unexplored. We studied two
types of autoimmunity against Desmoglein3 (Dsg3) using murine models of an experimental autoim-
mune dermatitis (EAD) and pemphigus vulgaris (PV). EAD is a Th1 response in which Dsg3-reac-
tive CD4 T cells attack keratinocytes to cause apoptosis, a condition that recapitulates histological
patterns seen in inflammatory skin disorders, termed interface dermatitis. PV is a Dsg3-specific Th2
humoral autoimmunity that recapitulates human PV. We first studied K5-Dsg3-eGFP mice, and found
that a subset of LC in steady state was Dsg3-eGFP-positive ex vivo, and that WT LCs were capable
of proliferating Dsg3-specific CD4 T cells in vitro, demonstrating that LC acquired Dsg3 and pre-
sented it in the context of MHC II. Examining LC in EAD revealed that CD4 T cells associated with
LC in situ, and LC in the lymph nodes had upregulated the immunoregulatory molecules PD-L1
and PD-L2. Consistent with these data, EAD in Langerin-DTA mice that constitutively lack LC, was
markedly exacerbated with prominent interface dermatitis. This demonstrated that LC suppressed
Th1 autoimmunity against Dsg3 in vivo. To further confirm these findings, we evaluated PV in Lan-
gerin-DTA mice. Circulating anti-Dsg3 IgG as well as IgG deposition in epidermis was more preva-
lent in Langerin-DTA mice. Although the predominant autoantibody subclass is IgG1 in PV, Lan-
gerin-DTA PV mice also produced IgG2c, indicating exacerbated Th1 responses in the absence of
LC. Consistently, IFN-gamma producing CD4 T cells were increased in Langerin-DTA PV. In aggre-
gate, not only does our findings for the first time demonstrate antigen-specific tolerogenic activity
by LC against a functional epidermal antigen, it also reveals for the first time, a contribution of LCs
in PV. Elucidation of this relevant immune process provides mechanistic and therapeutic implica-
tion for PV, as well as other epidermal antigen-specific autoimmunity.
073
A novel skin-resident vitamin D3 inducible CD141+ human dendritic cell playing a critical
role in tissue homeostasis and immunoregulation
N Ali,1 C Chu,1 P Karagiannis,1 P Di Meglio,1 G Barinaga,1 K Grys,1 SN Karagiannis,1 M Peakman,3
G Lombardi2 and FO Nestle1 1 St. John’s Institute of Dermatology, King’s College London and
NIHR Biomedical Research Centre, London, United Kingdom, 2 MRC Centre for
Transplantation, King’s College London and NIHR Biomedical Research Centre, London,
United Kingdom and 3 Department of Immunology, King’s College London and NIHR
Biomedical Research Centre, London, United Kingdom
Immune-activating dendritic cells (DCs) in human tissues have been well characterized while little
is known about regulatory DCs. We have identified a major CD141+ dermal DC (DDC) population
that constitutes 1/3 of total CD45+ migratory cells. Ex vivo isolated CD141+ DDCs were analysed
for their cytokine production and generation of regulatory T-cells (Tregs). CD141+ DDCs sponta-
neously secreted high levels of IL-10 in culture and induced suppressive FOXP3+CD25hi Tregs
(CD141 Tregs). In human skin grafted immunodeficient mice, CD141+ DDCs possessed skin drain-
ing lymph node migratory capacity. To test their ability to suppress skin inflammation, CD141 Tregs
were co-transferred with PBMCs into human skin transplanted mice where they prevented the devel-
opment of skin pathology. We next asked whether phenotypic and functional characteristics of
CD141+ DDCs are inducible by skin-relevant factors. Blood DCs cultured with VItD3 acquired
CD141+ DDC phenotype and function, with high levels of IL-10 production and poor T-cell allostim-
ulatory capacity. The immunosuppressive capacity of VitD3 CD141+ blood DCs as CD141+ DDC
equivalent cells was investigated in a xenograft model of graft-versus-host disease (GvHD) and
melanoma tumour alloimmunity in immunodeficient mice engrafted with human PBMCs. Co-injec-
tion of VitD3 CD141+ DCs resulted in increased survival time from GvHD and promoted human
melanoma tumour growth in vivo. We then undertook bioinformatics analysis of CD141+ DDCs
and VitD3 CD141+ blood DCs to reveal common genetic signatures. These findings suggest that
CD141+ DDCs play an essential role in sunlight-induced vitamin D3-dependent maintenance of
skin homeostasis and in the regulation of systemic and tumour alloimmunity.
074 
Programed necrotic cell death caused by NLRP3 activation is dispensable for TLR stimulation
T Satoh, K Naotomo and H Matsue Chiba University, Chiba, Japan
Cryopyrin-associated periodic syndrome (CAPS) is known as an autoinflammatory disease associ-
ated with missense point mutations in NLRP3 and clinically characterized by urticarial rash. NLRP3
is a cytoplasmic protein classified into NLR (NOD-like receptor) family, which serves as pattern
recognition receptors and senses microbial molecules in the cytoplasm of cells. CAPS-associated
NLRP3 mutants spontaneously form inflammasome, resulting in excessive IL-1β secretion and also
cause programmed necrotic cell death or “pyronecrosis”. Both are believed to be involved in the
pathogenesis of CAPS. However, the mechanistic details of pyronecrosis are largely unknown. There-
fore, we sought to investigate this type of cell death at molecular levels. TLR4-mediated microbial
ligands (e.g., LPS) induce the expression of NLRP3, leading to pyronecrosis in patients with CAPS
but not in healthy controls. However, LPS signal induces an array of genes including pro-IL-1β.
Currently, we do not know the involvement of any other proteins induced by LPS in pyronecrosis
except for NLRP3. Therefore, to look at the effect of NLRP3 per se, we generated cell lines that
expressed only NLRP3 upon doxycycline treatment using Tet-On system. Using these cell lines, we
found that the expression of CAPS-associated NLRP3 mutants induced necrotic cell death. In con-
trast, the expression of wild type-NLRP3 by the system did not. We also found that silencing ASC
gene by shRNA prevented the cell death induced by NLRP3 mutants, indicating that ASC is indis-
pensable for this type of cell death. In addition, when the cell lines expressing NLRP3 mutants by
Tet-On system were treated with pan-caspase inhibitor Z-VAD-fmk, necrotic cell death was pre-
vented and speckle patterns of ASC oligomerization were observed. Thus, programmed necrotic cell
death is provoked by downstream signals of NLRP3 inflammasome-induced ASC oligomerization.
Taken together, we hypothesized that pyronecrosis is independent of inflammation evoked by elab-
oration of pro-inflammatory cytokines through inflammasome and may play an important role in
self-defense against microbial invasion.
075 
Recombinant IL-6 treatment protects mice from organ-specific autoimmune disease by induc-
tion of IL-1ra, mediated by classical IL-6 signaling
US Samavedam,1 K Kalies,2 J Scheller,3 Y Gupta,1 MF Jonkman,5 E Schmidt,1 J Westermann,2
D Zillikens,1 S Rose-John4 and R Ludwig1 1 Department of Dermatology, University of Lübeck,
Lübeck, Germany, 2 Institute of Anatomy, University of Lübeck, Lübeck, Germany, 3 Institute
of Biochemistry and Molecular Biology-II, Heinrich-Heine-University, Düsseldorf, Germany, 4
Institute of Biochemistry, Christian-Albrechts-University, Kiel, Germany and 5 Department of
Dermatology, University of Groningen, Groningen, Netherlands
Cytokines are key regulators of physiological inflammatory responses, while aberrant cytokine expres-
sion contributes to pathogenesis of autoimmune diseases. We noted increased IL-6 levels in human
and murine epidermolysis bullosa acquisita (EBA), a prototypic organ-specific autoimmune bul-
lous dermatosis (AIBD) induced by autoantibodies to type VII collagen (COL7). In contrast to rheuma-
toid arthritis, blockade of IL-6 led to strikingly enhanced experimental EBA, while treatment with
recombinant IL-6 was protective. This was due to classical IL-6 signaling and independent of IL-6
trans-signaling, as treatment of mice with sgp130Fc had no impact on EBA manifestation. Induc-
tion of EBA in mice led to increased IL-1ra levels in skin and serum, while blockade of IL-6 com-
pletely inhibited IL-1ra expression induced by antibodies to COL7. In line, treatment of mice with
EBA with recombinant IL-6 induced IL-1ra concentrations exceeding those of untreated animals
with EBA. We here identified a novel anti-inflammatory pathway in an organ-specific autoimmune
disease. Modulation of this IL-1ra pathway by classical IL-6 signaling demonstrates anti-inflamma-
tory and protective activities of IL-6 in vivo.
076 
Targeting of myelin oligodendrocyte glycoprotein to DEC-205+ dendritic cells in vivo sup-
presses allergic experimental encephalomyelitis (EAE) in mice
S Ring, M Maas, A Enk and K Mahnke Ruprecht Karls University, Heidelberg, Germany
The antigen receptor DEC-205 is expressed by dendritic cells (DC) and greatly increases antigen
presentation over pinocytosis or phagocytosis. After injection of antigens coupled to antibodies
specific for DEC-205 into mice, effective presentation of the antigens to T cell follows. When anti-
gen presentation occurs by non-activated “steady state” DC in vivo, we observed induction of reg-
ulatory T cells. Therefore, we created single chain fragment variables (scFv) specific for DEC-205
fused to the self antigen MOG, to target non-activated DC in vivo and to induce tolerance to EAE.
DEC-scFv:MOG fusions proteins, as well as isotype controls were expressed and purified from E.coli
and immunohistochemical staining of CD11c+ dendritic cells displayed a positive staining for
scFv, colocalizing with MHC class II. For functional testing DEC-scFv:MOG was injected into mice
and DC were analyzed 3 days later. We found that DC isolated from DEC-scFv:MOG injected mice
stimulated vigorous proliferation of MOG-specific 2D2 T cells, indicating presentation of the rele-
vant MOG peptide in vitro. Furthermore, DC isolated from those animals produced significantly
more TGF-β as well as IL-10, as compared to isotype-treated or untreated mice, respectively. And
when analyzing the T cell compartment we recorded elevated numbers of CD4+CD25+FoxP3+ Treg
(16% of CD4) in the spleen after injection of DEC-scFv:MOG as compared to controls (12% of CD4).
Most importantly, when EAE was induced in either DEC-scFv:MOG-injected mice or in isotype-
scFv:MOG treated controls, none of the DEC-scFv:MOG injected mice developed any EAE symp-
toms. In addition the therapeutic treatment of mice, which had developed already EAE symptoms,
with DEC-scFv:MOG lead to abrogation of the disease in >90% of the animals tested. In contrast,
all animals in the control groups developed a severe EAE in preventive as well as in therapeutical
protocols. Thus, these data indicate that targeting of MOG to steady state DC in vivo prevents EAE
by a DC/Treg-driven mechanism.
S14 Journal of Investigative Dermatology (2012), Volume 132
ESDR12_Abstracts-3  7/20/12  1:26 PM  Page S14
Auto-Immunity and Inflammation | ABSTRACTS
077 
Interleukin (IL)-26 is over expressed in psoriasis and regulates TLR9 activation to self-DNA
S Meller,1 S Durr2 and M Gilliet2 1 Heinrich-Heine-University, Duesseldorf, Germany and 2
Lausanne University Hospital CHUV, Lausanne, Switzerland
Interleukin-26 is a Th17-derived cytokine belonging, like IL-22, to the IL-10 family. It is expressed
in many autoimmune disorders including Crohn’s disease rheumatoid arthritis and multiple sclero-
sis. IL-26 binds to the IL-26 receptor expressed exclusively by epithelial cells. In the gut, IL-26
mediates STAT1 and STAT3 activation of intestinal epithelial cells, leading to the expression of IL-
10 and IL-8 and inhibition of proliferation. In the skin, by contrast, the effect of IL-26 is less clear
and does not appear to have a major effect on keratinocyte activation. Interestingly, we found that
IL-26 is highly overexpressed in psoriasis compared to other inflammatory skin diseases suggesting
a pathogenic role in this disease. Moreover, we found that IL-26 is a highly cationic protein with
amphiphatic structure. This unique structure endowed IL-26 with direct antimicrobial activity and
with the capacity to form complexes with extracellular host-derived DNA. IL26-DNA complexes
were readily internalized by plasmacytoid dendritic cells leading to DNA-mediated activation of
TLR9 and production of high levels of IFN-a. Accordingly, Th17 cells were found to trigger TLR9
activation of pDCs through their release of IL-26. Thus, we uncover an unexpected function of IL-
26 via the breaking of innate tolerance to extracellular nucleic acids leading to type I IFN-driven
inflammation. These findings may provide a new mechanism for the pro-inflammatory function of
Th17 cells and shed new light on the pathogenesis of psoriasis.
079 
The Aryl hydrocarbon receptor modulates psoriasis-like skin inflammation
P Di Meglio,1 JH Duarte,1 H Muller,1 K Hirota,1 FO Nestle,2 U Mrowietz3 and B Stockinger1 1
Molecular Immunology, MRC National Institute for Medical Research, London, United
Kingdom, 2 St. John’s Institute of Dermatology, King’s College London and NIHR Biomedical
Research Centre, London, United Kingdom and 3 Department of Dermatology, University
Medical Centre Schleswig-Holstein, Kiel, Germany
Psoriasis is a chronic inflammatory skin disease resulting from the interaction of genetic and envi-
ronmental factors. The pathogenic cross-talk between innate and adaptive cells, i.e. keratinocytes,
dendritic cells (DCs) and T cells, underpins a dysregulated immune response leading to the aber-
rant epidermal proliferation. The Aryl hydrocarbon receptor (AhR) is a ligand-activated transcrip-
tion factor recognizing polycyclic aromatic hydrocarbons, a family of structurally-related environ-
mental pollutants. Recently, AhR has been shown to amplify Th17 cell developmental program and
to induce IL-22. AhR is broadly expressed in the skin which, by being in constant contact with the
environment, is exposed to potential exogenous and endogenous AhR agonists. Here, we aim at
investigating AhR role in psoriasis by using AhR-deficient mice in the imiquimod-induced psori-
asiform inflammation model. Complete AhR deficiency resulted in a more severe psoriasiform phe-
notype, with increased acanthosis, neutrophils/macrophage infiltration and expression of pro-inflam-
matory mediators. Next, by using cell type-specific AhR-deficient mice, we found that lack of AhR
in DCs did not enhance skin inflammation over that seen in wildtype mice. However, the increased
inflammation was recapitulated in bone marrow chimeras lacking AhR in the non-hematopoietic
compartment. These results suggest that AhR has a critical role in dampening skin immune responses
and that lack of AhR in non-hematopoietic cells exacerbates dysregulated cross-talk between innate
and adaptive cells in psoriasis. In parallel we are dissecting the effect of AhR ligation in skin biop-
sies from psoriatic patients and healthy controls, to elucidate the transcriptional regulation under-
lying psoriasis, with the ultimate aim to provide new therapeutic targets for the development of
novel effective therapies.
081
Proof of identical desmoglein 3-specific B cell clones in a pemphigus vulgaris patient 4 years
after first presentation and therapy
CM Hammers,1 S Kacir,2 CY Lin,1 AS Payne,1 DL Siegel2 and JR Stanley1 1 Dermatology, Univ. of
Penn, Phila., PA and 2 Path. & Lab. Med., Univ. of Penn, Phila., PA
Anti-desmoglein 3 (Dsg3) antibodies cause pemphigus vulgaris (PV). To determine whether the same
anti-Dsg3 clones persist or there is an ongoing loss of B cell tolerance to Dsg3, we used phage dis-
play to analyze the anti-Dsg3 response from a PV patient at presentation and 4 years later at relapse
after remission induced by prednisone and mycophenolate. B cells and the antibodies (abs) they
produce are considered clonal (i.e. from the same parent) if variable heavy chains (HC) have the
same CDR3 sequence (i.e. have undergone identical VDJ gene rearrangements). We also sequenced
the entire HCs completely to determine if they were identical or differed by somatic mutations. We
found an oligoclonal anti-Dsg3 ab response, with 5 clones at presentation and 4 clones in relapse.
Strikingly, 3 of the 4 clones in relapse were of the same clonal origin (i.e. had the same HC-CDR3)
as clones found at presentation. More importantly, these 3 clones had members in which the entire
HC sequences matched those in the initial library in full, proving that identical ab HCs persisted
over 4 years. One of the three clones had additional members in which the HCs differed by somatic
mutations from those found in the initial library. Though original HC and light chain (LC) pairings
are not necessarily preserved using phage display, LC gene usage was highly conserved between
the repertoires of anti-Dsg3 abs analyzed at the 2 time points, although all 4 clones in relapse had
unique LC sequences in their phage clones (showing these were not contaminating phage between
libraries). These data indicate that at least some PV patients do not have an ongoing loss of B cell
tolerance to Dsg3 (with formation of new autoantibody-producing clones over time), but most likely
have had some event that has caused loss of tolerance of a few B cells whose clones persist over
years, which suggests why aggressive initial therapy (e.g. with rituximab) that can eliminate aber-
rant B cell clones is so effective in PV.
080 
The role of mitochondrial genome in autoimmunity to type VII collagen
H Azakli,1 S Mueller,1 M Hirose,1 X Yu,2 RJ Ludwig,1 D Zillikens1 and SM Ibrahim1 1 Department
of Dermatology, University of Luebeck, Luebeck, Germany and 2 Department of Biochemical
Immunology, Reseach Center Borstel, Luebeck, Germany
Mitochondrial dysfunction is thought to contribute to autoimmunity. The most plausible mechanism
is the increased production of reactive oxygen species (ROS) and its downstream effects. The mito-
chondrial proteins involved in ROS production are encoded by both the mitochondrial and nuclear
genomes. Due to the lack of appropriate mitochondrial-genome mutant mice, most studies ana-
lyzing the role of the mitochondria in autoimmunity focused on the nuclear-genome-encoded pro-
teins. To study the role of mitochondrial-genome encoded proteins in autoimmunity, a series of mito-
chondrial mutant mice (conplastic strains) have been recently generated by our group. These include
16 conplastic strains with mostly single and potentially functional mutations. We induced tissue
damage in the skin by transferring rabbit anti-murine type VII collagen IgG into a series of conplastic
mice and observed varied disease susceptibility in mice with different mtDNA mutation. Of note,
mice carrying mitochondrial DNA (mtDNA) from the FVB/NJ strain (C57BL6/J-mtFVB/NJ) showed
a significantly lower disease activity score compared with mice carrying mtDNA from reference
strains. This mtDNA from the FVB/NJ contains one point mutation (G-T at position 7778), which
results in an aspartic acid to tyrosine (D-Y) substitution in the fifth amino acid of the highly con-
served N-terminus of ATP synthase 8 (ATP8). The nt7778T allele is exclusively carried by the FVB/NJ
mouse strain. Interestingly, the ATP8 mutant mice had an unique phenotype such as significantly
higher levels of ATP/ADP ratio and higher ROS production in the spleen. We are currently investi-
gating the effect of ATP8 mutation on immune cells and skin cells (target tissue) to elucidate the
pathway leading to reduced susceptibility to autoimmunity to type VII collagen in these mice.
Here, for the first time, we present evidence that mtDNA mutations contribute to susceptibility to
autoimmune skin blistering disease in the mouse.
078 
Interleukin-10-producing regulatory B cells (B10 cells) ameliorate psoriasis in mice
K Yanaba,1 Y Asano,1 Y Tada,1 M Sugaya,1 T Kadono,1 TF Tedder2 and S Sato1 1 Dermatology,
Faculty of Medicine, University of Tokyo, Tokyo, Japan and 2 Immunology, Duke University
Medical Center, Durham, NC
Psoriasis is an inflammatory cutaneous disorder characterized by marked epidermal thickening with
T helper 1 and 17 cell infiltration. At present, the contribution of B cells to the pathogenesis of pso-
riasis is unclear. In mice, topical application of imiquimod induces inflamed skin lesions resem-
bling human psoriasis and serves as an experimental animal model for human psoriasis. In this study,
we have shown that imiquimod-induced skin inflammation was more severe in CD19-deficient mice
than in wild-type mice. These inflammatory responses were negatively regulated by a unique inter-
leukin-10-producing CD1dhiCD5+ regulatory B cell subset (B10 cells) that was absent in CD19-
deficient mice and represented only 1–2% of splenic B220+ cells in wild-type mice. Splenic B10
cells entered the circulation and migrated to draining lymph nodes during imiquimod-induced skin
inflammation, thereby suppressing interferon-γ and interleukin-17 production. Furthermore, adop-
tive transfer of these B10 cells from wild-type mice reduced inflammation in CD19-deficient mice.
The present findings provide direct evidence that B10 cells regulate imiquimod-induced skin inflam-
mation and offer insights into regulatory B cell-based therapies for the treatment of psoriasis.
082 
AZ17 – a bispecific drug targeting IL6 and IL23 – suppresses Th17 cell development and
improves psoriasis in a human xenograft transplantation model
K Stenderup,1 C Rosada,1 MP Van Brunt,2 P Slagle,2 W Brady,2 G King,2 K Shanebeck,2 NW Nairn,2
KH Grabstein2 and TN Dam3 1 Department of Dermatology, Aarhus University Hospital,
Aarhus, Denmark, 2 Allozyne Inc., Seattle, WA and 3 Department of Dermatology, Roskilde
Hospital, Roskilde, Denmark
AZ17 is a bispecific drug consisting of two single-chain Fragment variables (scFvs), linked by a poly-
ethylene glycol (PEG) moiety where one scFv binds to IL6 and the other to IL23. IL6 and IL23 have
been shown to play important roles in inflammatory diseases. In the clinic, targeting IL6 (tocilizumab)
is used to treat rheumatoid arthritis (RA) and targeting IL23 (ustekinumab) is used to treat psoriasis.
In psoriasis, IL6 and IL23 trigger differentiation of naïve CD4 T cells into Th17 cells that have been
found to play a critical role in psoriasis development. The aim of the present study was to test the
efficacy of treating psoriasis by targeting both IL6 and IL23 with the bispecific drug AZ17. In neu-
tralization assays AZ17 neutralized both IL6 and IL23 with the same potency as free scFvs. To test
the efficacy of AZ17 to block Th17 cell development in vitro, stimulated peripheral blood mononu-
clear cells (PBMCs) from 4 healthy donors were treated with AZ17. The percentage of IL-17+ cells
was determined by flow cytometry and significantly decreased upon AZ17 treatment. To test the
effect of AZ17 to treat psoriasis in vivo, we employed immune-deficient mice xenografted with
involved psoriatic skin from 10 psoriasis patients. Xenografted mice were treated i.p. every second
day for 14 days. AZ17 treatment significantly decreased the semi-quantitative clinical psoriasis score
and the epidermal thickness measured on HE stained biopsy sections from the treated grafts. In
conclusion, AZ17 was demonstrated to significantly suppress the development of Th17 cells, in vitro,
and to significantly treat xenografted psoriasis skin, in vivo. These data suggest a significant thera-
peutic potential of AZ17 for the treatment of psoriasis.
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The in vivo imaging of extracellular ATP reveals that ATP released from viable keratinocytes
initiates inflammation in skin barrier disruption
T Takahashi,1 Y Kimura,1 Y Nakajima,2 Y Ohmiya,2 K Yamasaki1 and S Aiba1 1 Dermatology,
Tohoku University Graduate School of Medicine, Sendai, Japan and 2 National Institute of
Advanced Industrial Science and Technology, Tsukuba, Japan
Extracellular ATP is an essential danger signal that activates inflammasome leading to IL-1β and IL-
18 secretion. Although ATP release is observed in various stress models in vitro, studies demon-
strating ATP release in vivo is very limited. To visualize extracellular ATP in vivo, we developed an
enhanced green-emitting luciferase immobilized on agarose beads (Eluc-agarose). The subcutaneous
injection of Eluc-agarose with ATP into the skin of BALB/c mice following intraperitoneal injection
of luciferin produced a detectable and quantitative bioluminescence under IVIS imaging system. To
examine if the barrier disruption causes ATP release in the skin, we repeated tape stripping of mice
skin in various times, and examined extracellular ATP by in vivo imaging. Compared with non-
treated skin, we detected bright bioluminescence localized at treated skin from 10 to 30 min after
tape stripping. This bioluminescence was suppressed by the local application of an adenosine diphos-
phatase apyrase. Interestingly, Eluc-agarose bioluminescence was observed in mice skin where
transepidermal water loss (TEWL) levels were between 100 to 140 g/m2h, however, it was abol-
ished by an excess of tape stripping (more than 160 g/m2h in TEWL). Histological examination
revealed that the skin with detectable extracellular ATP demonstrated the retained viable epidermis
and subepidermal neutrophil infiltration, which was also attenuated by apyrase. On the other
hand, the tape-stripped skin with lost ATP responses lacked viable epidermis and was not accom-
panied by neutrophil infiltration in the upper dermis. These results show that skin barrier disruption
by tape stripping releases ATP from viable epidermal keratinocytes, which facilitates the subepi-
dermal migration of inflammatory cells in the skin. In addition, it is also demonstrated that Eluc-
agarose can be a useful tool to detect extracellular ATP in various murine models of skin disorders
in vivo.
084 
T helper -17 and T regulatory cells in the complexity of vitiligo?. A case- controlled study on
eighty-four non-segmental vitiligo patients
M Abo ElEla,1 HM Rasheed,1 RA Hegazy,1 MM Fawzy1 and L Rashed2 1 Dermatology, KasrAlAini
Hospital, Cairo University, Cairo University, Egypt and 2 Biochemistry, KasrAlAini Hospital,
Cairo University, Cairo University, Egypt
Skewing of responses towards T helper (Th) 17 and away from T regulatory cells (Tregs) has been
suggested to be partially involved in autoimmune diseases as vitiligo. Thereby our aim was to clar-
ify the possible role and relation between Th17 cells and Tregs in vitiligo by measuring tissue and
serum levels of interleukin (IL)-17, IL-22 and Forkhead box P3 (FoxP3). 84 nonsegmental vitiligo
patients and 80 controls were included following proper inclusion criteria. Vitiligo Area Scoring
Index (VASI), Vitiligo Disease Activity (VIDA) and stress score were determined. 5 mm skin biopsies
underwent Immunohistochemical staining for IL-17, IL-22 and FoxP3. 5ml venous blood samples
were collected to determine serum levels of IL-17 and IL-22 as well as FoxP3-mRNA gene expres-
sion in whole blood by quantitative real time PCR. Mean area % of +ve immunostaining and serum
levels of IL-17 (34.12 ± 5.12, 23.62 ± 8.17 pg/ml) and IL-22 (48.63 ± 19.23, 43.53 ± 11.95 pg/ml)
were significantly higher in patients compared to controls (15.33 ± 4.19, 12.83 ± 3.29 pg/ml) (13.44±
3.82, 9.92 ± 4.7 pg/ml) (P<0.001). Mean area % of +ve immunostaining and serum levels of FoxP3
were significantly lower in patients (2.67± 0.54, 0.574 ± 0.32) compared to controls (7.12 ± 0.18,
1.48 ± 0.49) (P<0.001). In patients, positive correlation between IL-17 and IL-22 was detected (r
=0.671, P<0.001), each showing negative correlation with FoxP3 (r=-0.548, P<0.001),(r=-382,
P<0.001). VASI, VIDA and stress score correlated positively with IL-17 and IL-22 and negatively with
FoxP3. Multivariate logistic regression analysis showed FoxP3 to be significant predictor for vitiligo
(OR = 0.06, P= 0.004). In conclusion, this study demonstrated that Th17 cells and Tregs are inter-
twined in the complexity of vitiligo with hope existing in its treatment through adjuvant therapies
aiming at controlling the delicate balance between them.
085
microRNA-150 down-regulation contributes to the constitutive type I collagen overexpres-
sion in scleroderma dermal fibroblasts via the induction of integrin β3
N Honda,1 M Jinnin,1 K Makino,1 T Makino,1 S Fukushima,1 Y Inoue,1 Y Okamoto,2 M Hasegawa,2
M Fujimoto2 and H Ihn1 1 Department of Dermatology and Plastic Surgery, Faculty of Life
Sciences, Kumamoto University, Kumamoto, Japan and 2 Department of Dermatology and
Plastic Surgery, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
Overexpression of integrins in dermal fibroblasts is thought to play a key role in the pathogenesis
of systemic sclerosis. However, its mechanism is still unknown. We tried to evaluate the possibility
that microRNAs (miRNAs) are involved in the regulation of integrin β3 in these cells. miRNA expres-
sion profile was evaluated by miRNA PCR array and real-time PCR. The protein expression of inte-
grin β3 was determined by immunoblotting. In vivo detection of miRNA in paraffin section was
performed by in situ hybridization. miR-150 expression was decreased in SSc fibroblasts both in
vivo and in vitro. The transfection of miR-150 inhibitor into normal fibroblasts leads to the overex-
pression of integrin β3, whereas forced overexpression of the miRNA resulted in the down-regula-
tion of integrin β3 in SSc fibroblasts. Treatment of SSc fibroblasts with 5-AdC revealed miR-150
down-regulation in these cells is caused by DNA methylation. In addition, we found miR-150 was
detectable and quantitative in the serum. Serum miR-150 levels were also decreased in SSc patients.
Furthermore, SSc patients with lower serum miR-150 levels tended to have severer clinical mani-
festation. miR-150 may play an important role in the pathogenesis of SSc via the integrin β3 over-
expression. Investigation of the regulatory mechanisms of tissue fibrosis by miR-150 may lead to
develop new diagnosis tools and new treatments using miRNA.
086
MiR-31, a microRNA up-regulated in psoriasis, modulates chemokine production in ker-
atinocytes via targeting serine/threonine kinase 40
N Xu, F Meisgen, M Ståhle, A Pivarcsi and E Sonkoly Unit of Dermatology, Department of
Medicine, Karolinska Institute, Stockholm, Sweden
MicroRNAs (miRNA) are ~22 nucleotides single-stranded noncoding RNAs, which play important
roles in gene regulation. We previously identified a specific miRNA expression profile in psoriasis,
distinct from that of healthy skin. One of the miRNAs upregulated in psoriasis skin was miRNA-31
(miR-31). By in situ hybridization we showed that the major cell type responsible for increased miR-
31 levels in psoriasis lesions was keratinocytes. We found that TGF-beta1, a cytokine highly expressed
in the epidermis and serum of psoriatic patients, up-regulated miR-31 expression in keratinocytes
both in vitro and in vivo. To explore the role of miR-31 on cellular functions, we transfected miR-
31 inhibitor oligonucleotides into primary human keratinocytes. Interestingly, inhibition of endoge-
nous miR-31 decreased keratinocyte proliferation rate and suppressed the production of several
chemokines playing key roles in psoriasis, such as CXCL1, CXCL5 and CXCL8. Furthermore, we
identified genes regulated by miR-31 in keratinocytes by microarray expression profiling. Among
these genes, we identified serine/threonine kinase 40 (STK40), a modulator of NF-kappaB signalling,
as a direct target for miR-31 by luciferase reporter assays. Inhibition of STK40 by siRNA rescued the
suppressive effect of miR-31 inhibitors on chemokine expression indicating that miR-31 regulates
chemokine expression by targeting STK40 in keratinocytes. Taken together, our results demonstrate
a role for miR-31 in regulating keratinocyte proliferation and chemokine expression. MiR-31 may
become a novel target for psoriasis therapeutic intervention.
087
Loss of epidermal phospholipase C δ1 results in IL-23/IL-17 axis activation and granulocyto-
sis
K Kanemaru, Y Nakamura and K Fukami Laboratory of Genome and Biosignals, School of Life
Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan
Phospholipase C (PLC) is a key enzyme in phosphoinositide turnover. We found that mice lacking
a PLC isozyme, PLCδ1, spontaneously developed granulocytosis. Hematopoietic loss of PLCδ1 did
not cause granulocytosis, indicating that the granulocytosis in the PLCδ1-knockout mice was not
hematopoietic cell-intrinsic. Instead, the granulopoietic cytokines interleukin (IL)-17 and granulo-
cyte colony-stimulating factor were increased in serum of PLCδ1-knockout mice. Surprisingly, we
were able to reconstitute granulocytosis and IL-17 upregulation simply by ablating PLCδ1 in epi-
dermal keratinocytes. The reintroduction of PLCδ1 into the keratinocytes of PLCδ1-deficient mice
reversed these phenotypes, indicating that PLCδ1 in keratinocytes is both required and sufficient
for the maintenance of normal granulocyte counts and IL-17 levels. Interestingly, IL-17 and its key
upstream regulator IL-23 were upregulated in epidermis of keratinocyte-specific PLCδ1-knockout
mice. In addition, loss of PLCδ1 in the keratinocytes exacerbates hapten-induced contact hyper-
sensitivity responses, mouse model for human allergic contact dermatitis in an IL-17-dependent
manner. Furthermore, loss of PLCδ1 from keratinocytes caused features of IL-17-associated inflam-
matory skin diseases. Indeed, PLCδ1 protein was downregulated in a mouse model of psoriasis.
These results demonstrate that phosphoinositide turnover in keratinocytes regulates not only local
inflammatory responses, but also serum cytokine levels and systemic leukocyte counts and affects
homeostasis of distant haematopoietic organs.
088
Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation
A Johnston,1 SM Dawes,2 PM Al-Attar,1 Y Fritz,2 CS Chen,1 W Fu,2 JE Gudjonsson,2 TS McCormick1
and NL Ward1 1 U of Michigan, Ann Arbor, MI and 2 Case Western Reserve U, Cleveland, OH
IL-17C is a functionally distinct IL-17 family member that binds IL-17RE/A to promote innate defense
in epithelial cells and regulates Th17 cell differentiation. Here, we show that IL-17C (not IL-17A) is
the most abundant IL-17 cytokine in lesional psoriasis skin (1058pg/ml vs 8pg/ml; P<0.001) and
localizes to keratinocytes (KCs), endothelial cells (ECs) and leukocytes. Prior work demonstrated IL-
17A/TNFα synergy induces >300 psoriasis-signature genes, including a ~50-fold increase in IL-17C.
ECs stimulated with IL-17C produce a ~3.7-fold increase in TNFα (P=0.028) and KCs stimulated
with IL-17C and TNFα produce similar inflammatory gene response patterns as those elicited by IL-
17A/TNFα, including increases in IL-17C, TNFα, IL-6, IL-8, IL-19, IL-1α/β, IL-1F5/F9, CCL20,
S100A7/A8/A9, DEFB4, LCN2 and PI3 (P<0.05). Psoriasis patients treated with etanercept rapidly
decrease cutaneous IL-17C levels (by 72hrs) prior to skin improvement and decreases in serum IL-
17A and IL-22 (P=0.02). Taken together, these results suggest IL-17C may amplify Th17/Th22/TNFα-
mediated inflammatory signaling critical for psoriasis pathogenesis. To examine IL-17C contribu-
tions to psoriasiform inflammation, we genetically engineered mice to overexpress IL-17C in KCs.
Mice develop areas of erythematous, flakey “involved” skin adjacent to areas of normal appearing
“uninvolved” skin, despite increased IL-17C expression in both areas (~60-fold; P=0.0003). Unin-
volved skin displays increased angiogenesis, modest leukocyte infiltration and elevated DEFB3 and
S100A8/A9 expression (P<0.05) but no epidermal hyperplasia; whereas involved skin exhibits robust
epidermal hyperplasia, leukocyte infiltration and upregulated IL-17A, IL-1α, IL-23p19, IFNα/γ, TNFα
and CCL20 (P<0.05) compared to uninvolved skin, suggesting that IL-17C, when coupled with other
pro-inflammatory signals, initiates the development of psoriasiform dermatitis. These findings iden-
tify a pro-inflammatory and pathogenic role for the elevated IL-17C observed in lesional psoriasis
skin.
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Dsg3 specific IgG directed against C-terminal epitopes in pemphigus vulgaris induces loss of
keratinocyte adhesion in vitro
D Rafei, M Llamazares, M Hertl and R Eming Dermatology and Allergology, Philipps-
Universität, Marburg, Germany
Desmosomal cadherins are targeted by IgG autoantibodies (auto-ab) in pemphigus. Several in vitro
and in vivo studies support the concept that desmoglein 3 (Dsg3)- and Dsg1-specific IgG auto-ab
are necessary for blister formation. Previous findings strongly suggest that the major pathogenic
epitopes are located within the amino-terminal domain of Dsg3, in particular the extracellular
domain 1 (EC1). However, many pemphigus vulgaris (PV) patients exhibit auto-ab directed against
the C-terminal extracellular epitopes, EC4 or EC5. Thus, the purpose of our study was to purify EC4
reactive auto-ab and determine their pathogenic relevance in vitro. 6xHis-tagged recombinant pro-
teins covering the entire Dsg3 extracellular domain (rDsg3), the EC1 and EC4 ectodomain of Dsg3,
respectively, were produced in a baculovirus system. Four PV patients with mucocutaneous ero-
sions, as well as high IgG-titers against rDsg3, EC1 and/or EC4 recombinant proteins as visualized
by immunoblot and ELISA, were selected for this study. CNBR-sepharose affinity columns were
loaded with the NiNTA purified rDsg3, EC1 or EC4 proteins and incubated overnight with the patients’
sera. Antigen specific reactivity of the isolated auto-ab was analyzed by western blot and ELISA
using the recombinant Dsg3 proteins. In addition, the affinity-purified auto-ab bound native Dsg3
as shown by indirect immunofluorescence on cultured primary human keratinocytes. Finally, we
could demonstrate that both EC1- and EC4-reactive IgG disrupted the adhesion of cultured human
keratinocytes in a dispase-based dissociation assay. Our findings indicate that, besides anti-Dsg3-
EC1 specific IgG, also auto-ab against C-terminal epitopes of the Dsg3-ectodomain are capable of
interrupting adhesion of epidermal keratinocytes in vitro, and thus might contribute to blister for-
mation in PV patients. Whether these effects result from direct interference with Dsg3 binding or
activation of intracellular pathways remains to be elucidated in future studies.
091
Denervation impairs clinical development of imiquimod-induced psoriasiform skin inflam-
mation in mice
EM Baerveldt,1 AJ Onderdijk,1 C Wohn,2 M Kant,1 EF Florencia,1 IJ Hekking-Weijma,3
ET Walbeehm,3 WR Swindell,4 JE Gudjonsson4 and EP Prens1 1 Dermatology, Erasmus MC,
Rotterdam, Netherlands, 2 Immunology, Erasmus MC, Rotterdam, Netherlands, 3 Plastic
Surgery, Erasmus MC, Rotterdam, Netherlands and 4 Dermatology, University of Michigan
Medical School, Ann Arbor, MI
Participation of peripheral nerves in the initiation and maintenance of psoriatic plaques is supported
by increased nerve fibre numbers and elevated expression of neuropeptides. Furthermore reports
of clinical cases link nerve injury to disease improvement. The presence of calcitonin gene related
peptide (CGRP) and substance P (SP) proved critical in the maintenance of chronic psoriasiform der-
matitis in mice. However, the role of nerves in the initiation of psoriasis remains unclear. We there-
fore investigated the effects of denervation in imiquimod (IMQ)-induced psoriasiform skin inflam-
mation in mice. C57/BL6 mice underwent sham surgery, or denervation of cutaneous nerves of
unilateral back skin. Epidermal denervation was confirmed post surgery by the absence of in situ
protein gene product 9.5 expression, and denervation resulted in a significant increase in CGRP
and TAC-1 mRNA (SP-precursor). In denervated skin, daily IMQ painting for up to 10 days did not
induce the psoriasiform phenotype, which was mimicked in great part by sham surgery. Both inter-
ventions prevented IMQ-induced weight loss and development of acanthosis. After 7 days, TAC-1,
CGRP, IL-1β, IL-22 and IL-23p19 mRNA levels increased in denervated skin, but without visible
skin pathology. There were no clear differences in the number of CD4+ T cells and macrophages,
however, the number of FOXp3+ T cells increased significantly in denervated skin. Microarray analy-
sis showed that both interventions profoundly affect the leukocyte infiltration signature of the IMQ
phenotype. Our data indicate that innervation is critical in the initiation of clinical psoriasis, most
likely via interruption of leukocyte infiltration and by intervening in subsequent psoriasis-inducing
mechanisms.
093
Interleukin-1 mediates autoantibody-induced tissue injury through modulation of endothe-
lial adhesion molecules
H Sadeghi,1 K Kalies,3 A Lockmann,2 A Hund,2 A Recke,1 U Samavedam,1 M Schön,2 D Zillikens,1
E Schmidt1 and R Ludwig1 1 Dermatology, University of Lübeck, Lübeck, Germany, 2
Dermatology, Venereology and Allergology, Georg August, Göttingen, Germany and 3
Anatomy, University of Lübeck, Lübeck, Germany
Notwithstanding numerous reports documenting aberrant cytokine expression in autoimmune bul-
lous dermatoses (AIBD), cytokine-targeting therapies are not established in these disorders. AIBD
are characterized by autoantibodies against cutaneous structural proteins, mucocutaneous tissue
injury as well as considerable morbidity and increased mortality. Interleukin (IL)-1 is one major
cytokine implicated in the pathogenesis of many inflammatory diseases, and IL-1 expression is
increased in AIBD. Therefore, we analyzed the contribution of IL-1 to pathogenesis of autoantibody-
induced tissue injury in experimental epidermolysis bullosa acquisita (EBA), an AIBD targeting type
VII collagen (COL7). When EBA was induced in mice by repetitive injections of anti-COL7 IgG,
serum levels of both IL-1α and IL-1β serum concentrations were elevated and correlated with dis-
ease extent. Genetic (IL-1 receptor (IL-1R) deficiency) or pharmacological (anakinra) inhibition of
IL-1 function impaired experimental EBA induction. This was accompanied by a reduced cuta-
neous infiltration with Gr1-positive leukocytes in IL-1R deficient or anakinra-treated mice. These
findings suggested that IL-1 contributed to recruitment of inflammatory cells into the skin in EBA.
In addition, we observed a decreased expression of ICAM-1 in IL-1R-deficient and anakinra-treated
mice after the induction of EBA. This effect appeared to be specifically attributable to IL-1, since
anakinra blocked up-regulation of several endothelial adhesion molecules on IL-1-, but not on TNFα-
stimulated, cultured endothelial cells. Thus, IL-1-modulated endothelial adhesion molecule expres-
sion presumably contributes to the pathogenesis of experimental EBA, rendering IL-1 functions a
potential therapeutic target for diseases with autoantibody-induced tissue injury.
092
CD4+ T cells control loss of self-tolerance in experimental epidermolysis bullosa acquisita
H Iwata,1 K Bieber,1 S Leinweber,2 B Tiburzy,3 A Shimizu,4 A Ishiko,4 E Schmidt,1 R Manz,3
D Zillikens1 and K Seeger2 1 Dermatology, University of Luebeck, Luebeck, Germany, 2
Chemistry, University of Luebeck, Luebeck, Germany, 3 Institute for Systemic Inflammation
Research, University of Luebeck, Luebeck, Germany and 4 Dermatology, Toho University,
Ohta-ku, Japan
Autoimmunity is characterized by loss of self-tolerance and subsequently an immune response
against self antigens. The exact mechanism of induction and maintenance of autoimmunity is still
not completely understood. Epidermolysis bullosa acquisita (EBA) is a prototypical, organ-specific
autoimmune disease and is characterized by subepidermal blisters associated with antibodies to
type VII collagen (COL7). Epitopes recognized by the majority of EBA sera were mapped to the
non-collagenous 1 domain of COL7, including the von Willebrand Factor A2 (vWFA2) sub-domain.
Here, we established a disease model of EBA by immunization of mice with 60 μg of recombinant
murine vWFA2 emulsified in adjuvant. SJL/J and B6.SJL-H2s mice, but not B6 and BALB/c mice,
developed skin lesions on ears within 4-6 weeks after immunization. Subsequently, lesions spread
to tails, snout and limbs. Most commonly, erosions, crusts and alopecia were observed. The aver-
age disease severity of SJL/J mice increased until 8 weeks and 12 weeks after immunization in male
and female mice, respectively. This single immunization induced a disease for more than 36 weeks.
Histologically, lesional skin showed split formation in the upper dermis accompanied by neu-
trophil infiltrates; by electron microscopy, the split was located beneath the lamina densa. To address,
which cells are required for the induction of autoimmunity in this model, alternatively, B cells as
well as CD4+ and CD8+ T cells were depleted between 0 to 2 weeks after immunization. While
no effect on disease manifestation was observed in mice with previous either B cell- or CD8+ T cell
depletion, EBA onset was significantly delayed after temporal CD4+ T cell depletion. These results
suggest that loss of tolerance in immunization-induced EBA is strongly dependent on the MHC H2s
haplotype and mainly controlled by CD4+ T cells, but not by B or CD8+ T cells.
090
Anti-inflammatory activity of IKKa in psoriasis explored by ChIP-sequencing
E Botti, G Spallone, M Talamonti, B Marinari, V Pinetti, F Moretti, S Chimenti and A Costanzo
Dermatology, University of Rome Tor Vergata, Rome, Italy
Epidermal hyperproliferation and inflammation are key features of psoriatic skin. Inflammatory
cytokines such as TNFa and INFg are important factors contributing to the maintenance of psoriatic
plaque phenotype and TNFa is target of effective biologic therapies. Psoriatic keratinocytes are hyper-
sensitive to inflammatory stimuli, overproducing inflammatory cytokines and chemokines. IKKa is
a component of the IkappaB kinase complex, which is activated by several inflammatory stimuli,
including TNFa, and leads to the nuclear translocation of NFkappaB transcription factors. In addi-
tion, IKKa possess kinase-independent functions, being necessary for the definite exit of keratinocytes
from the cell cycle and for the termination of NFkappaB-dependent transcription of inflammatory
genes. Both of these new functions are dependent on the nuclear fraction of IKKa. We have hypoth-
esized that IKKa may be defective in psoriatic skin, favouring hyperproliferation and keratinocytes
hypersensitivity to inflammation. Therefore, in this study we have examined IKKa expression in nor-
mal and psoriatic skin observing a strong downregulation in psoriatic plaques that correlated with
increased NFkappaB activation. To determine the molecular mechanisms responsible for nuclear
IKKa anti-inflammatory activity, we performed ChIP-seq experiments on primary keratinocytes iden-
tifying several inflammatory genes involved in psoriasis pathogenesis (e.g. IL23R, IL20RB, IL6R)
directly bound to and repressed by IKKa. To confirm the anti-inflammatory activity of IKKa in pso-
riasis, we downregulated its expression by siRNA and observed increased IL-6 production by IKKa-
depleted keratinocytes in response to TNFa. Treatment of patients with the TNFa blocking agent etan-
ercept induced re-expression of IKKa in keratinocyte nuclei that correlated with decreased proliferation
and NFkappaB activation. These data suggest that IKKa molecule may contribute to keratinocyte
sensitivity to inflammatory stimuli in psoriasis.
094
Synthetically-modified small interfering RNA targeting p40 protects from autoimmune dis-
ease in vivo
J Brück,1 J Geisel,1 I Glocova,1 K Fuchs,2 K Dengler,1 B Pichler,2 A Yazdi,1 M Röcken1 and
K Ghoreschi1 1 Department of Dermatology, University of Tuebingen, Tuebingen, Germany
and 2 Department of Preclinical Imaging, University of Tuebingen, Tuebingen, Germany
Experimental autoimmune encephalomyelitis (EAE) is a prototypic model of an organ-specific autoim-
mune disease mediated by T helper cells expressing interferon (IFN)-γ (Th1 cells) and interleukin
(IL-)17 (Th17 cells). The dendritic cell (DC) cytokines promoting these subsets, IL-12 and IL-23, are
critically implicated in EAE pathogenesis. Importantly, IL-12 and IL-23 are both heterodimers shar-
ing the p40 subunit. p40-deficient or anti-p40-treated mice do not develop severe encephalomyelitis
after immunization. Here, we describe a synthetically-modified small interfering RNA (sm-siRNA)
directed against p40 improving experimental autoimmunity. Treating mice with p40 sm-siRNA sup-
pressed TLR-activated IL-12 and IL-23 production in vivo. Since the uptake of siRNA by DC is crit-
ical we analyzed the uptake of the sm-siRNA by DC in vitro and in vivo. Therefore we used fluo-
rescence labeled as well as phosphor-33 (P-33) labeled sm-siRNA and non-modified siRNA as
control. By flow cytometry and fluorescence microscopy we could show significant uptake of sm-
siRNA by DC without using transfection reagents. In contrast, only a low percentage of DC incor-
porated non-modified siRNA. The in vivo uptake was studied by using P-33 labeled siRNA. As in
vitro also in vivo sm-siRNA was detectable in CD11c-positive DC, while non-modified siRNA was
almost undetectable in DC. In addition we quantified the biodistribution of sm-siRNA and non-
modified siRNA. The highest uptake of sm-siRNA was observed in spleen and lymphnodes. To inves-
tigate the immunmodulatory effect in vivo, we treated mice with p40 sm-siRNA or control siRNA
and immunized the mice for EAE. The p40 sm-siRNA protected mice from severe encephalomyelitis.
Furthermore, the p40 sm-siRNA strongly reduced IL-17 and IFN-γ production by T cells in the periph-
ery and within the CNS in vivo. Thus, sm-siRNA provides a novel approach to directly silence p40
in DC as well as Th17-mediated autoimmune pathology in vivo.
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IL-17 induces RIP4 molecule via Egr-1 activation in human keratinocyte
H Bae, Y Jang, Y Park, W Ryu and S Son Korea University College of Medicine, Laboratory of
Cell Signaling and Nanomedicine, Department of Dermatology, seoul, Republic of Korea
RIP family is a serine/threonine kinase and plays a critical role in cell proliferation, differentiation,
cell survival and apoptosis. Especially, RIP4 was identified a important regulator in development of
the epidermis and cutaneous inflammation. But, studies for regulatory mechanism of IL-17 induced
RIP4 molecule have not been characterized. In this study, we investigate the expression and regu-
latory mechanism of IL-17 induced RIP4 molecule via Egr-1 activation in human keratinocytes. After
treatment of IL-17, expression of Egr-1 and RIP4 mRNA and protein was increased in a time-depend-
ent manner. And transcriptional activity of Egr-1 and RIP4 promoter is increased by IL-17. Also, IL-
17 positively induce expression of Egr-1 via ERK pathway, but not p38/JNK pathways. By analysis
of RIP4 promoter, RIP4 promoter have three Egr-1 binding site. RIP4 promoter luciferase activity was
increased by IL17 treatment. Also, Co-treatment of Egr-1 siRNA and IL-17 resulting in the abolish-
ment of IL-17 induced RIP4 activation. For screening of genes regulated by RIP4, we performed
microarray analysis using RIP4 siRNA and RIP4 over-expression vector. In microarray analysis, total
448 genes regulated by RIP4 are identified. Among them, genes related inflammation and immune
response were significantly changed. To confirm expression of RIP4 specific target molecules expres-
sion selected by microarray analysis, real time PCR is performed. Expression of immune response
related genes were significantly changed by RIP4 molecule. These findings from the present study
indicate that IL-17 induces RIP4 expression via activation of Egr-1 and may contribute to IL-17
induced inflammation in human keratinocytes.
096
Osteopontin and Adiponectin: Are those two players related in the complexity of psoriasis?
DM Kadry,1 RA Hegazy1 and L Rashed2 1 Dermatology, KasrAlAini Hospital, Cairo University,
Cairo, Egypt and 2 Biochemistry, KasrAlAini Hospital, Cairo University, Cairo, Egypt
Increasing attention has been drawn towards the involvement of both osteopontin (OPN) and
adiponectin in psoriasis. The relationship between them has been studied before in the context of
essential hypertension. To our knowledge whether a relation between them exists in cases of pso-
riasis and the metabolic status in such patients has not been investigated. We aimed to verify their
possible roles and relations in psoriasis and its metabolic associations. 35 psoriatic patients and 35
age, gender and body mass index (BMI) matched healthy controls were included. Patients were clin-
ically assessed by Psoriasis Area and Severity Index (PASI) and all participants were investigated for
the presence of metabolic syndrome (MetS) and/or its components. Plasma levels of OPN and
adiponectin were measured using enzyme linked immunosorbent assay. On comparing psoriatics
to controls; patients showed significantly elevated levels of OPN (90.474 + 21.22 ng/mL vs 34.709
+ 13.95 ng/mL) and significantly depressed levels of adiponectin (4,586 + 1.187 ng/mL vs 5,905 +
1.374 ng/mL), (p <0.001). A strong negative correlation between plasma OPN and adiponectin was
detected in patients (r= -0.912, p <0.001), but not in controls. In patients, plasma OPN positively
correlated with PASI (r=0.920, p <0.001), DM (r=0.382, p =0.024), IR (r=0.354, p =0.037) and MetS
(r= 0.533, p=0.003). Whereas adiponectin negatively correlated with disease duration (r= -0.397,
p =0.018), PASI (r= -0.907, p <0.001), BMI (r= -0.271, p=0.04) and MetS (r= -0.589, p=0.001). This
study demonstrates for the first time a significant correlation between OPN and adiponectin in pso-
riasis, hypothesized to be mostly attributed to the inflammatory milieu of psoriasis and MetS as
well as the enhanced renin-angiotensin-aldosterone system previously documented in psoriasis.
Adjuvant therapies aiming at modulating levels of OPN and adiponectin are speculated to add
benefit in psoriasis treatment and protecting against its metabolic risks.
097
Mast cell-deficient KitW-Sh/W-Sh mice as a model for polymorphic light eruption
N Schweintzger,1 A Gruber-Wackernagel,1 E Reginato,1 G Mayer,1 I Bambach,1 A Limon Flores,3
S Ullrich,2 S Byrne4 and P Wolf1 1 Research Unit for Photodermatology, Department of
Dermatology, Medical University of Graz, Graz, Austria, 2 Department of Immunology, UT
MD Anderson Cancer Center, Houston, TX, 3 Escuela Nacional de Ciencias Biológicas-IPN,
Mexico City, Mexico and 4 Cellular Photoimmunology Group, Infectious Diseases and
Immunology, Sydney Medical School, The University of Sydney, Sydney, NSW, Australia
Evidence indicates that polymorphic light eruption (PLE) patients are resistant to the immune sup-
pressive effects of sunlight, including an impaired migration of Langerhans cells out of the skin and
a reduced infiltration of neutrophils and macrophages into the skin upon UV exposure. The exact
mechanisms by which UV leads to the foresaid immunological disturbances in PLE remain to be
determined. To elucidate potential involvement of mast cells and mechanisms we used a mast cell-
deficient mouse model (KitW-Sh/W-Sh). Mast cell-deficient mice and their wild-type controls were
subjected to different single dosages of UVB and a chronic UVB regime over 4 weeks, mimicking
photohardening therapy as administered to PLE patients. The results of our work indicated that KitW-
Sh mice displayed a reduced tolerance to UVB radiation compared to wild-type littermates, as deter-
mined by hyperplasia, inflammation and cellular infiltration of the skin. Moreover, immediately after
UVB irradiation mast cell-deficient mice exhibited an excessive scratching behaviour (with up to
78 bouts per 30 min) that was entirely absent in wild-type mice. The minimal scratching dose of
KitW-Sh mice was below their inflammatory threshold dose, as determined by UVB dose response
studies. Although photohardening did not affect the abnormal UV tolerance and scratching behav-
iour of the mice, the phenotype was dependent on a deficiency in mast cells because engraftment
of wild type mast cells into KitW-Sh mice rescued them. Taken together these results suggest that i)
the KitW-Sh mouse model is useful to study the pathogenic mechanisms of photodermatoses (such
as PLE) and ii) mast cells may be required for disease desensitization through photohardening.
098
Involvement of TNF-α converting enzyme in the development of psoriasis-like lesions in
K5.Stat3C transgenic mice
K Sato,1 M Takaishi,1 S Tokuoka2 and S Sano1 1 Dermatology, Kochi Medical School, Kochi
University, Kochi, Japan and 2 Kaken Pharmaceutical Co., Ltd., Kyoto, Japan
K5.Stat3C transgenic mice develop psoriasis-like skin lesions spontaneously or following wound-
ing or topical treatment with the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA). These
skin lesions closely resemble psoriasis and well fit the criteria for animal model of psoriasis regard-
ing clinical, histological, immunophenotypic and biological criteria. Therefore, K5.Stat3C trans-
genic mice provide a platform for screening of potential therapeutic targets for the treatment of pso-
riasis. A proinflammatory cytokine TNF-α is involved in the pathogenesis of psoriasis. TNF-α is
produced as a membrane-bound form and processed by TNF-α converting enzyme (TACE) to become
a soluble form. In addition, TACE also processes membrane-bound EGFR ligands such as heparin-
binding EGF (HB-EGF), amphiregulin and TGF-α, all of which contribute to development of psori-
asis. To address the potential contribution of TACE to psoriasis, we investigated gene and protein
expression of TACE-related factors and the effects of TNF-α and EGFR inhibitors on the develop-
ment of TPA-induced skin lesions in K5.Stat3C transgenic mice. Expression of TNF-α, HB-EGF,
amphiregulin and TGF-α were up-regulated in the psoriasis-like skin lesions of K5.Stat3C mice.
However, the lesions showed a down-regulation of tissue inhibitor of metalloproteinase-3 (TIMP-
3), an inhibitor of TACE, and an increase in soluble form of TNF-α. These results implied the increase
of TACE enzymatic activity and resulting TACE substrates in the development of the pathology of
this mouse model. Furthermore, treatment of K5.Stat3C mice with TNF-α and EGFR inhibitors atten-
uated the skin lesions. Since human psoriatic lesions showed increased levels of TNF-α and EGFR
ligands, these results suggest that TACE may be involved in the development of psoriasis. Therefore,
TACE may be a novel therapeutic target for the treatment of psoriasis.
099
Involvement of mast cells in the development of lupus-like skin lesions on MRL-lpr/lpr mice
T Yoshimasu,1 N Kanazawa,2 H Li,2 N Mikita2 and F Furukawa2 1 Dermatology, Arida Municipal
Hospital, Arida, Japan and 2 Dermatology, Wakayama Medical University, Wakayama, Japan
Hyperkeratotic skin lesions are occasionally developed on the upper back of lupus-prone MRL-
lpr/lpr mice and are considered as the model of lupus erythematosus. Although a lot of mast cells
are infiltrated in the skin lesions, their functions have not been elucidated. Therefore in this study,
mast cell-deficient MRL-lpr/lpr mice have been generated by crossing the mice with mast cell-defi-
cient Kit (Wsh/Wsh) mice. As Kit (Wsh/Wsh) mice were C57BL/6 background, G1 offspring between
Kit (Wsh/Wsh) and MRL-lpr/lpr mice were backcrossed with their parental MRL-lpr/lpr mice to
generate G2 offspring and selected lpr/lpr-Kit (Wsh/+) mice were repeatedly crossed with MRL-
lpr/lpr mice until generation of MRL-background G10 offspring. Finally, MRL-lpr/lpr-Kit (+/+), MRL-
lpr/lpr-Kit (Wsh/+) and MRL-lpr/lpr-Kit (Wsh/Wsh) mice were obtained by crossing G10 offspring
with each other. By comparison between these 3 groups, no apparent difference was observed in
the frequency of skin lesions, however, spontaneous regression of the skin lesions was specifically
seen in MRL-lpr/lpr-Kit (Wsh/Wsh) mice. Histologically, mast cells were completely absent in skin
lesions of MRL-lpr/lpr-Kit (Wsh/Wsh) mice, whereas the number of infiltrated mast cells were sig-
nificantly increased in association with exacerbation of skin lesions on MRL-lpr/lpr-Kit (+/+) and
MRL-lpr/lpr-Kit (Wsh/+) mice. By RT-PCR analyses, higher production of IL-1α was detected in skin
lesions than in non-lesional skin, whereas productions of IFN-γ, TNF-α and IL-10 were similarly
observed in both lesional and non-lesional skin of all 3 groups of MRL-lpr/lpr mice. On the other
hand, no apparent characteristics have been identified in MRL-lpr/lpr-Kit (Wsh/Wsh) mice skin.
These results suggest that mast cells are involved in the development of skin lesions on MRL-lpr/lpr
mice by any unknown mechanisms.
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A comparative study of direct and indirect immunofluorescence and enzyme-liked immunosor-
bent assays in the diagnosis of bullous pemphigoid
M Sárdy,1 D Kostaki,2 R Varga1 and T Ruzicka1 1 Dept. of Dermatology and Allergology, Ludwig
Maximilian University, Munich, Germany and 2 Dept. of Dermatology, University of L’Aquila,
L’Aquila, Italy
Bullous pemphigoid (BP) is the most common autoimmune blistering disorder in adults mediated
by IgG autoantibodies targeting bullous pemphigoid antigen 1 (BPAG1) and bullous pemphigoid
antigen 2 (BPAG2). Direct (DIF) and indirect immunofluorescence (IIF) and enzyme-liked immunosor-
bent assays (ELISAs) are used for diagnosis of BP. The aim of this single-center retrospective study
was to evaluate the diagnostic value of DIF, IIF on rabbit and monkey oesophagus and salt-split skin
as well as commercial ELISAs for BPAG1 and BPAG2 in patients with BP. The diagnostic results
from 265 patients affected by BP and 403 controls examined consecutively in the last 3.5 years were
analysed. DIF was the most sensitive test (90.6%) while sensitivities for IIF on oesophagus, salt-split
skin, BPAG1 ELISA and BPAG2 ELISA were 77%, 75.2%, 70.7% and 61.1%, respectively. The sen-
sitivity of IIF on rabbit oesophagus was somewhat higher than that on monkey oesophagus. The
sensitivity of all serological tests together was 87.9%. The specificities of BPAG2 ELISA and IIF on
salt-split skin were perfect (100%), the specificities for DIF, IIF on oesophagus, and BPAG1 ELISA
were 98.3%, 97.5%, and 90.6%, respectively. If the diagnosis of BP is suspected, both serological
tests and DIF are necessary to perform. All serological tests together almost reach the sensitivity of
DIF. The ELISAs had a relatively low sensitivity but our results are consistent with the literature. IIF
on rabbit oesophagus had the same or even slightly superior diagnostic performance than that on
monkey oesophagus. Therefore, the use of the oesophagus from expensive and endangered primates
does not seem to be justified. The specificities of all tested assays were satisfactory.
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Scurfy mice show autoimmune skin inflammation with features of atopic dermatitis includ-
ing systemic upregulation of IL-31 and TSLP
M Salz, X Wei, B Heckmann, AH Enk and EN Hadaschik Dermatology, University of
Heidelberg, Heidelberg, Germany
Scurfy mice lack functional regulatory T cells and spontaneously develop autoimmune inflamma-
tion in multiple organs including the skin. The disease is clearly CD4+ T cell-mediated since iso-
lated Scurfy CD4+ T cells transfer disease in RAG-/- recipients after i.v. injection. We have previ-
ously shown that CD4+ T cells are the predominant cell type in inflamed Scurfy skin and as determined
by intracellular FACS-analysis these skin-derived autoreactive CD4+ T cells reveal a Th2-phenotype.
Here we aimed to analyse the skin phenotype in more detail and identify potential Th2-differenti-
ation factors. First we performed histological analysis of the skin inflammation in Scurfy mice: On
H&E staining Scurfy skin shows acanthosis, parakeratosis with neutrophils present in the epider-
mis. There is a heavy T cell infiltrate in the dermis with exocytosis of T cells in the epidermis. On
immunohistological staining keratin 14 expression is reduced and keratin 6 is upregulated in inflamed
Scurfy skin in comparison to WT skin. Next we analysed a set of differentiation factors known to
be involved in Th2-differentiation: IL25 (IL17E), IL31, IL33 and TSLP were measured by ELISA in sera
from Scurfy and WT littermate control mice. There were no differences in IL25 and IL33 serum lev-
els. In contrast Scurfy mice show high TSLP as well as IL31-serum levels in comparison to WT ani-
mals. In summary we show that skin inflammation in Scurfy mice histologically shows features of
eczema which resembles atopic dermatitis. In addition we show systemic upregulation of the Th2-
differentiaion factors IL31 and TSLP in Scurfy but not WT serum. These data delineate IL31 and
TSLP as potential driving factors for the Th2-deviation of autoreactive CD4+ T cells in inflamed
Scurfy skin.
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Characterization of immunodominant T cell epitopes of the human autoantigen Hom s 2 in
atopic dermatitis
LM Rösner,1 A Heratizadeh,1 H Balaji,1 S Hradetzky,1 I Mittermann,2 R Valenta,2 WW Kwok3 and
TA Werfel1 1 Division of Immunodermatology and Allergy Research, Department of
Dermatology and Allergy, Hannover Medical School, Hannover, Germany, 2 Division of
Immunopathology, Department of Pathophysiology, Centre for Physiology and
Pathophysiology, Medical University of Vienna, Vienna, Austria and 3 the Benaroya Research
Institute at Virginia Mason, Seattle, WA
Autoreactivity to several human proteins has been described to contribute to the pathomechanism
in a subgroup of patients with atopic dermatitis (AD). First described on IgE level, we were recently
able to show autoreactivity against human proteins also by T helper and cytotoxic T cells in vitro.
In that study we were able to generate and characterize T cell clones proliferating in presence of
the recombinant protein and described T helper cells as well as cytotoxic T cells specific for Hom
s 2, the alpha-chain of the nascent polypeptide-associated complex. We now mapped the T helper
cell epitopes of Hom s 2 using overlapping 15mer peptides spanning the entire protein to stimulate
Hom s 2 specific T cell lines and T cell clones. Mapping of cytotoxic T cell immunodominant regions
was performed measuring proliferation of CD8+ T cells of sensitized patients in response to 9mer
peptides, which were selected by prediction software. We identified two major T cell epitopes pre-
sented via MHC class II and two major T cell epitopes presented via MHC class I. Knowledge of
immunodominant epitopes is predominantly of interest in specific immunotherapy, but it is also a
key step in designing MHC tetramers allowing detection of specific T cells. By this means, we
report successful MHC class II tetramer staining of Hom s 2 specific T cells in sensitized patients
and, to a smaller extent, in healthy individuals. A detailed characterization of these cells may pro-
vide new insights in the pathogenesis of autoantigen-specific T cells in AD. In summary we were
able to confirm T cell reactivity against Hom s 2 and open-up new possibilities in detection of autore-
active T cells and in immunotherapy identifying immunodominat regions of Hom s 2.
105
Active Chronic Sarcoidosis Is Characterized By Increased Transitional Blood B Cells, Increased
Il-10-Producing Regulatory B Cells And High Baff Levels
A Saussine,1 A Tazi,2 M Rybojad,1 A Janin,3 A Bensussan,4 M Bagot1 and J Bouaziz1 1
Dermatology, Saint Louis Hospital, Paris, France, 2 Pulmonary medicine, Saint Louis Hospital,
Paris, France, 3 Pathology, Saint Louis Hospital, Paris, France and 4 INSERM U-976, Paris VII
University, Paris, France
Sarcoidosis is a multisystemic disease of unknown etiology characterized by a disproportionate
Th1 granulomatous immune response in the organs involved. Plasmatic hypergammaglobulinemia
and B cell accumulation in granulomatous lesions suggest the possible role of humoral immune
responses in the pathogenesis of sarcoidosis. The purpose of this study is to describe B cell periph-
eral compartment in sarcoidosis. We analyzed blood B cell subsets and BAFF levels in 33 patients
with chronic sarcoidosis (active sarcoidosis before any treatment n=18; inactive sarcoidosis n=15)
and 18 healthy donors. Active chronic sarcoidosis patients had significantly less circulating mem-
ory B cells (p<0.01), more transitional (p<0.01) and increased numbers of IL-10-producing regula-
tory B cells (p<0.05) compared with healthy donors and patients with inactive sarcoidosis. BAFF
serum levels were significantly higher in patients with active sarcoidosis (p<0.01 versus healthy
donors and inactive sarcoidosis patients) and strongly correlated with serum hypergammaglobu-
linemia (r=0.53, p=0.0015) and angiotensin converting enzyme levels (r=0.61; p=0.00022). These
data show that there is an altered B cell homeostasis in active sarcoidosis and suggest BAFF antag-
onist drugs as potential new treatments of this disease. Key-words: B cell, BAFF, Interleukin 10, sar-
coidosis
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Alterations in RNA profiles in skin derived Langerhans cells during psoriasis
M Wikén, M Ståhle and L Eidsmo Molecular Dermatology, Department of Medicine, Karolinska
Institutet, Stockholm, Sweden
Psoriasis vulgaris is a T cell driven. It is not clear what drives the chronic T cell inflammation in the
skin or to what extent the vast number of skin resident and inflammatory dendritic cells in lesional
skin locally stimulates the T cells. Langerhans cells (LCs) are skin resident dendritic cells residing
in the epidermis. Upon stimulation, LCs rapidly exit the skin and migrate to draining lymph nodes
through the lymphatics where they have been proposed to stimulate tolerogenic T cell responses.
In psoriasis, LC show impaired migration properties but it is not known if, and how, LCs participate
in psoriasis inflammation. We suggest that LCs play a local role in the inflamed skin during psoria-
sis and set out to determine if LCs display a proinflammatory or tolerogenic profile during psoria-
sis. LC distribution, morphology and RNA expression were analysed during different phases of pso-
riasis. EpCAM+ HLADR+ LCs and myeloid CD11c+ HLADR+ cells were sorted from freshly prepared
epidermal and dermal cell suspensions prepared from healthy controls (n=10), lesional and non-
lesional psoriasis biopsies(n=8). Biopsies from healed psoriasis lesions during anti-TNF alpha or
UVB treatment were included in the analysis (n=4). By confocal imaging and EM we detected LCs
in dermis in close contact with T cells in active psoriasis lesions. RNA expression profiles revealed
that LCs displayed a pro-inflammatory profile with increased RNA expression of IL1b, IL-8 and IL-
6 as compared to healthy or non-lesional skin. IL-10 was only detected in one lesional sample and
although RNA levels of TGFbeta expression was higher in lesional as compared to non-lesional or
healthy skin, this did not reach significance. In the healed skin, IL-1b and IL-6 was normalised
whereas IL-8 and TNFa remained high in LCs. Our results suggest that LCs display a pro-inflamma-
tory profile in psoriasis lesional skin and LCs are found in close contact with T cells. The previously
impaired migration out if psoriatic skin may be due to local interactions with dermal T or epider-
mal T cells.
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Function of the Receptor for Advanced Glycation End Products in Keratinocytes on Regula-
tion of Skin Inflammation
J Leibold,1 A Riehl,1 A Bierhaus,2 P Angel1 and J Hess3 1 Division of Signal Transduction and
Growth Control, DKFZ-ZMBH Alliance, DKFZ, Heidelberg, Germany, 2 Department of
Medicine I and Clinical Chemistry, University of Heidelberg, Heidelberg, Germany and 3
Department of Otolaryngology, Head and Neck Surgery, University of Heidelberg,
Heidelberg, Germany
Our project aims to highlight the specific role of the Receptor for Advanced Glycation End Prod-
ucts (Rage) in keratinocytes and its contribution to the establishment and maintenance of inflam-
mation. Recently, we demonstrated a critical role for Rage in a mouse model of skin inflammation
induced by topical application of the phorbol ester TPA (12-O-tetradecanoylphorbol-13-acetate).
Moreover, we found that Rage expression on immune cells has a strong impact on their dermal infil-
tration and induction of epidermal hyperplasia. However, Rage is also expressed in keratinocytes,
which critically contribute to the spatial and temporal regulation of skin inflammation. Consequently,
our project aims to highlight the specific role of Rage in keratinocytes and its contribution to the
pathogenesis of inflammation. We generated keratinocyte-specific knock-out mice (RageΔker), and
topically treated the back skin of Rageflx and RageΔker animals with TPA for 6 – 48 hours. Immuno-
histochemical staining of skin sections revealed a comparable initial inflammatory response, whereas
the number of infiltrating immune cells was strongly reduced in RageΔker as compared to Rageflx
animals at 48 hours post treatment. This suggests that Rage prolongs cutaneous inflammation,
eventually by regulating immune cell retention through soluble factors. To understand how this
retention is induced at earlier time points, we isolated TPA-treated epidermis by laser microdissec-
tion and currently analyze Rage-dependent gene expression. Furthermore, we have established a
cell culture model system that enables Rage deletion in immortalized mouse keratinocytes in vitro
allowing a detailed analysis of the molecular mechanism of Rage function. Combining the results
of our model systems, we want to get deeper insights in Rage function and understand its role dur-
ing cutaneous inflammation.
106
Increased expression of Aryl Hydrocarbon Receptor in Atopic Dermatitis
H Kim, Y Yang, J Kim, S Cho, B Chung, C Park and C Lee Dermatology, Kangnam Sacred Heart
Hospital, Seoul, Republic of Korea
Dioxin is one of the major environmental hormones. The receptor of dioxin, aryl hydrocarbon recep-
tor (AhR), is the ligand-activated transcription factor. The purpose of this study is to determine the
significance of AhR in AD. AD patients were measured their EASI score to evaluate AD. Serum lev-
els of Tetra-Chlor-Dibenzo-Dioxine (TCDD) and Polychlorinated BinPhenyls (PCBs) were deter-
mined by high resolution gas chromatography and mass spectrometry in 19 atopic dermatitis patients
and 10 controls. The expression of AhR and ARNT were determined by immunohistochemistry in
acute lesional skins of AD (n=18), and controls (n=10). Real-time PCR were performed to detect
AhR, ARNT and AIP (AhR interacting protein) expression in acute lesional skins of AD (n=18) and
controls (n=6). MTT assay, cytokine array (for G-CSF, IL-13, IL-10, IL-17A, IL-2, IL-6, IL-5, TGF-α,
INF-γ, TNF-α, IL-4, IL-12, IL-22) were performed in cultured normal human epidermal keratinocytes
after TCDD, PCB stimulations. The serum levels of TCDDs and PCBs in AD group were higher than
those of control group. However, it was not statistically significant. AhR, ARNT, AIP and CYP1A1
mRNA expression were significantly increased in AD patient’s lesional skin. In the immunohisto-
chemistrical results, the staining levels of AhR antibody were significantly stronger in AD than con-
trols but not in the case of ARNT. The number of stained cells with AhR and ARNT antibody in the
dermis was higher in the AD group than in the normal control with a statistical significance. After
treatment with TCDD and PCBs with various concentrations (0.1, 1, 10nmol/L), normal human ker-
atinocytes showed dose dependent increase in IL-6 and IL-13 expression level. IL-6 is known to
induce IL-22, which is increased in AD and IL-13 is well known for its associations with AD and
asthma. Thus we believe it is comprehensive to say that our study result suggests a relationship
between AhR and the development of AD.
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Strong Th2-polarization of autoreactive CD4+ T cells in inflamed Scurfy skin and lung with
Thymic Stromal Lymphopoietin (TSLP) as potential differentiation factor
X Wei, B Heckmann, AH Enk and EN Hadaschik Dermatology, University of Heidelberg,
Heidelberg, Germany
Scurfy mice lack functional regulatory T cells because of a deletion in the Foxp3 gene and subse-
quently develop autoimmune multiorgan inflammation including the skin and lung. CD4+ T cells
are known to mediate the disease since transfer of Scurfy CD4+ T cells into RAG-/- recipients after
i.v. injection leads to the same disease. The inflammatory infiltrate in Scurfy skin and lung and the
cytokine profile of skin-infiltrating autoreactive CD4+ T cells were analyzed, particularly with regard
to Thymic Stromal Lymphopoietin (TSLP) as potential differentiation factor. As revealed by FACS-
analysis, CD4+ T cells and granulocytes are the predominant cell types in inflamed skin. Using intra-
cellular FACS-analysis after in vitro restimulation with PMA/Ionomycin, we found CD4+ T cells iso-
lated from inflamed Scurfy skin and lung secreted high levels of the Th2-cytokines (IL-4 and IL-5),
but low levels of the Th1-cytokine interferon-γ. Then we analyzed the expression of TSLP, which is
known to mediate Th2-differentiation of CD4+ T cells: Scurfy mice presented high TSLP-serum lev-
els compared to WT mice as measured by ELISA. Since TSLP is secreted by epithelial cells under
stress-conditions, we further analyzed TSLP expression in inflamed Scurfy skin by immunohisto-
chemistry and demonstrated high TSLP expression in Scurfy epidermis but low expression in WT
epidermis. To determine if skin-infiltrating CD4+ T cells can respond to TSLP, we finally performed
FACS-analysis of TSLP-receptor expression: CD4+ T cells in Scurfy but not in WT skin presented
high TSLP-receptor expression. In summary these results indicate that skin-infiltrating CD4+ T cells
in Scurfy mice spontaneously develop a Th2-phenotype with upregulation of the Th2-differentia-
tion factor TSLP in Scurfy epidermis and serum as potential driving factor for this Th2-deviation.
108
Interleukin-31-induced pruritus: involvement of leukotriene B4 released from epidermal
keratinocytes in mice
T Andoh, A Harada and Y Kuraishi Department of Applied Pharmacology, University of
Toyama, Toyama, Japan
Interleukin-31 (IL-31) is a T-cell cytokine and functions through activation of a heterodimeric recep-
tor composed of IL-31 receptor and oncostatin M receptor. An interesting function of IL-31 in
atopic dermatitis is the induction of pruritus. IL-31 is thought to elicit itch mainly through the direct
activation of primary afferents. However, IL-31 receptor is expressed in epidermal keratinocytes and
its activation regulates keratinocyte functions, including chemokine production. Keratinocytes pro-
duce leukotriene B4 (LTB4 ), an arachidonic acid metabolite, which is involved in itch-related response
in mice with atopy-like dermatitis. In the present study, we investigated whether keratinocytes and
LTB4 are involved in IL-31-induced itch-related responses in mice. An intradermal injection of IL-
31 (10–1,000 ng/site) into the rostral back elicited scratching. Dose-response curve was bell shaped,
with a maximal effect at 100 ng/site. IL-31 (100 ng/site)-induced scratching was inhibited by the
opioid antagonist naltrexone (1 and 10 mg/kg). It was inhibited by azelastine (30 mg/kg), but not
by tefenadine (30 mg/kg); both are H1 histamine receptor antagonists and the former inhibits the
action and production of LTB4 . The 5-lipoxygenase inhibitor zileuton (100 mg/kg), but not the
cyclooxygenase inhibitor indomethacin (10 mg/kg), inhibited the IL-31-induced scratching. Both
IL-31 receptor α and oncostatin M receptor α mRNAs were expressed in the mouse dorsal root
ganglia and primary cultures of mouse keratinocytes. IL-31 (0.2 and 2 μg/mL) dose dependently
increased the production of LTB4 in primary cultures of mouse keratinocytes, which was suppressed
by zileuton (10 μM). The present results suggest that IL-31-induced production of LTB4 in epider-
mal keratinocytes is involved in IL-31-mediated pruritus.
109
Elucidating roles of microRNA (miR)-125b in the inflammatory processes of psoriasis
H Christiansen,1 MN Primo,2 RO Bak,2 TN Dam,3 C Rosada,1 JG Mikkelsen2 and K Stenderup1 1
Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark, 2 Department of
Biomedicine, Aarhus University, Aarhus, Denmark and 3 Department of Dermatology,
Roskilde Hospital, Roskilde, Denmark
miR-125b is suggested to play an important regulatory role in psoriasis; in psoriatic skin the expres-
sion level of miR-125b has been shown to be down-regulated and to increase upon treatment. Over-
expression of miR-125b in primary human keratinocytes (NHEKs) has been shown to suppress pro-
liferation and induce differentiation, whereas inhibition of miR-125b activity promotes proliferation
and delays differentiation. In the present study, we aim to identify targets of miR-125b in the inflam-
matory processes of psoriasis and to exploit lentiviral miRNA delivery to human skin, xenografted
onto immune-deficient mice, to explore the effects of enhanced miR-125b expression in vivo. To
choose the most efficient delivery method of miR-125b to NHEKs in vitro, we compared transfer of
the eGFP reporter gene to NHEKs by plasmid DNA transfection and lentiviral vector (LV) transduc-
tion. By flow cytometry, we showed that transduction by VSVG-pseudotyped LVs was more effi-
cient than transfection. A LV encoding miR-125b was constructed and the expression of miR-125b
was confirmed by miRNA-qPCR on RNA isolated from LV-transduced HEK293T cells. Functional-
ity of the LV-encoded miR-125b was validated by analyzing expression of a luciferase reporter gene
fused to the perfect target sequence of miR-125b. In a similar reporter assay, to identify possible
miR-125b target genes, we screened thirteen 3’-untranslated regions (UTRs) of genes that play a
potential role in inflammatory processes of psoriasis. Taken together, previous and present results
suggest that miR-125b is a player in the inflammatory processes of psoriasis. We expect that stud-
ies based on treatment of xenotransplanted human psoriasis skin with LVs encoding miR-125b may
assist in validating target genes and describing miR-125b’s function in the inflammatory processes
of psoriasis.
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IL-17A up regulates IL-33 expression in keratinocytes; negative feedback loop in psoriatic epi-
dermis
J Meephansan,1 H Tsuda,1 M Komine,1 M Karakawa,1 S Tominaga2 and M Ohtsuki1 1
Dermatology, Jichi Medical University, Shimotsuke, Japan and 2 Biochemistry, Jichi Medical
University, Shimotsuke, Japan
IL-33 is an IL-1 cytokine family member that functions as a cytokine and nuclear factor. Activation
of immune cells by IL-33 promotes Th-2 inflammation. Expression of IL-33 in keratinocytes in pso-
riasis was reported in some studies. IL-17A is a key cytokine that has a critical role in the patho-
genesis of psoriasis. We hypothesize that psoriasis which highly expresses IL-17A, may in turn
influence IL-33 expression. We demonstrated the expression of IL-33 in the nucleus of the suprabasal
layer of keratinocytes in psoriasis, which also expressed ST2L. In cultured normal human epider-
mal keratinocytes (NHEKs), IL-17A strongly induced IL-33 expression at mRNA and protein levels
in dose- and time- dependent manner. The induction of IL-33 by IL-17A was suppressed by inhibitors
of ERK and p38 MAPK pathways. We found that the inhibitor of signal transducer and activator of
transcription (STAT) 3, but not STAT1 suppressed the regulation of IL-33 expression induced by IL-
17A. Janus kinase 1, 2 and 3 inhibitors almost completely suppressed the effect of IL-17A on IL-33
expression. We could not detect the 20 kDa band, which considered as mature form of IL-33 when
NHEKs were stimulated with IL-17A and TNF-α, while it was detected when NHEKs were stimu-
lated with IFN-γ and TNF-α. Combination of IL-17A and TNF-α synergistically induced IL-33 at
mRNA and protein levels at early time point but at 24 h the expression of IL-33 was suppressed.
Secretion of IL-33 was not detected in our experiment conditions. Recombinant mature form of IL-
33 induced IL-8 production, while IL-33 knock down with siRNA enhanced IL-8 mRNA and pro-
tein production induced by TNF-α, suggesting a dual function of IL-33 in NHEKs as a pro-inflam-
matory cytokine and as a nuclear factor suppressive on inflammation. The results indicate that IL-17A
might be an important cytokine in the induction of IL-33 in psoriasis. Induced IL-33 may act as a
nuclear factor, suppressing the immune response in the epidermis of psoriasis.
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Caspase-1 mediates UV-induced apoptosis independently of inflammasome components
G Sollberger,1 U Auf dem Keller2 and H Beer1 1 Department of Dermatology, University
Hospital Zurich, Zurich, Switzerland and 2 Institute of Cell Biology, ETH Zurich, Zurich,
Switzerland
Excessive exposure to sunlight is a major health threat since the emitted UV radiation damages DNA
and induces sunburn, an inflammatory reaction of the irradiated skin. Both DNA damage as well
as inflammation are of high carcinogenic potential and indeed UV irradiation is one of the main
causes of skin cancer. The establishment of sunburn depends on the pro-inflammatory cytokine inter-
leukin(IL)-1, which is not only secreted from professional immune cells but also from UV-irradiated
keratinocytes, the most abundant cell type of the epidermis. Two proteins of the IL-1 family ago-
nistically bind to the IL-1 receptor type 1, IL-1α and IL-1β. Whilst proIL-1α is biologically active,
proIL-1β is produced as an inactive precursor and gets activated upon processing by the protease
caspase-1. Caspase-1 itself is produced as an inactive zymogen and both the activation of caspase-
1 and the subsequent maturation of proIL-1β occur in macromolecular complexes termed inflam-
masomes. Most caspases are associated with apoptosis, however, an involvement of caspase-1 in
this programmed form of cell death is still under debate. We therefore analyzed, whether caspase-
1 is not only a crucial component of UV-induced inflammation but also of UV-induced apoptosis.
Using a combination of knockdown experiments and biochemical assays, we were able to demon-
strate that active caspase-1 mediates UV-induced apoptosis in human primary keratinocytes as
well as in other cell types. Most importantly, this caspase-1 activation occurs independently of the
classical inflammasome proteins NLRP-1 or NLRP-3, suggesting a secondary, inflammasome-inde-
pendent, caspase-1 activation pathway. In order to identify the substrates of active caspase-1, we
performed a proteomics substrate screen and identified a protein which has implications in apop-
tosis. Taken together, we discovered a novel apoptosis pathway involving caspase-1, which is trig-
gered by UV irradiation in different cell types.
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IL-37 is expressed in a differentiation dependent manner by keratinocytes of normal skin and
is diminished in inflammatory disease
AM Foster,1 J Baliwag,1 A Aphale,1 X Xing,1 S Getsios,2 JE Gudjonsson1 and A Johnston1 1
Dermatology, University of Michigan, Ann Arbor, MI and 2 Dermatology, Northwestern
University, Chicago, IL
IL-37 (IL-1F7) is a novel anti-inflammatory member of the IL-1 family. Given the potent roles of IL-
1 cytokines in skin inflammation, we asked how IL-37 was expressed in normal and inflamed skin
and studied its induction in keratinocytes. Immunohistochemical analysis of normal skin revealed
exclusive expression of IL-37 by a tight band of cells in the upper viable epidermis co-localizing
with the cornified cell envelope protein loricrin. On examination of psoriasis and squamous cell
carcinoma (SCC) lesions, staining for IL-37 and loricrin was decreased in both conditions, which
was confirmed by QRT-PCR where IL-37 mRNA was decreased in psoriasis (6.7-fold, p<0.001) and
SCC (3-fold, p<0.01). To understand these changes, we examined IL-37 expression by monolayer
normal human keratinocytes (NHK) and found that IL-37 mRNA expression was detectable in pre-
confluent NHK and this increased in post-confluent cells (3.7-fold, p=0.01) and was enhanced under
high-calcium (1.4mM) conditions (5.7-fold, p=0.034). Treatment of pre-confluent cells for 24h
with TGF-α, TNF-α or HB-EGF lead to significant increases in IL-37 mRNA, particularly under
high-calcium conditions (6.0, 5.1 and 7.7-fold respectively, all p<0.01); importantly, post-conflu-
ent cultures expressed markedly more IL-37 on stimulation, with induction by IL-1α (30-fold
increased), TGF-α (11-fold) and IFN-γ (10-fold). Given that NHK expressed IL-37 as a function of
differentiation, we next examined IL-37 expression by 3D epidermal cultures. During maturation,
IL-37 mRNA expression increased with markers of stratification (loricrin, K1, K10) and mature cul-
tures expressed a distinct band of IL-37 similar to that seen in normal skin. These data indicate that
IL-37 is expressed in a highly differentiation-dependent fashion by keratinocytes and the disruption
of the normal differentiation program, as seen in psoriasis and SCC, may result in a deficit of IL-37
expression leading to altered cytokine regulation.
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miRNA Normalization Candidates for qPCR in Lesional and Nonlesional Psoriatic Skin
AL Nielsen, L Raaby, C Johansen and L Iversen Department of Dermatology, Aarhus University
Hospital, Aarhus, Denmark
MicroRNA (miRNA) is an upcoming research area and qPCR is an important tool in the investiga-
tion. The small non-coding RNA candidates that can be used for normalization in psoriatic skin
biopsies have never been sufficiently validated. The purpose of this study was to identify a reliable
normalization candidate for miRNA analysis with qPCR in lesional versus nonlesional psoriatic skin.
Five miRNA normalization candidates previously used for normalization of miRNA expression in
psoriatic skin biopsies were identified through search in the literature. Moreover 5 new candidates
were uncovered using the NormFinder algorithm on miRNA microArray data based on 6 paired pso-
riatic skin samples. The 10 candidates in total were tested on 10 paired samples of psoriatic skin
biopsies with qPCR. A paired t-test was performed and candidates with a significant regulation
between lesional and nonlesional skin were excluded (miR-30b, RNU6b, let-7f and miR-103). The
stability of the 6 remaining miRNAs was determined using NormFinder and geNorm algorithms.
Both NormFinder and geNorm ranked the candidates similarly and there was an excellent correla-
tion between the two methods (R2=0.98). miR-26a (geNorm M-value (gMv)=0.566 and NormFinder
stability value (NFsv)=0.285) and miR-23b (gMv=0.566 and NFsv= 0.295) had the best stability
throughout all samples followed by miR-423-5p (gMv=0.698 and NFsv= 0.449). RNU48, which is
the most commonly used candidate for normalization, had less favorable stability in the samples
(gMv=0.803 and NFsv=0.532). snoRNAZ30 (gMv=1.276 and NFsv= 0.726) and miR-664 (gMv=1.261
and NFsv=0.748) ranked as the least optimal candidates. This is the first study to validate the relia-
bility of miRNA candidates for normalization by qPCR. From this study we conclude that miR-26a
and miR-23b are the best candidates and better candidates than those previously used. miR-26a
and/or miR-23b should therefore be used for miRNA normalization in future studies when com-
paring biopsies of lesional and nonlesional psoriatic skin.
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Keratinocytes show a cytokine dependent impaired regulation of the Suppressor of Cytokine
Signalling (SOCS)1 and SOCS3 negative feedback mechanisms as compared to macrophages
J Zeitvogel,1 M Wittmann2 and T Werfel1 1 Division for Immunodermatology and Allergy
Research, Clinic for Dermatology, Allergy and Venereology, Hannover Medical School,
Hannover, Germany and 2 Division of Rheumatic and Musculoskeletal Disease, Leeds
Institute of Molecular Medicine, Univercity of Leeds, Leeds, United Kingdom
In chronic inflammatory skin diseases a de-regulated immune regulation occurs which seemed to
be partly due to a restricted ability of keratinocytes to up-regulate SOCS3 in response to STAT3 acti-
vating cytokines like IL-27. Therefore, it was the aim of this study to investigate whether keratinocytes
have in general a lack in inducing the important feedback mechanisms of SOCS3 or SOCS1. T cell
derived cytokines and other cytokines involved in inflammatory skin diseases (like IL-1b, IL-18,
TNFa) were analyzed by qRT-PCR in regard to their potential to up regulate SOCS1 or SOCS3 in
keratinocytes as compared to macrophages. Furthermore, a demethylation assay and pyrosequencing
was performed to check for epigenetic based alterations in SOCS3 expression. We found that only
IFNg was able to induce SOCS3 but not SOCS1 in keratinocytes. In macrophages IFNg was able to
induce high amounts of both SOCS1 and SOCS3. Interestingly, in both cell types highest amounts
of SOCS1 mRNA were detected after IL-4 treatment. Moderate mRNA level of SOCS1 were induced
by TNFa and IL-18 in keratinocytes and IL-1b and TNFa in macrophages. Although the treatment of
keratinocytes with a demethylation reagent resulted in significant higher amounts of SOCS3 mRNA
level, pyrosequencing of two putative methylation sites in the SOCS3 gene revealed no differences
in keratinocytes as compared to autologous macrophages. However, further epigenetic analysis of
the SOCS3 and SOCS1 gene will be necessary to clarify this issue. We conclude that keratinocytes
have a cytokine dependent distinct regulation of the SOCS1 and SOCS3 feedback mechanisms as
compared to macrophages which may contribute to the establishment of the chronic phase of inflam-
matory skin diseases.
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Increased levels of serum IL-17, 23, 1β, and TNF-α in Patients with Yusho patients 44 years
after accidental poisoning with polychlorinated biphenyls in Nagasaki, Japan
Y Kuwatsuka,1 F Ogawa,1 K Shimizu,1 Y Akiyama,2 Y Koike,2 M Furue2 and A Utani1 1
Department of Dermatology, Nagasaki University Graduate School of Biomedical Sciences,
Nagasaki City, Japan and 2 Research and Clinical Center for Yusho and Dioxin, Kyushu
University Hospital, Fukuoka City, Japan
Forty-four years have passed since the accidental intake of dioxin such as polychlorinated biphenyls
(PCB) at 1968 in western Japan. More than hundreds of patients have been suffering from various
symptoms called as Yusho. Even now, high concentrations of PCB are still detected in serum of the
Yusho patients. The skin symptoms of Yusho patients are characterized acneiform eruptions, pig-
mentation of the skin, nails and conjunctivas. The aryl hydrocarbon receptor (AhR), also recog-
nized as a dioxin receptor, is a transcriptional regulator best known for mediating toxicity of dioxin.
Recent studies have revealed that dioxin caused immunotoxic effects via AhR. In addition, AhR acti-
vation by its ligands dysregulated T cells producing interleukin(IL)-17 (Th17). Therefore, we hypoth-
esized dysregulation of Th17 immune system may happen in the Yusho patients. In 2005, we meas-
ured Th17 cells secreting cytokines such as IL-17 and -22 in the serum of about 40 Yusho patients
and age-matched 40 controls by enzyme-linked immunosorbent assay. Moreover, serum levels of
IL-1β and -23, which induce Th17 cells differentiation from naive Th0 cells, were examined. In addi-
tion, we measured serum levels of tumor necrosis factor (TNF)-αmainly produced by macrophages,
which was acitivated by Th17 cells. The mean serum IL-17 levels in the Yusho patients were signif-
icantly higher than in the controls (p<0.0001). Furthermore, serum levels of IL-1β, -23, and TNF-α
in the Yusho patients were significantly increased.In contrast, serum IL-22 levels in the Yusho patients
were significantly lower than in the controls (p<0.0001).In conclusion, persistent dysregulation of
Th17 immune system in the Yusho patients may provoke chronic inflammation in the Yusho patients
even after 44 years have passed.
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In vivo imaging of cell proliferation by 3’-deoxy-3’-18F-fluorothymidine ([18F]FLT) and small
animal Positron Emission Tomography (PET) enables the detection of experimental arthritis
K Fuchs,1 U Kohlhofer,2 L Quintanilla-Martinez,2 D Lamparter,1 G Reischl,1 M Röcken,3 BJ Pichler1
and M Kneilling3 1 Department of Preclinical Imaging and Radiopharmacy, University
Tübingen, Tübingen, Germany, 2 Department of Pathology, University Tübingen, Tübingen,
Germany and 3 Department of Dermatology, University Tübingen, Tübingen, Germany
Rheumatoid arthritis (RA) is characterized by systemic and erosive synovitis and joint destruction.
Thus, early diagnosis of RA before onset of joint destruction is of special importance. The aim of
our study was to investigate the potential of [18F]FLT-PET, [18F]FLT-PET/computed tomography
(CT) and [18F]FLT-PET/magnet resonance imaging (MRI) to quantify cell proliferation in experimental
RA. We injected BALB/c mice with either glucose-6-phosphate-isomerase (GPI)-specific antibody-
containing serum to induce experimental RA or control-serum. Animals were injected with [18F]FLT
at days 1, 3, 6 and 8 after the onset of disease and were measured by PET/CT and PET/MRI addi-
tionally, we performed Ki-67 staining. Analysis of different stages of arthritic joint disease revealed
enhanced [18F]FLT uptake in arthritic ankles and fore paws compared with healthy ankles or fore
paws as early as one day after GPI-serum injection, a time point with clear histological signs of RA
but without measurable ankle swelling. [18F]FLT uptake in arthritic ankles reached the maximum
observed level at day 8. Ki-67 staining of the arthritic ankles revealed a strong correlation with
[18F]FLT PET data. Detailed analysis exhibited that resident cells, synovial fibroblasts as well as
infiltrating cells such as neutrophils stained positive for Ki-67. Combined PET/CT and PET/MRI meas-
urements enabled us to detect inflammation induced cell proliferation, to identify the exact foci of
enhanced [18F]FLT uptake in arthritic joints and to differentiate between bone and soft tissue. Thus,
non-invasive in vivo measurement of cell proliferation using 18F-FLT-PET might be a promising tool
to measure the magnitude of inflammation induced cell proliferation in autoimmune diseases such
as psoriasis arthritis.
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Acute paradoxic psoriasis induced by anti-TNF-α treatment: Yin-Yang of TNF-α and type I IFN
C Conrad, C Belkhouja, O Demaria, A Lapointe and M Gilliet Department of Dermatology,
CHUV, University Hospital Lausanne, Lausanne, Switzerland
Anti-TNF-α agents are currently used for the treatment of chronic plaque psoriasis. Long term treat-
ment with anti-TNF-α agents can also trigger acute flares of psoriasis (paradoxic psoriasis), although
the pathogenic mechanism involved has remained elusive. Here we analyze a series of 9 cases of
acute paradoxic psoriasis induced by anti-TNF treatment and performed comprehensive clinical
and immuno-histological evaluation and gene expression analyses. Previously, we have shown that
the development of psoriatic lesions is initiated by IFN-α produced by a subset of circulating cells
called plasmacytoid dendritic cells (pDCs). Here, we found significantly higher number of pDCs
and increased IFN-α signature in skin of acute flares of paradoxic psoriasis as compared to classi-
cal chronic psoriasis. Furthermore, we demonstrate in vitro that TNF-α inhibits IFN-α production
by pDCs. Conversely, addition of anti-TNF-α antibodies increased IFN-α production capacity of
pDCs. These data suggest the yin-yang model, in which TNF-α controls the expression of IFN-α by
pDCs and, that acute flares of paradoxic psoriasis result from an unabated IFN-α production by
pDCs. Thus, anti-TNF-α treatment tips the balance form TNF-α to IFN-α and thereby inhibits chronic
TNF-α-driven inflammation, while predisposing psoriatic patients to IFN-α-driven flares of acute
psoriasis. Thus, our findings provide a new pathogenic mechanism for acute paradoxic psoriasis
induced by anti-TNF-α treatment and provides basis for novel therapeutic options.
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CXCL10, A Potential Mediator of Th17-Associated Inflammation In Bullous Pemphigoid
S Le Jan,1 D Vallerand,1 A Dupont,2 E Delanez,1 A Durlach,3 P Bernard4 and F Antonicelli1 1
Dermatology, University of Reims, Reims, France, 2 Biochemistry, University of Reims, Reims,
France, 3 Laboratory Pol Bouin, CHU Reims, Reims, France and 4 Dermatology, CHU Reims,
Reims, France
Bullous pemphigoid (BP) is one of the main autoimmune blistering skin disorders of elderly peo-
ple. A hallmark of this disorder is the presence of IgG autoantibodies that target two hemidesmo-
somal antigens, BP230 and BP180, resulting in tissue damage, dermal-epidermal disadhesion and
consequently formation of subepidermal blisters. By combining ELISA and immunohistochemistry
studies, we aimed at 1) investigating the level of inflammatory cytokines in the blister fluids and in
the sera of a large series of patients and 2) analyzing the tissue distribution of CXCL10 in the vicin-
ity of lesion site. Blister fluids and sera from 31 consecutive patients with BP admitted from 2009
to 2011 and 16 controls were collected at time of diagnosis. Biopsies studies were made from 19
patients. Levels of leukocyte-derived cytokines were measured in sera and blister fluids. In addition
to an increase in levels of IL17 in sera, a Th17 cytokine profile (IL17, IL22 and IL23) was clearly
established in blister fluid from BP patients compared to controls. Th17 orientation was correlated
to TGFβ increase in sera and to IL-22 and IL-23 in blister fluid. Th17-associated inflammation was
characterized by a marked increase of CXCL10 in both sera and blister fluid. Body fluid CXCL10
overexpression was associated with an in situ increase of CXCL10 release by inflammatory cells,
mainly neutrophils, and by several skin-related cells such as keratinocytes, endothelial cells and
fibroblasts. The pathological role of both CXCL10 and IL17 cytokines in BP was further addressed
by demonstrating that these cytokines increased MMP-9 expression from PBMC issued from patients
and control. We here bring evidences that TGFβ could prime Th17 polarization in the blood circu-
lation and that subsequent exposure to IL23 at site of injury could trigger or exacerbate pathogenicity,
especially by inducing expression of CXCL10 in bullous-located inflammatory cells.
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Antibodies to laminin γ1 do not induce blisters in vivo or ex vivo
S Groth, K Vafia, T Beckmann, J Dworschak, A Recke, RJ Ludwig, D Zillikens and E Schmidt
Department of Dermatology, University of Luebeck, Luebeck, Germany
Anti-p200 pemphigoid is a subepidermal blistering skin disease characterized by autoantibodies
against a 200 kDa protein (p200) of the dermal-epidermal junction. Recently, the C-terminus of
laminin γ1 (LAMC1-cterm) has been identified as target antigen in anti-p200 pemphigoid. However,
the pathogenic relevance of these autoantibodies has not yet been analysed in vivo. Here, we
explored the effect of anti-LAMC1-cterm antibodies in various experimental models. Since patient
autoantibodies only weakly crossreact with murine skin, antibodies against murine LAMC1-cterm
were raised in rabbits. Doses of 60 mg/g and 90 mg/g body weight of rabbit IgG were injected over
a period of 10 days into neonatal and adult C57BL/6mice, respectively. While high levels of circu-
lating anti-mLAMC1-cterm antibodies were present in the peripheral blood of all animals, binding
of IgG at the DEJ was week, did not attract C3 at the DEJ, and failed to induce blisters clinically and
histologically. Similar findings were obtained when mice from different strains were immunized
with murine LAMC1-cterm using different immunization protocols. Finally, we affinity-purified
patients’ autoantibodies against the full length protein of laminin γ1 (LAMC1-FL). These LAMC1-FL
IgG failed to induce dermal-epidermal separation in cryosections of human skin using an ex vivo
model of autoantibody-mediated leukocyte-dependent neutrophil activation. We conclude that path-
ogenicity in anti-p200 pemphigoid is not mediated by autoantibodies against laminin γ1. Further
studies are needed to explore the pathogenicity of autoantibodies in anti-p200 pemphigoid.
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Biochip technology for the serological diagnosis of bullous pemphigoid
E Zattra, H Zarian, A Peserico, A Saponeri, A Michelotto and M Alaibac Unit of Dermatology,
University of Padua, Padua, Italy
Bullous pemphigoid is an autoimmune blistering skin disease characterized by the presence of cir-
culating autoantibodies which recognize specific proteins of the epidermis and dermoepidermal
junction. Diagnosis is based on clinical criteria and laboratory investigations, notably histology
and direct and indirect immunofluorescence. The aim of the study was to detect BP180 and BP230
autoantibodies by BIOCHIP Technology using both a specially designed recombinant BP180-NC16A
protein and cells expressing an optimized antigen fragment (BP230-gC).We investigated the diag-
nostic value of this new technology for the diagnosis of bullous pemphigoid. 18 patients with bul-
lous pemphigoid were included in the study. To detect autoantibodies by BIOCHIP Technology, the
recombinant tetrameric NC16A was spotted on cover-glasses, which were further fragmented on
“BIOCHIPs”. Autoantibodies against BP230 were detected using cells expressing on optimised anti-
gen fragment (BP230-gC), which has been shown to provide higher sensitivity than the full-length
protein (BP230-FL). A BIOCHIP mosaic was formed containing these substrates together with pri-
mate esophagus. Autoantibodies anti-BP180 were detected in 83.33% of patients with clinical, sero-
logical and immunohistological confirmed bullous pemphigoid while auto-antibodies against BP230-
gC were detected only in 39% of patients with bullous pemphigoid. Combined detection of
anti-BP180-NC16A and anti-BP230-gC by a new Cell-based immunoassay is a suitable alternative
to in-house assays employing tissue sections of esophagus and skin.Cell-based immunofluorescence
provides an effective alternative to immunoassays based on purified antigens, such as ELISA and
immunoblot. The BIOCHIP method is faster, cheaper and easy to use when compared with the ELISA
approach, but it is less sensitive than the more complex ELISA method. For this reason, the new
method could be used as an initial screening test to identify patients with bullous pemphigoid and
the results could then be confirmed by ELISA.
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Expression of dual specificity phosphatase 1 in skin inflammation
RB Kjellerup, C Johansen, K Kragballe and L Iversen Department of Dermatology, Aarhus
University Hospital, DK-8000 Aarhus C, Denmark
The dual specificity phosphatase 1 (DUSP1) is an important negative regulator of p38 mitogen-acti-
vated protein kinase (MAPK) activity. p38 MAPK is important to inflammation and displays increased
activity in psoriasis. The purpose of this study was to analyse DUSP1 expression in skin inflamma-
tion. DUSP1 mRNA expression was analysed by RT-qPCR in paired biopsies from nonlesional and
lesional skin of patients with chronic plaque-type psoriasis or atopic dermatitis. Furthermore, the
mRNA expression of the DUSP1-transcript stabilizing protein Hu antigen R (HuR) and the destabi-
lizing protein tristetraproline (TTP) were investigated in psoriatic skin. We also analysed DUSP1
mRNA expression in the early phase of the imiquimod-induced mouse model of psoriasis-like skin
inflammation using wildtype C57BL/6 mice and daily topical applications of imiquimod for up to
3 days. We demonstrated a downregulation of DUSP1 mRNA expression in lesional psoriatic skin
compared with nonlesional psoriatic skin in 21 patients, whereas a small increase was seen in 7
patients. The overall downregulation was significant and approximately 35%. In atopic dermatitis
no significant difference in DUSP1 mRNA expression was detected in 6 patients investigated. In
separate sets of biopsies HuR mRNA expression was found to be increased approximately 1.5-fold
in lesional psoriatic skin, whereas no difference was seen in TTP mRNA expression. In the imiquimod
mouse model DUSP1 mRNA expression was increased almost 2-fold after 8 hours, but approxi-
mately 60% decreased after 3 days compared with control mice having received no topical treat-
ment and sacrificed at day 3. In conclusion, the downregulation of DUSP1 mRNA in lesional pso-
riatic skin was not explained by differences in the mRNA expression of DUSP1-transcript stability
affecting proteins, but the downregulation was reflected in the imiquimod mouse model at day 3.
Although unclear what causes DUSP1 mRNA downregulation in lesional psoriatic skin, the down-
regulation is likely to be of pathogenic importance in maintaining the inflammation.
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Neoepitopes on the modified amino-terminus of the shed ectodomain of collagen XVII
W Nishie,1 H Ujiie,1 S Shinkuma,1 L Bruckner-Tuderman2 and H Shimizu1 1 Department of
Dermatology, Hokkaido University Graduate School of Medicine, Sapporo, Japan and 2
Department of Dermatology, University Medical Center Freiburg, Freiburg, Germany
Collagen XVII (COL17)/BP180, a major autoantigen for bullous pemphigoid (BP), is expressed as a
transmembrane protein in basal keratinocytes. The extracellular part of COL17 can be cleaved from
the cell surface, which is known as ectodomain shedding. Interestingly, autoantibodies in certain
blistering diseases, including BP, preferentially target the shed ectodomain. Previous studies have
suggested that ectodomain shedding of COL17 generates neoepitopes on the shed form, which can
be targeted by the autoantibodies. However, the precise mechanism of neoepitope generation remains
uncertain. To address this, we investigated a unique cleavage site whose N-terminus was physio-
logically modified from Gln525 into pyroglutamate (pyroGlu525). A new polyclonal antibody to
the modified N-terminus (Ab-pyroGlu525) specifically reacted with the shed form but not with the
full-length COL17, suggesting that the modified N-terminus is involved in the generation of neoepi-
topes. The Ab-pyroGlu525 revealed that the COL17 shed ectodomain with modified N-terminus is
generally presented at the dermal-epidermal junction in normal human skin; in contrast, it was not
detectable in the migration tracks of cultured normal human keratinocytes. These results suggest
that ectodomain shedding of COL17 may be differentially regulated in a context-dependent man-
ner. Furthermore, we showed that ectodomain shedding of mouse COL17 also generates a neoepi-
tope on the shed form. Another rabbit antibody targeting the modified pyroglutamate (pyroGlu532)
N-terminus of the murine COL17 shed ectodomain specifically reacted with the shed ectodomain
but not with the full-length form. Thus, generation of neoepitopes on the modified N-terminus of
the shed ectodomain can be produced on diverse COL17 molecules from different species. This
study clearly demonstrates that the modified N-terminus of both human and mouse COL17 gener-
ates neoepitopes that specifically appear after ectodomain shedding.
123
In vivo and ex vivo suppression of inflammation during anti-interleukin-1 beta treatment in
Schnitzler’s syndrome
HD de Koning,1 J Schalkwijk,1 J van der Ven-Jongekrijg,2 IM van Vlijmen-Willems,1 D Rodijk-
Olthuis,1 M Stoffels,2 JW van der Meer2 and A Simon2 1 Dermatology, Radboud University
Nijmegen Medical Centre, Nijmegen, Netherlands and 2 Internal Medicine, Radboud
University Nijmegen Medical Centre, Nijmegen, Netherlands
Schnitzler’s syndrome (SchS) is an autoinflammatory disorder characterized by chronic urticaria,
fever, gammopathy and bone pain. Etiology is unknown, but interleukin-1 (IL-1) inhibition is very
effective. We studied the effect of IL-1β inhibition on inflammatory responses in vivo and ex vivo
during a trial of the anti-IL-1β antibody canakinumab in SchS. Eight patients with SchS received
monthly injections with 150mg canakinumab s.c. for six months. Blood was drawn at several time
points for serum markers of inflammation and isolation of peripheral blood mononuclear cells
(PBMCs), which were stimulated with lipopolysaccharide (LPS). Skin biopsies of urticae and clini-
cally uninvolved skin were used for mRNA, histology and keratinocyte cultures. All data were com-
pared to results of healthy controls. C-reactive protein was high during active disease and low dur-
ing treatment. IL-6 protein concentration in lysates of freshly isolated PBMCs correlated with disease
activity. Stimulation of PBMCs with 0,1 ng/ml LPS induced more IL-6 and IL-1β production in SchS
PBMCs than in controls. In lesional epidermis, RNA expression of several antimicrobial proteins
was elevated. Validation at the protein level showed increased expression of psoriasin, elafin and
human beta-defensin 2 in keratinocytes. In primary human keratinocytes, poly:IC, IL-1β, IL-17 and
interferon gamma induced mRNA expression levels of several antimicrobial proteins and cytokines
to a similar extent in patient and control cells. In conclusion, clinical efficacy of IL-1β inhibition in
patients with SchS is associated with in vivo and ex vivo suppression of inflammation. Our data
underscore that IL-1β plays a pivotal role in this disease. Also, we show strong upregulation of antimi-
crobial proteins in the epidermis of these neutrophilic urticaria, and that these proteins can be
induced in primary human keratinocytes by IL-1β.
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Dermatomyositis and Polymyositis are associated differently with cancer: results of a meta-
analysis of the literature
D Di Rollo,1 D Abeni,2 M Auriemma,1 M Tracanna,1 F Giuliani1 and P Amerio1 1 Dermatologic
Department, G. d’Annunzio University, Chieti, Italy and 2 Servizi Sanitari, Istituto
Dermopatico Immacolata-IRCCS, Rome, Italy
The idiopathic inflammatory myopathies (IIMs) are a group of diseases characterized by the pres-
ence of proximal muscle weakness, increased levels of muscle-specific enzymes, specific elec-
tromyographic abnormalities, and the presence of inflammatory cell infiltrates in skeletal muscle.
The association between IIM and cancer is well described in adults, although the patho-physio-
logical mechanisms underlying the association remain elusive. Many epidemiological studies con-
firm this association, which appears stronger for Dermatomyositis (DM) compared to Polymyositis
(PM). We performed a meta-analysis through systematic review of English literature from 1969 to
March 2011 to clarify the overall association of cancer with adult DM and PM and to investigate
the frequency of specific cancer types. The PubMed database was searched for papers (series cases,
review and letters) reporting the association of DM and cancer. One hundred and six studies were
retrieved. The relative risk of malignancy for DM vs. PM was 2.02 (p 0,006). The relative risk of can-
cer in DM was significantly elevated in the male vs. female patients (RR 1.6; CI 95% 1.44-1.78).
The relative risk of cancer in male vs. female PM patients was 1.04 (0.82-1.33). The most common
types of cancer were gastrointestinal cancer (19,6%), lung cancer (16,5%), head and neck cancer
(15,6%) among patients with DM. In patients with PM there was a raised frequency of lung cancer
(15,6%), breast cancer (12,6%) and hematological and lymphatic neoplasia (10,8%) among patients
with PM. The diagnosis of the most cancers was made after the diagnoses of DM (48,8%) and PM
(64,8%). We have confirmed that both DM and PM are associated with an increased risk of malig-
nant disease, but that this risk is substantially greater for DM. Our results showed that DM and PM
are different diseases, in respect of the relative risk of cancer and types of associated neoplasias.
S22 Journal of Investigative Dermatology (2012), Volume 132
ESDR12_Abstracts-3  7/20/12  1:26 PM  Page S22
Auto-Immunity and Inflammation | ABSTRACTS
125
Effects of Antimicrobial Peptides on T-cells – Downregulation of Th2 Cytokines by Human
Beta-defensine-2
K Wichmann,1 M Wollny,1 U Staar,1 M Kleine2 and T Werfel1 1 Department of Dermatology and
Allergy, Division of Immunodermatology and Allergy Research, Hannover Medical School,
Hannover, Germany and 2 PLANTON GmbH, Kiel, Germany
Human beta-defensine-2 (hBD-2) is an antimicrobial peptide produced by keratinocytes in the skin
which is mainly active against Gram-negative bacteria and fungi . It is downregulated by Th2 cytokines
which are overexpressed in the acute phase of atopic dermatitis. Furthermore hBD-2 mediates
immunomodulatory functions such as chemoattracting dendritic cells and T-cells as well as neu-
trophils and mast cells. In this study a possible direct effect of hBD-2 on T-cells regarding cytokine
production was investigated in detail. Human PBMCs and isolated CD4+ T-cells as well as differ-
ent T-cell populations were stimulated with recombinant hBD-2 from transgenic plants and the
expression and secretion of the Th2 cytokines IL-4, IL-5 and IL-13 were measured by PCR and ELISA.
A significant downregulation of the IL-13 production could be shown on protein level as well as
on mRNA by hBD-2 in human PBMCs and CD4+ T-cells as well as in polarized Th2 cells. This
effect was also detectable in lymphocytes from birch pollen allergic patients. The effect of hBD-2
on IL-13 was exclusive since effects on IL- 4 and IL-5 did not reach statistical significance. These
are the first data showing a direct effect of hBD-2 on a Th2 cytokine in human T-cells. The down-
regulation of the Th2 cytokine IL-13 by hBD-2 may contribute to the cytokine shift during different
phase of atopic dermatitis and may influence atopic inflammation in situ.
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Analysis of epitope profile of autoantibodies in pemphigus vulgaris using domain-swapped
desmoglein 3 (Dsg3)/Dsg2 ELISAs
MA Saleh,4 K Ishii,2 J Yamagami,1 T Hachiya3 and M Amagai1 1 Department of Dermatology,
Keio University School of Medicine, Tokyo, Japan, 2 The First Department of Dermatology,
Toho University School of Medicine, Tokyo, Japan, 3 Medical and Biological Laborarories Co.
Ltd., Nagoya, Japan and 4 Department of Dermatology, Cairo University School of Medicine,
Cairo, Egypt
Pemphigus vulgaris is an autoimmune blistering disease caused by IgG autoantibodies against
desmoglein3 (Dsg3). Epitopes are considered to be one of important factors in determining patho-
genicity of autoantibodies in pemphigus. Epitope profiles were previously characterized by an
immunoprecipitation-immunoblot method using Dsg3/Dsg2 domain-swapped molecules, repre-
senting various extracellular (EC) domains of Dsg3 on a backbone of Dsg2. However there are
some technical limitations to analyze autoantibodies by the methods, for example, it is not a quan-
titative assay or it cannot detect autoantibodies when the titer is low. To overcome the limitation,
we developed ELISA system using Dsg3/Dsg2 domain-swapped molecules which were produced
by baculovirus dual expression system with furin to obtain the mature forms retaining conforma-
tional epitopes. Of 34 pemphigus vulgaris (PV) patient sera tested, Dsg3 EC1, EC2, EC3, EC4 and
EC5 were recognized by 88%, 23%, 20%, 8%, and 29%, respectively. The reactivity against EC1
was significantly higher than that against other domains. Next, we analyzed the epitope profiles of
34 patients with PV along time course. In 13 cases, the anti-Dsg3 antibodies fluctuated mainly on
EC1 domain only. In most cases who recognized epitopes on multiple EC domains, the immune
response fluctuated proportionately over time but some cases showed disproportionate fluctuation.
Two cases showed apparent epitope spreading. These ELISAs will provide easier and more sensi-
tive detection of epitope analysis for pemphigus and should facilitate further study for immunopatho-
genesis of pemphigus.
129
Overexpression of miR-21 in psoriasis keratinocytes is mediated by T-cell derived cytokines
F Meisgen, N Xu, M Ståhle, A Pivarcsi and E Sonkoly Molecular Dermatology, Karolinska
Institutet, Stockholm, Sweden
MicroRNAs are a growing class of small, endogenous non-coding RNAs, which suppress the expres-
sion of their target genes through sequence-specific interactions. Previously, we showed that cer-
tain microRNAs are deregulated in psoriasis skin. We demonstrated that these microRNAs can reg-
ulate keratinocyte and leukocyte functions, and may thus play a pathogenic role in psoriasis. However,
the molecular basis of microRNA expression in psoriasis is poorly understood. In this study, we
investigated the cells of origin and the molecular basis of miR-21 overexpression in psoriasis. We
determined that miR-21 is overexpressed in the epidermal compartment of skin of psoriasis patients
by laser capture microdissection of epidermal keratinocytes from both psoriasis and healthy skin.
Moreover, q-PCR analysis of miR-21 expression in CD45-negative cells from healthy and psoriasis
epidermis confirmed the up-regulation of miR-21 in non-leukocyte cell populations. Next, we aimed
to understand the underlying cause of the observed up-regulation of miR-21 expression. To this end,
we measured the effect of T-cell derived inflammatory cytokines on the expression level of miR-21,
using a three-dimensional skin tissue model which exhibits in vivo-like morphological and growth
characteristics. We treated 3D skin equivalents with cytokines that are known to play an important
role in psoriasis (IL-1β, IL-17, IL-20, IL-22, IFNγ and TGFβ). Morphological changes and a deregu-
lated expression of inflammatory mediators confirmed the effect of the cytokines on the keratinocytes.
We found that miR-21 was up-regulated by IL-22 and IFNγ. These results indicate that overexpres-
sion of miR-21 may be mediated by T-cell derived cytokines and that microRNAs may function as
intracellular mediators of cytokine responses in psoriasis.
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A protective role of the physical presence of water in the stratum corneum in contact allergy
Y Mizukawa, T Doi, Y Komatsu, Y Yamazaki and T Shiohara Dermatology, Kyorin University
School of Medicien, Mitaka, Japan
Environmental factors are increasingly recognized as having a strong impact on the rise in allergic
diseases in the developed world. However, the study of investigating the role of the decreased humid-
ity associated with the industrialized lifestyle on occurrence of allergic diseases has been extremely
limited, although there has been concern that a reduced water content of stratun corneum (SC) due
to a decrease in environmental humidity may have a direct role in occurrence of allergic skin dis-
eases. In a mouse model for cutaneous contact hypersensitivity (CH) responses, we initially inves-
tigated whether the magnitude of CH responses could be influenced by strain-dependent or humid-
ity-dependent differences in the water content of SC at the site of hapten application. Regardless of
the strains of mice used, mice displayed a reduced CH response when elicited at the site of high
water content of SC. This adverse relationship between the water content of SC and the magnitude
of CH responses was only observed in the elicitation phase and not in the sensitization phase. An
increase in the water content of SC induced by exposure to a high humidity condition for 6 h was
sufficient to ameliorate the magnitude of CH even in mice with the genetic defect in attenuating
the CH responses, such as neuromedin U-/- mice and TCRδ -/- mice (B6 background). The CH
responses in mice elicited under high humidity conditions resulted in a decrease in tissue damage
and leukocyte infiltration, and significant down-regulation of IL-1 α, IL-4 and IFN-γmRNA expres-
sion. We also found that epicutaneously applied hapten can penetrate more readily through the SC
with lower water content than that with higher water content. These findings indicate that the genetic
defect in attenuating the CH responses could only be corrected by exposing such deficient mice to
a high humidity environment during the elicitation phase and suggest that increased levels of water
in the SC may serve to ameliorate the CH responses beyond the genetic effects.
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Susceptibility-associated genetic variation at IL12B enhances Th1 polarization in psoriasis
A Johnston,1 X Xing,1 WR Swindell,1 J Kochkodan,1 RP Nair,1 PE Stuart,1 J Ding,2 JJ Voorhees,1
JT Elder1 and JE Gudjonsson1 1 Department of Dermatology, University of Michigan, Ann
Arbor, MI and 2 Center for Statistical Genetics, Department of Biostatistics, University of
Michigan, Ann Arbor, MI
The IL12B gene encodes the common p40 subunit of IL-12 and IL-23, cytokines with key roles in
Th1 and Th17 biology respectively, and genetic variation in this region significantly influences risk
of psoriasis. Here we demonstrate that the psoriasis associated IL12B risk allele, as defined by the
G allele of rs6887695, leads to increased expression of IL12B (p<0.01) along with a modest increase
in IL12A expression (p<0.05) by monocytes. This correlated with increased serum IL-12 levels in
risk carriers (p<0.05), whereas IL-23 levels were decreased (p<0.001). We further demonstrate that
IL-12 is increased in psoriatic skin and that risk carriers manifest a skewing of the inflammatory net-
work towards stronger IFN-γ responses (p<0.001) along with weaker IL-17 and IL-22 response
(p<0.001 and 0.001 respectively). Taken together, our data demonstrate that the risk variant in IL12B
associates with its increased expression, and indicates that the risk variant predisposes to stronger
Th1 responses in psoriatic skin through deviation of the local inflammatory environment towards
increased IL-12 at the expense of IL-23.
130
Role of single-immunoglobulin interleukin-1 related receptor (SIGIRR) in psoriasis
R Di Caprio, F Ayala, N Balato, M Mattii, M Schiattarella, S Lembo and A Balato Department of
Dermatology, University of Naples Federico II, Napoli, Italy
Single-immunoglobulin interleukin-1 related receptor (SIGIRR), also known as Toll/interleukin-1
receptor 8 (TIR-8), is a member of TIR domain–containing family of receptors. It was first charac-
terized as an inhibitor of interleukin-1 receptor (IL-1R) and Toll-like receptor (TLR) signalling. Inter-
leukin (IL)-1 family comprises 11 members that takes part in the inflammatory process and recent
evidences have showed a possible role in psoriasis. The purpose of this study was to investigate a
possible role of SIGIRR in psoriasis pathogenesis. Through quantitative reverse transcription poly-
merase chain reaction, we found that IL-1 family members gene expression increased in lesional
skin of psoriatic subjects whereas SIGIRR levels decreased. On the other hand, after anti-TNFα treat-
ment, SIGIRR levels increased in lesional psoriatic skin whereas IL-1 family members were down-
regulated. Through immunohistochemical analysis, we also found that SIGIRR was strongly expressed
in all epidermal layers of healthy skin but only in the stratum spinosum and the stratum corneum
of psoriatic plaques. Moreover, we treated peripheral blood mononuclear cells (PBMC) isolated
from healthy donors with TNF-α as well as anti-TNF-α and SIGIRR gene expression was analyzed;
SIGIRR was decreased by TNF-α and increased by anti-TNF-α treatment. Our study provides first
evidence that SIGIRR is involved in psoriasis and that TNF-α downregulated it, so that the lack of
a negative regulation may be at the basis of psoriasis pathogenesis.
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Increased Expression of Transforming Growth Factor β Receptor II in Mesenchymal Stem Cells
from Systemic Sclerosis Patients
V Vanneaux,1 D Farge-Bancel,2 S Lecourt,1 J Baraut,3 F Jean-Louis,3 C Brun,3 J Larghero,1
F Verrecchia4 and L Michel3 1 Unité de Thérapie Cellulaire, CIC-BT501, UMR940, AP-HP,
Inserm, Hôpital Saint-Louis, Paris, France, 2 Unité de Médecine Interne et Pathologie
Vasculaire, AP-HP, Hôpital Saint-Louis, Paris, France, 3 UMR976, Inserm, Univ. Paris Diderot,
Sorbonne Paris Cité, Hôpital Saint-Louis, Paris, France and 4 UMR957, Inserm, Univ. Nantes
Atlantiques, Nantes, France
Multipotent Mesenchymal Stromal Cells (MSC) have potential therapeutic interest for patients with
systemic sclerosis (SSc). Since TGF-β plays a critical role during the development of fibrosis in SSc,
we aimed to evaluate the expression of TGF-β receptors, TGF-β signaling pathways and conse-
quences of TGF-β activation in bone marrow-derived MSC from SSc patients. Both TGF-β, TGF-β
receptor type I (TBRI) and II (TBRII) mRNA and protein expression were assessed in MSC from SSc
patients and healthy donors by quantitative PCR and flow cytometry, respectively. MSC were exposed
to TGF-β (5 ng/ml), and collagen 1α2 synthesis and Smad expression were quantified 24 hours
after. Primary cultures of dermal fibroblasts were also analysed according to a similar set of exper-
iments. Our results showed that MSC from 9 SSc patients showed a significant increase in mRNA
levels (p<0.002) and in membrane expression (p<0.0001) of TBRII in comparison to MSC from 9
controls. In response to TGF-β activation, a significant increase in collagen 1α2 synthesis (p<0.05)
and Smad-3 phosphorylation was upregulated in SSc MSC. Similar results were obtained on 8 SSc-
derived dermal fibroblasts compared to fibroblasts from 6 healthy controls. In conclusion, TGF-β
receptor type II gene and protein expression defect in MSC derived from SSc patients may have
pathological significance. These findings should be taken in account when considering the use of
MSC-based therapies in an autologous setting.
132
Fc receptor (FcR)- dependent recruitment of slan (6-sulfo LacNAc) dendritic cells (DCs) to
immune complexes in a model of physiologically relevant fluid shear stress
AS Lonsdorf, T Döbel, A Hänsel, AH Enk and K Schäkel Dermatology, Ruprecht-Karls-University,
Heidelberg, Germany
Immune complex (IC) deposition in the skin is a critical early event in the generation of antimicro-
bial and autoimmune inflammatory responses. The interaction of locally accruing ICs with FcR-
expressing DCs contributes to IC-triggered inflammation and the pathogenesis of autoimmune dis-
eases. Among the distinct subsets of human blood DCs we previously identified the population of
slanDCs, a human CD1c- CD11c+ DC subset characterized by its pronounced expression of the
low affinity FcγRIII (CD16). We can demonstrate that their marked CD16 expression equips highly
proinflammatory slanDCs with a unique capacity to capture soluble ICs. Here we asked whether
ICs that are deposited in the vasculature have the capacity to locally recruit slanDCs. By applying
a flow chamber assay and time-lapse video microscopy we show that surface-coated ICs alone are
highly effective in mediating the firm arrest of slanDCs under physiological shear stress conditions.
In contrast, immobilized ICs do not enhance adhesion of other human DC populations (i.e. plas-
mocytoid DC and CD1c+ DC) or isolated T cells. By blocking selective FcγRs on slanDCs, we demon-
strate that their shear-resistant adherence to immobilized ICs is critically dependent on CD16, while
CD32 (FcγRII) expression is completely dispensable. In support of an effective CD16/IC-mediated
immune cell recruitment at the endothelial interface, pre-incubation of monolayers of human endothe-
lial cells with anti-endothelial IgG antibodies significantly potentiates the CD16-dependent arrest
of slanDC under physiologic flow conditions as compared to Ig isotype controls. In summary, we
identified CD16 as a critical structure for 1) the capture of soluble ICs and 2) the effective, shear-
resistant adhesion of circulating proinflammatory slanDCs to immobilized ICs. Our data provide
first evidence for a novel conduit of rapid FcR-coordinated recruitment of immune cells in IC-
mediated tissue inflammation.
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Mast cell/CD8+ T cell interactions in the pathobiology of lichen planopilaris
MJ Harries, CE Griffiths and R Paus The University of Manchester, Manchester, United Kingdom
Mast cells (MCs) operate as crucial links between the innate and adaptive immune systems and are
implicated in both pro-inflamatory and immunoregulatory functions. They can direct antigen-spe-
cific CD8+ T cell responses, and may play a role in immune privilege (IP) collapse. On this basis
we have investigated MCs and their interactions with CD8+ T cells in lichen planopilaris (LPP),
where a perifollicular infiltrate destroys HF epithelial stem cells and leads to collapse of bulge IP.
Paired frozen biopsies of lesional and non-lesional scalp skin from patients with LPP (n=10), along
with paraffin samples from patients (n=31) and normal controls (n=16) were examined using immuno-
histochemistry (IHC). Additional paired lesional and non-lesional samples were sectioned for laser
capture microdissection of bulge cells for gene expression profiling (microarray; n=7 pairs), with
selected genes validated using IHC and qRT-PCR. Sgnificantly increased numbers of total and degran-
ulated MCs were identified in the CTS adjacent to the bulge in LPP compared with normal control
HFs (5.3 ± 0.69 vs. 3.2 ± 0.53 mean cell count (± SEM); p=0.03). By microarray and qRT-PCR, this
corresponded to a downregulation of cannabinoid receptor 1 (CNR1) transcription in lesional LPP
compared to non-lesional LPP bulge tissue (CNR1 stimulation suppresses excessive maturation and
activation of human CTS MCs). Double-IHC showed that the number of perifollicular MC-CD8+ T
cell complexes was significantly increased in LPP versus healthy control HFs (2.2 ± 0.61 vs. 0 com-
plexes (±SEM); p<0.01). This corresponded to an up-regulation of genes associated with T cell acti-
vation (e.g. CTLA4, IL18, CCL19, CXCL9/10/11) in lesional versus non-lesional LPP bulge epithe-
lium (microarray) and increased numbers of CXCR3+ infiltrating cells in the bulge epithelium (6.93
± 2.02 vs. 0.09 ±0.06 mean cell count (±SEM); p<0.001) and CTS. Taken together, these findings
support the hypothesis that MC-CD8+ T cell interactions may play an important role in the patho-
biology LPP and deserve to be further explored as potential new therapeutic targets in LPP.
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Skin immunization with pancreatic β-cell antigen through topical calcipotriol and betametha-
sone diproprionate-treated skin delays autoimmune diabetes in non-obese diabetic mice
M Ghoreishi and JP Dutz Department of Dermatology and Skin Science, University of British
Columbia, Vancouver, BC, Canada
Skin immunization through calcipotriol (vitamin D derivative) treated or ultraviolet (UV) light irra-
diated skin, induces antigen-specific tolerance. However, calcipotriol induces inflammation through
the up-regulation of TSLP and UV is oncogenic. Corticosteroids are anti-inflammatory and may
also promote regulatory T cell activation. Here we demonstrate that topical application of Dovo-
bet®, a synthetic combination of calcipotriol and betamethasone dipropionate, prior to intrader-
mal injection of islet-derived peptides, but not topical treatment alone or peptide alone, prevents
autoimmune diabetes in non-obese diabetic (NOD) mice. Using adoptive transfer of diabetogenic
BDC2.5 CD4+ T cells, we demonstrate that intradermal administration of the agonist peptide 1040-
63 following topical Dovobet® treatment of the skin results in a significant increase in the propor-
tion and the activation of antigen-specific FoxP3+ Tregs in the pancreatic lymph nodes of recipient
NOD mice. This treatment resulted in a significant increase in the proliferation of Tregs and anti-
gen-specific CD4+ conventional T cells in skin draining LNs. Treatment with Dovobet® and pep-
tide 1040-63 increased the expression of the CCR4+/CD103hi tissue homing phenotype on FoxP3+
BDC2.5 Tregs in pancreatic LNs. Cytotoxic CD8+T cells play a critical and final role in pancreatic
β-cell destruction. Using a tetrameric class I MHC complex of Kb and the IGRP mimetope peptide
NRP-7 to identify diabetogenic CD8+ T cells, we found a significant decrease in the frequency of
these cells in the peripheral blood of mice treated with Dovobet® and 1040-63 peptide. Weekly
treatment of NOD mice with topical immunomodulator Dovobet® and intradermal mimetope
peptide 1040-63, but not treatment with topical or peptide alone, resulted in a significant decrease
in the incidence of diabetes. These studies suggest that topical Dovobet® and immunization through
the skin, may be used to generate β-cell specific Tregs to prevent type 1diabetes.
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β7 integrin deficiency attenuates immune complex-mediated tissue injury
D Yamada, T Kadono, Y Masui, Y Asano, Y Tada, M Sugaya and S Sato Department of
Dermatology, Faculty of Medicine, University of Tokyo, Tokyo, Japan
The deposition of immune complexes induces an acute inflammatory response with significant tis-
sue injury. Immune complex-induced inflammation is mediated by inflammatory cell infiltration, a
process highly regulated by expression of multiple adhesion molecules. β7 integrin, a cell adhe-
sion molecule, is present in the form of α4β7 or αEβ7 integrin. α4β7 integrin is expressed on most
leukocytes and is essential for their migration to gut-associated lymphoid tissues by interacting with
its primary ligand, mucosal addressin cell adhesion molecule-1. On the other hand, αEβ7 integrin
is known to retain intraepithelial lymphocytes within the gut epithelium through E-cadherin bind-
ing. Although involvement of β7 integrin in intestinal immunity is well-established, little has been
known about the engagements of β7 integrin in cutaneous immune responses. In this study, we
investigated the role of β7 integrin in immune complex-mediated tissue injury using mouse model
of cutaneous reverse passive Arthus reaction. The reaction was attenuated in β7 integrin deficient
mice compared to C57BL/6 mice. Local cytokine mRNA expression levels were measured by real-
time PCR, and IL-6 mRNA levels tended to decrease in β7 integrin deficient mice compared to wild-
type mice. We also analyzed peritoneal reverse passive Arthus reaction and found that the infiltra-
tion of neutrophils and mast cells was reduced by β7 integrin deficiency. These results overall indicate
an important role of β7 integrin in immune complex-mediated tissue injury in the skin and peri-
toneum.
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Fumaric acid esters in psoriasis – impact on regulatory T cells and lesional T cell subsets
A Jacobi,1 T Carbone,2 A Cavani,2 BH Greene,3 R Moll,4 M Hertl1 and C Möbs1 1 Dermatology
and Allergology, Philipp University Marburg, Marburg, Germany, 2 Laboratory of
Immunology, Istitutio Dermopatico dell`Immacolata, IRCCS, Rome, Italy, 3 Medical Biometry
and Epidemiology, Philipp University Marburg, Marburg, Germany and 4 Pathology, Philipp
University Marburg, Marburg, Germany
Psoriasis is considered a T cell dependent chronic inflammatory disease. Agents that block TNF-
alpha may restore the capacity of regulatory T cells (Treg) and increase peripheral Treg count. Since
fumaric acid esters (FAE) have been shown to be effective in psoriasis through inhibition of TNF-
induced gene expression in endothelial cells by a mechanism involving NF-κB, the aim of this inves-
tigator initiated study was to find out whether therapeutic efficacy of FAE is associated with a mod-
ulation of Treg. We investigated the dynamics of Treg populations in the peripheral blood and in
lesional skin of patients with moderate to severe plaque-psoriasis (n=13) who received FAE during
the entire 24 week observation period. Peripheral blood samples were examined every 4 weeks
using flow cytometry and skin biopsies were analyzed at week 8 by immunohistochemical stain-
ing. All patients showed a marked clinical response documented by a significant decrease of PASI
and DLQI throughout the observation period. Treatment with FAE showed no significant increase
of peripheral Treg within the subpopulation of CD4+ T cells, measured by surface marker expres-
sion of CD4, CD25, CD127. This was accompanied by a significant decrease of the proinflamma-
tory skin infiltrate consisting of CD4+, CD8+, CLA+ T cells and Th17 cells, but not Foxp3+ T cells
in psoriatic skin. These T cell subsets are presumably critical regulators of skin inflammation in pso-
riasis. Ex vivo, regulatory T cells showed a similar suppressive function upon co-culture with effec-
tor T cells pre- and during treatment with FAE. These findings suggest that treatment with FAE may
not target disease-modifying Treg.
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TNF-α and IL-17A-induced S100A7 expression is regulated by a p38 MAPK and ERK1/2 depend-
ent mechanism in cultured human keratinocytes
Z Kang, M Mose, L Lversen and C Johansen Department of Dermatology, Aarhus University
Hospital, Aarhus, Denmark
S100A7 (also known as psoriasin), is an antimicrobial protein, known to be overexpressed in lesional
psoriatic skin. The mechanism regulating its expression, however, is poorly understood. The p38
mitogen-activated protein kinase (MAPK) and extracellular signal regulated kinase (ERK1/2) signal-
ing pathways have previously been demonstrated to be activated in lesional psoriatic skin. The pur-
pose of this study was to investigate the role of p38 MAPK and ERK1/2 in the expression and regu-
lation of S100A7 in cultured human kerationcytes. We demonstrated that stimulation of human
keratinocytes with TNF-α and IL-17A in combination resulted in an increased mRNA and protein
level of S100A7, which was significantly higher than the observed increase in S100A7 induced by
the individual cytokines. To analyze the signaling pathways involved in the regulation of S100A7,
we preincubated keratinocytes with a p38 MAPK, an ERK1/2 or a c-Jun NH2-terminal kinase (JNK)
inhibitor before stimulation with TNF-α and IL-17A. By quantitative PCR, we demonstrated that the
mRNA expression of S100A7 was significantly reduced by a p38 MAPK (p=0.031) and an ERK1/2
inhibitor (p=0.046), whereas preincubation with a JNK inhibitor had no effect on the mRNA expres-
sion of S100A7. Similar results were found at the protein level of S100A7, as demonstrated by
western blotting. In conclusion, our results demonstrate that the p38 MAPK and ERK1/2 signaling
pathways are involved in the TNF-α and IL-17A-induced regulation of S100A7.
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Activation of protease-activated receptor (PAR)-2 by pemphigus vulgaris IgG in cultured
human keratinocytes
S Lee,1 S Kim2 and S Kim2 1 Dermatology, CHA Bundang Medical Center, CHA University,
Seongnam-si, Republic of Korea and 2 Dermatology, Yonsei University College of Medicine,
Seoul, Republic of Korea
Pemphigus vulgaris (PV) is an autoimmune disease in which autoantibodies cause acantholysis.
Although proteases such as plasmin and matrix metalloproteinase were shown to be involved in
acantholysis, the role of protease-activated receptor-2 (PAR-2) in the PV IgG-induced acantholysis
remains uncertain. Therefore, we investigated whether PV IgG could activate PAR-2 on keratinocytes
and induce p38MAPK activation, which is known to be involved in acantholysis, via PAR-2. More-
over, we examined PAR-2 expression in PV lesions using immunofluorescence staining. The effect
of PV IgG on Ca2+ signaling was measured using a fluorescence method. Primary human keratinocytes
were treated with PV IgG for 2-8 h and with PAR-2 agonist peptide (AP) or trypsin for 0.5-2 h as
positive controls. Phospho-p38MAPK protein expression was analyzed using western blot. PV IgG
induced increases in [Ca2+]i in keratinocytes within 200 sec, similar to AP or trypsin. Desensitiza-
tion by repetitive trypsin stimulation abolished the Ca2+ signals induced by PV IgG, indicating that
PV IgG induces Ca2+ signaling in keratinocytes via PAR-2. AP or trypsin caused a significant increase
in the phosphorylation levels of p38 MAPK at 2-6 h. Phosphorylation of p38 MAPK was also increased
in keratinocytes treated with PV IgG at 2 h but decreased at 6-8 h relative to the 2 h time-point, sug-
gesting that PV IgG stimulates a transient increase in p38 MAPK activity within the first 2 h. In addi-
tion, PAR-2 immunostaining on skin cryosections from PV lesional skin and normal skin showed
the higher expression of PAR-2 in skin lesions of patients with PV compared to normal healthy
donors. In summary, we have demonstrated that PV IgG can activate PAR-2 on keratinocytes and
PAR-2 activation via PV IgG or AP induces p38MAPK activation. Moreover, we found increased
PAR-2 expression in PV lesional skin. We therefore suggest that PAR-2 might play a role in the pem-
phigus acantholysis by activating keratinocyte signaling pathways including p38MAPK in response
to PV IgG.
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Human skin lesion morphology reflects and predicts the recirculation patterns of pathogenic
T cells
R Watanabe, M Tawa, DC Fisher, T Kupper and RA Clark The Dana Farber/Brigham and
Women’s Cancer Center, Boston, MA
Human skin contains 20 billion memory T cells. 80% are non-recirculating, sessile skin resident
effector memory cells (TRM) and 20% are recirculating central memory T cells (TCM). We find that
the clinical morphology of skin lesions is tightly linked to the recirculation patterns of pathogenic
T cells. Mycosis fungoides (MF) is a malignancy of sessile TRM and leukemic CTCL (including Sézary
syndrome) is a cancer of recirculating TCM. Malignant T cells from fixed, well demarcated MF skin
lesions were L-selectin-/CCR7-, consistent with a sessile behavior (fixed TRM). These patients responded
fully to skin directed therapies but not to alemtuzumab, a therapy that depletes T cells in blood but
not skin. In contrast, pathogenic T cells from the diffuse erythema of L-CTCL patients were L-
selectin+/CCR7+ (TCM phenotype), consistent with their ability to migrate through the skin, blood
and lymph nodes. These patients required systemic therapies such as alemtuzumab. In mice, CCR7
expression allows T cells to exit skin and enter lymphatics. In patients with worsening MF, with
new skin lesions but no blood disease, pathogenic T cells were CCR7+/L-selectin- (mobile TEM). Cur-
rent understanding predicts such cells would leave skin, enter the draining LN, be released into
blood, but could only home back to skin, where they would give rise to new skin lesions. These
patients responded to skin directed therapies of the entire skin surface. In short, the clinical appear-
ance of skin lesions was highly predictive of the behavior and re-circulation patterns of pathogenic
T cells. For example, we predict the diffuse pruritic erythema of atopic dermatitis (AD) is mediated
by allergen-specific TCM and lichen simplex chronicus by TRM. We predict autoreactive TRM give rise
to morphea and systemic sclerosis is caused by autoreactive TCM. Skin lesion morphology reflects
the behavior of pathogenic T cells, can provide novel biologic insights and can predict which ther-
apies will be most effective.
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System-level investigation of risk factors for atopic dermatitis by mathematical modelling and
analysis
E Dominguez-Huttinger,1 M Ono,2 M Barahona1 and RJ Tanaka1 1 Imperial College London,
London, United Kingdom and 2 UCL, London, United Kingdom
Atopic dermatitis (AD) is a widespread inflammatory disease characterized by skin barrier dys-
function and hypersensitivity to environmental challenges. Several risk factors for deregulation of
the skin barrier homeostasis have already been identified, such as fillagrin deficiency and over-acti-
vation of Kallikreins. However, none of them seem to be necessary or sufficient to clearly explain
the development of AD by itself, indicating that a systems-level understanding of the regulatory inter-
play between the multiple risk factors and their effects on skin barrier homeostasis is fundamental.
This study aims to investigate the system-level effects of AD risk factors through the development
of a mathematical model that integrates existing knowledge of the regulatory networks known to
play a role in the AD conditions. Our model focuses on the highly interdependent relationship
between two key elements in AD skin: inflammatory responses to environmental stimuli and skin
barrier deficiency. Computational simulations and analysis of our model enables a systematic inves-
tigation of the dynamical responses of the interaction networks that regulate skin barrier home-
ostasis. We explored the role of different risk factors by varying parameter regimes that correspond
to alterations in the regulatory components and by quantitatively evaluating the AD severity with
our proposed indices. Our model successfully reproduced the typical clinical features of AD: increased
sensitivity to environmental stimuli, persistence of the inflammation, and loss of skin barrier func-
tion. It predicts that each risk factor is associated with a particular phenotype and that the presence
of two or more risk factors concurrently increases dramatically the chances of developing AD. The
model predictions were validated with microarray and clinical data from AD patients. Our novel
modelling approach to understand AD is expected to identify more effective, patient specific treat-
ment of AD.
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B-Cell Growth Factors in Autoimmune Blistering Skin Disease
EC Benton, JB Mee, BS Bhogal and RW Groves Department of Immunodermatology., St John’s
Institute of Dermatology. Guy’s and St Thomas’ NHS Trust, London, United Kingdom
Autoimmune blistering diseases represent a heterogeneous group of disorders characterized by path-
ogenic circulating autoantibodies to structural components of skin and mucosal membranes. BAFF
(B cell activating factor, TNFSF13B) and APRIL (A PRoliferation Inducing Ligand, TNFSF13A) both
belong to the tumour necrosis factor superfamily. They are crucial mediators of B cell survival and
function and over-expression of these ligands has been shown to promote autoimmunity. Elevated
serum levels of BAFF and/or APRIL have been reported in several autoimmune diseases and may
correlate with disease activity and/or titres of pathogenic autoantibodies. We were interested in eval-
uating the role of BAFF and APRIL in the pathogenesis of autoimmune blistering skin disease. Cir-
culating APRIL levels were elevated in patients, compared to controls with highest levels observed
in those patients with sub-epidermal blistering conditions; bullous pemphigoid (BP) (n= 65; mean
= 16.2 ng/ml, range 1.6 -45.2 ng/ml) and epidermolysis bullosa (EBA) (n= 18; mean = 15.9 ng/ml,
range 3.7- 40.7 ng/ml) compared with those patients with intra-epidermal blistering disorders; pem-
phigus vulgaris (PV) (n=27 mean = 10.5 ng/ml, range 0-27.5 ng/ml) or pemphigus foliaceus (PF)
(n=19; mean= 10.9 ng/ml, range 3.7 – 40.7 ng/ml). Interestingly, BAFF levels were not significantly
elevated in any disease state but increased following B-cell depletion therapy with rituximab in asso-
ciation with B cell recovery. BAFF and APRIL levels did correlate in BP patients (p = 0.0028, r2 =
0.1274). Correlation with disease severity was observed between APRIL and Desmoglein 1 (DSG1)
antibodies in PV. In BP there appeared to be no correlation between APRIL or BAFF with BP180 or
230. Our data suggest that different B-cell control mechanisms may exist in sub-epidermal immunob-
ullous disease (pemphigoid and EBA) compared with pemphigus variants, where blistering is intra-
epidermal. Consequently, therapeutic interference with BAFF and APRIL pathways may have dif-
ferential effects in these disorders.
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Cutaneous toxicity of sulfur mustard and inflammatory biomarkers of exposure in SKH-1 hair-
less mouse skin
S Mouret, J Wartelle, C Cléry-Barraud, S Emorine, M Bertoni, N El Bakdouri, N Nguon and
I Boudry Toxicologie et Risques Chimiques - Unité Brûlure Chimique, Institut de Recherche
Biomédicale des Armées (IRBA), La Tronche, France
Sulfur mustard (SM) is a strong bifonctional alkylating agent that causes severe skin burns charac-
terized by erythema, edema, inflammation and subepidermal blisters. Effective medical counter-
measures against SM are lacking because the molecular mechanisms of these events remain unclear.
In order to define new healing strategies, it is necessary to have a detailed understanding of the cel-
lular and molecular changes associated with skin exposure. Using the SKH-1 hairless mouse model,
the objective of this study was to characterize the skin lesion development and to identify potential
biomarkers after skin exposure to SM. For this purpose, mice were exposed to three doses of liquid
SM (0.6, 6 and 60 mg/kg) then the macroscopic progression of skin lesion and the transepidermal
water loss measurement (TEWL) were followed for 21 days. Skin biopsies were collected at D1, D3
and D7 after exposure in order to investigate the time dependent quantitative gene and proteins
expression profile of the inflammatory response. After skin contact, we showed that time to onset
and severity of symptoms were dose dependent. The time course of skin lesion was characterized
by a low and transient erythema followed by a severe edema at D1 and necrosis started to be visi-
ble from D2. TEWL was altered from D1 and values were still 3 to 6 times higher than baseline on
D21. Using RT-qPCR analysis, specific cytokine mRNA (IL-1β, IL-6, Cxcl2 and Ccr1) were up-reg-
ulated in a dose dependent manner from D1 to D7 with a maximal change observed at D1. Using
a cytokine antibody array, L-selectin was the only one protein up-regulated for all doses of SM dur-
ing a 7-day period while the cytokine profile was altered in a dose dependent manner. Further inves-
tigations would need to be conducted to specify the importance of L-selectin. Nevertheless, L-selectin
could be used as a potential biomarker of SM exposure and also as a potential therapeutic target.
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Sensitivity of different assays for the serological diagnosis of epidermolysis bullosa acquisita:
analysis of a cohort of 24 Italian patients
V Calabresi,1 A Sinistro,1 E Cozzani,2 C Cerasaro,1 F Lolicato,1 M Muscianese,1 A Parodi,2
B Didona,3 G Zambruno1 and G Di Zenzo1 1 Molecular and Cell Biology Laboratory, IDI-
IRCCS, Rome, Italy, 2 Section of Dermatology, DISSAL, Azienda Ospedaliera San Martino - IST,
IRCCS, Genova, Italy and 3 I Dermatology Division, IDI-IRCCS, Rome, Italy
Epidermolysis bullosa acquisita (EBA) is a subepidermal autoimmune blistering disease character-
ized by tissue-bound and circulating autoantibodies (autoAb) to the dermal-epidermal junction. The
autoAbs target type VII collagen (Col VII) that is a structural component of anchoring fibrils involved
in the dermal-epidermal adhesion. Diagnosis is made by clinical findings, assessment of subepi-
dermal blister by histopathology, linear deposition of autoAbs, mainly IgG, at the basement mem-
brane zone by direct immunofluorescence, and binding to the dermal side of salt-split skin by indi-
rect immunofluorescence (IIF). However, the detection of specific anti-Col VII reactivity has an
important confirmatory value. The aim of the present study was to compare the sensitivity of dif-
ferent approaches for the serological diagnosis of EBA in a cohort of 24 Italian patients. The vast
majority of EBA sera (79.2%) bound to the non-collagenous domains (NC1 and NC2) by a com-
mercial ELISA, while a small but significant proportion of patients (12.5%) exclusively reacted to
the collagenous domain by immunoblotting (IB) using Col VII produced by an epithelial cell line.
Of note, the autoAb reactivity to Col VII was more frequently detected by IB (91.7%) than by IIF
(83.3%) and ELISA (79.2%). Interestingly, 2 out of 24 sera recognized Col VII epitopes absent in the
native secreted protein but present in the context of extracellular matrix proteins, as assessed by
immunomapping on Col VII- and laminin 332-deficient skin. Finally, we have shown that, in addi-
tion to IIF positive sera, also negative ones (17%) were able to react with Col VII by ELISA and/or
IB. Altogether, these findings allow to delineate an efficient algorithm for the serological diagnosis
of EBA.
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Expression and functional studies on the PRINS non-coding RNA
A Göblös,1 S Bacsa,1 Z Bata-Csörgö,1 L Kemény1 and M Széll2 1 Dermatology and Allergology,
University of Szeged, Szeged, Hungary and 2 Dermatological Research Group of the
Hungarian Academy of Science, University of Szeged, Szeged, Hungary
Our research group has previously identified and characterized a non-coding (nc) RNA molecule,
called PRINS (Psoriasis Susceptibility-related Non-coding RNA). Our in vitro experiments showed
that PRINS expression is induced by various stress factors. Next we demonstrated that nucleophosmin
(NPM) is a direct interacting partner of PRINS. It has been previously demonstrated that the nucle-
olar–nucleoplasmic shuttling of the multifunctional phosphoprotein NPM is affected by ultraviolet
(UV) light in fibroblasts and cancer cells. We aimed to examine the cellular and histological distri-
bution of PRINS ncRNA using in situ hybridization and to study the role of PRINS in the intracel-
lular trafficking of NPM. The in situ hybridization experiments demonstrated variable staining pat-
tern in human tissue samples: high levels of PRINS were detected in the gut, lungs, lymph nodes,
uterus, testicles and skin, however no staining was observed in the cerebrum and cerebellum. The
epidermis and the in vitro cultured keratinocyte cells exhibited strong nucleolar and perinuclear
expression and a moderate homogenous cytoplasmic staining. Gene specific silencing of the PRINS
expression in UV-B-irradiated keratinocytes resulted in the retention of NPM in the nucleolus, sug-
gesting that PRINS is physically and functionally linked to NPM. Taken together, in situ hybridiza-
tion experiments demonstrated that PRINS is expressed in various tissue types but the level of expres-
sion shows great variety. Functional experiments suggest that PRINS may play a role in NPM-mediated
cellular stress response in the skin.
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PD-1 and other new molecules in the psoriatic infiltrate: an immunohistochemical and con-
focal laser microscopic study
AV Marzano,1 S Recalcati,1 S Tavecchio,1 C Crosti1 and E Berti2 1 U.O. Dermatology, Fondazione
IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy and 2 University of Milano-
Bicocca, Milan, Italy
Basic and translational research is recently focusing on immunopathogenesis of psoriasis for the
development of new therapeutic strategies. Psoriatic infiltrate includes several cell types, mostly
represented by T-lymphocytes (Th1, Th17, Th22, Tc1, T-reg), dendritic cells (DC1 and DC2),
macrophages (M1 and M2) and neutrophils. Few studies have recently demonstrated the role of
PD-1, PD1-L and CTLA-4, B7-1/2 inhibitory molecules in the control of T-cell activation and in
favouring T-reg proliferation. The aim of our study was to evaluate the expression of these mole-
cules in the psoriatic infiltrate of 10 patients affected by psoriasis at baseline conditions. An immuno-
histochemical method, with a large panel of monoclonal antibodies against leucocyte differentia-
tion antigens, was used. All samples were examined by light microscopy; PD1 staining was also
evaluated by using triple staining confocal laser microscopy. PD1 expression was clearly detected
on CD8+, TIA1+ cytotoxic T cells, particularly those present in the epidermis; it was also expressed
on several CD4+, T-Bet+, TIA-1- (Th1) lymphocytes in the papillary and superficial dermis, but not
on CD11c+ dendritic cells. Only few PD-1 positive macrophages were observed. High expression
of PD1-L was observed on fibroblasts, macrophages, endothelial cells and keratinocytes of lesional
skin. As regards other cell types composing the inflammatory infiltrate, our results showed many
CD11c+ cells in both the dermis and epidermis, several BDCA2+ plasmacytoid dendritic cells in a
perivascular distribution and isolated Langerin+, CD103+ DCs. Many macrophages were also
present, particularly CD163+ (M2) cells that were located in the papillary dermis. Few CTLA-4+ T-
cells and T-reg (Fox-P3+) were stained. Monoclonal antibodies against classic cytokines, such as
TNFa, labelled macrophages, lymphocytes and endothelial cells. These results pave the way to new
drugs that act regulating PD1 expression in autoimmune disorders and tumors.
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Changes in circulating microRNA levels after anti-TNF therapy in psoriasis patients
A Pivarcsi, F Meisgen, N Xu, M Ståhle and E Sonkoly Unit of Dermatology and Venerology,
Department of Medicine, Karolinska Institutet, Stockholm, Sweden
MicroRNAs (miRNAs) are endogenous, non-protein-coding, regulatory RNAs with important roles
in health and disease. Interestingly, miRNAs are present in the circulation in a stable form and their
level is altered in diseases. Here we aimed to determine whether anti-TNF therapy affects serum
miRNA levels in psoriasis patients. To this end, serum samples were obtained from patients with
chronic plaque psoriasis before and 12 weeks after the initiation of treatment with the TNF-inhibitor
etanercept. MiRNA expression profiling was utilized to identify anti-TNF-regulated microRNAs in
sera of 9 patients responding to therapy. A panel of 38 miRNAs whose level significantly changed
after etanercept-treatment was identified. Several miRNAs regulated by etanercept have previously
been implicated in inflammation and autoimmunity. Five miRNAs (miR-106b, miR-26b, miR-142-
3p, miR-223 and miR-126) were selected for further analysis by qPCR on a larger set of samples
including both responders (PASI change >50%) and nonresponders. The studied miRNA were sig-
nificantly regulated in the responder group. Interestingly, methotrexate, an antipsoriatic drug with
other modes of action than etanercept, did not significantly affect the levels of miR-106b, miR-26b,
miR-142-3p, miR-223 and miR-126, suggesting that the decreased level of these miRNAs is an
anti-TNF-specific effect. These results reveal a previously unknown effect of anti-TNF therapy and
warrant for further investigation of serum miRNAs as potential biomarkers for therapy response in
psoriasis.
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Role of the PPARγ modulator (R)-(3)-(4-Aminophenyl)-2-methoxypropionic acid in control-
ling keratinocyte proliferation and differentiation
A Mastrofrancesco,1 D Kovacs,1 E Camera,1 P Desremaux,2 G Cardinali1 and M Picardo1 1
Cutaneous Physiopathology Laboratory, San Gallicano Dermatologic Institute, IRCCS, Rome,
Italy and 2 Department of Hepatogastroenterology and Nutrition, University of Lille, Lille,
France
Peroxisome proliferator-activated receptors (PPARs) and their ligands mediate important functions
in the skin such as proliferation, differentiation, and inflammation. PPARγ agonists have been suc-
cessfully used in different inflammatory skin disorders, including psoriasis. In this study, we inves-
tigated the effects of a novel PPARγ agonist, (R)-(3)-(4-Aminophenyl)-2-methoxypropionic acid, GPD-
L34, which has been reported to exhibit a strong binding affinity to PPARγ and low cytotoxicity in
preclinical studies, on human primary keratinocytes proliferation/differentiation balance. We pre-
viously demonstrated that GPD-L34 suppresses the inflammatory pathway in keratinocytes inter-
fering with NF-kB signaling. We proceed to demonstrate that GPD-L34 (0.5 mM) specifically induces
mRNA expression of PPARγ without acting on the α and β/σ PPAR isoforms. In addition, this com-
pound was able to significantly downmodulate the expression of the vascular endothelial growth
factor (VEGF) and epidermal growth factor (EGF) up to 30% following 24h of TNF-α treatment. More-
over, we showed that GPD-L34 significantly reduced keratinocyte proliferation (15-30%) induced
by EGF growth factor family members and counteracted the altered expression of differentiation
markers induced by TNF-α. Our findings support the possible therapeutic application of GPD-L34
in psoriasis as the activation of the EGFR pathway is crucial in the sustaining of the disease through
the stimulation of keratinocyte proliferation.
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Anti-inflammatory and sebum regulating effects of a novel PPARγ agonist (GMG-43AC): a
possible innovative treatment of acne
M Ottaviani,1 A Mastrofrancesco,1 M Ludovici,1 C Zouboulis,2 E Camera1 and M Picardo1 1
Cutaneous Physiopathology Laboratory, San Gallicano Dermatological Institute, Rome, Italy
and 2 Depts of Dermatology, Venereology, Allergology and Immunology, Dessau Medical
Center, Dessau, Germany
Sebum quantitative and qualitative alterations are accounted among the major factors involved in
the pathogenesis of acne as well as inflammatory state. Considering the role of peroxisome prolif-
erators-activated receptor gamma (PPARγ) isoform in the control of lipogenesis and inflammation
we have investigated the capacity of a newly designed PPARγ agonist (GMG-43AC) to exert anti-
inflammatory and sebum regulating effects. In sebocytes cells (SZ95) sebogenesis was induced by
lipogenic stimuli working out through different mechanisms. Linoleic acid, the combination linoleic
acid/testosterone or insulin have been used. The data obtained showed that GMG-43AC (1 mM)
specifically increased PPARγ mRNA expression in association with a significant reduction of the
sebaceous lipid synthesis, as demonstrated by the Nile Red assay. The reduction of lipid synthesis
by GMG-43AC is more pronounced in the case of the combination linoleic acid/testosterone than
linoleic acid alone. Gas chromatography-mass spectrometry quantitative analysis of the fatty acid
moiety showed that GMG-43AC doesn’t seem to interfere with the up-take and the beta-oxidation
process of free fatty acids used as source for the induction of sebum synthesis, but with the desat-
urase and elongase enzymes that lead to the formation of unsaturated very long chain fatty acids.
In addition we observed the reduction in the mRNA expression of key lipogenic genes, such as
Fatty Acid Synthase and Stearoyl-CoA Desaturase-1 in the case of insulin-induced lipogenesis. GMG-
43AC has also been shown to have anti-inflammatory properties: the SZ95 treatment with GMG-
43AC reduced IL-6 and IL-8 secretion induced by LPS. In conclusion GMG-43AC has been demon-
strated to have the ability to counteract inflammation and induced sebogenesis offering the possibility
for a new promising drug for the treatment of acne.
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Keratinocyte growth factor can increase the expression of the EDA+ fibronectin
K Vas,1 B Kormos,2 A Bebes,1 A Göblös,1 M Széll,2 L Kemény1 and Z Bata-Csörgö1 1 Department
of Dermatology and Allergology, University of Szeged, Szeged, Hungary and 2
Dermatological Research Group of the Hungarian Academy of Sciences, University of
Szeged, Szeged, Hungary
In our previous work we showed that the fibronectin splice variant EDA+FN, its receptor the alpha5-
integrin, the keratinocyte growth factor (KGF), and its receptor (KGFR) are overexpressed in psori-
atic uninvolved skin, compared to normal skin. EDA+FN and KGF both stimulate keratinocyte pro-
liferation, moreover KGF is also known to induce alpha5-integrin expression. In the present work
we aimed to measure the effect of exogenous KGF on the EDA+FN production of fibroblasts, ker-
atinocytes and HaCaT cells. Cultured normal human fibroblasts, keratinocytes and HaCaT cells
were incubated with different concentrations of human recombinant KGF (10 ng/ml, 25 ng/ml, 50
ng/ml, 100 ng/ml). We carried out real-time RT-PCR, immunocytochemistry and flow cytometric
analysis of EDA+FN 24 hours after exogen KGF treatment. EDA+FN protein expression signifi-
cantly increased in fibroblasts (n=4, p< 0.01), the mRNA also increased (n=2). The maximal effect
was observed at 25 ng/ml KGF concentration. No differences were detected in the gene expression
of EDA+FN in normal human keratinocytes (n=3), no changes were detected in protein expression
at 10 and 25 ng/ml concentrations, however the EDA+FN protein levels significantly decreased
(n=4, p<0.05) at higher concentrations (100 ng/ml) of KGF. In HaCaT keratinocytes exogen KGF
(25 ng/ml) treatment induced an 8-fold increase in mRNA expressions (n=2), and there was no sig-
nificant change in the protein levels (n=2) as determined by flow cytometry, although on cytospin
preparations we detected an increase in EDA+FN expressions at 25 ng/ml KGF concentrations (n=3).
Our results suggest that KGF can promote the production of EDA+FN, therefore it may contribute
to the altered homeostasis in the uninvolved skin of psoriatic patients.
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Effect of an Adenosine A2A receptor Agonist on a murine model of skin hyperplasia
J Arasa,2 P Martos,1 S López-Dieguez,1 RM Andrés,1 M Paya,1 F Valcuende,3 MC Terencio1 and
MC Montesinos1 1 Pharmacology, University of Valencia, Valencia, Spain, 2 Center of
Molecular Recognition and Technological Development (IDM), Valencia, Spain and 3
Dermatology, Hospital La Plana, Vila-Real, Spain
Adenosine is a known regulator of inflammation and immunity via interaction with one or more of
four known cell-surface receptors (A1, A2A, A2B and A3), that mediates, at least in part, the anti-
inflammatory effect of methotrexate. We sought to determine the effect of topical application CGS-
21680, a selective adenosine A2A receptor agonist, on the epidermal hyperplasia induced by the
protein kinase C (PKC) activator 12-O-tetradecanoylphorbol-13-acetate (TPA). CGS-21680 (5 μg/site),
the reference agent dexamethasone (200 μg/site) or vehicle (acetone) was applied on the shaved
backs of female Swiss mice 30 minutes before TPA (2 nmol/site) for three consecutive days. The
next day, animals were sacrificed and 1 cm2 punch biopsies were collected, weighed and either
homogenized or processed for histological analysis. A reduction in inflammatory infiltrate was
observed in H&E stained paraffin-embedded tissue sections that correlated with diminished myeloper-
oxidase (MPO) activity in skin homogenates of agonist-treated mice. Similarly, CGS-21680 treat-
ment reduced the levels of LTB4 (184.9±10.0 ng/ml versus 260.2±30.9 ng/ml in vehicle-treated,
n=5-8, p<0.05) and PGE2 (52.7±5.4 ng/ml versus 103.6±17.4 ng/ml in vehicle-treated, n=5-8,
p<0.05) in skin homogenates. However, topical application of CGS-21680 produced a modest
inhibitory effect on epidermal hyperplasia and edema (129.4±8.0 mg of tissue versus 148.5±4.8
mg of vehicle-treated tissue, n=5-8, p<0.05). In contrast, dexamethasone potently inhibited epi-
dermal hyperplasia and cell infiltration as well as all the inflammatory mediators analyzed in skin
homogenates. Our results suggest that activation of the adenosine A2A receptor could regulate the
inflammatory response in skin.
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Characteristics of scratching behavior in an atopic dermatitis model induced by repeated top-
ical application of Dermatophagoides farinae extract in NC/Nga mice
Y Yamada, Y Ueda, A Nakamura, S Kanayama, R Tamura and R Ishii Research Laboratories, Kyoto
R&D center, Maruho Co.,Ltd., Kyoto, Japan
Atopic dermatitis (AD) is a chronic inflammatory skin disease accompanied by severe itching and
eczematous lesion. AD-like skin lesions can be induced by repeated topical application of an oint-
ment containing Dermatophagoides farinae extract (Df) in NC/Nga mice. Moreover, Df results in
early onset and chronic AD-like skin lesions. The aim of the study was to clarify the characteristics,
especially scratching behavior, and possible mechanisms in the AD-like model developed using
Df. To induce AD-like dermatitis, Df was applied twice-weekly onto the shaved dorsal skin with bar-
rier disruption for 2 weeks. Only mice with dermatitis were used for experiments, and Df was applied
weekly. The therapeutic effects of 0.1% tacrolimus hydrate- and 0.12% betamethasone valerate-
containing ointments were investigated for another 2 weeks. Following repeated topical applica-
tion of Df, the dermatitis score was gradually increased at 2 weeks and was accompanied by an
elevation of total IgE in plasma, and both Th1 and Th2 cytokines in lymph node cells. Significant
plasma leakage in the local skin was also induced 1 hour after application of Df. Interestingly, the
scratching behavior was significantly increased in a biphasic fashion; a transient increase in the
early phase was followed by a persistent increase in the later phase when measured for 24 hours
after every application of Df. The scratching in the early and later phases was reduced by chlor-
pheniramine and cromoglycate, and by a protease inhibitor and anti-PAR2 but not by anti-CD4 or
anti-CD8a, respectively. Tacrolimus and betamethasone valerate significantly ameliorated both
dermatitis and scratching. Tacrolimus was more potent than betamethasone valerate for decreasing
scratching. In conclusion, these results suggest that immediate allergic skin reaction and protease
are involved in scratching behavior in this AD-like model.
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Intranuclear protein fractions of lymphoid cells in patients with localized scleroderma
I Khamaganova,1 M Savina2 and S Khromova3 1 skin diseases&cosmetology, Russian national
research medical university, Moscow, Russian Federation, 2 clinical diagnostics, Russian
national research medical university, Moscow, Russian Federation and 3 microbiology&virol-
ogy, Russian national research medical university, Moscow, Russian Federation
The objective was to assess the intranuclear protein fractions of lymphoid cells in peripheral blood
by examining histones/DNA ratio in patients with localized scleroderma. 81 patients (10 males and
71 females) aged 16 to 56 years with localized scleroderma were examined. Histone fractions
were obtained by stepped extraction. The content of DNA per lymphocyte was assessed by spec-
trophotometric analysis. Three types of intranuclear changes of protein fractions in lymphoid cells
were found in patients with localized scleroderma. The histones/DNA ratio was higher in patients
of the first group (1, 03±0, 04) than in controls (0, 64±0, 03, P<0,02). The duration of the disease
was about 5 to 8 years, previous therapy was not enough effective in the first group. The histones/DNA
ratio was lower in the patients of the second group (0, 49±0, 02) than in controls (0, 64±0, 03, P<0,
02). The duration of the disease in the second group was not longer than 2 weeks, the patients did
not get any treatment. The histones/DNA ratio was lower in the patients third group(0,29±0,02)
than in controls (0,64±0,03, P<0,02).The duration of the disease was 2 to 6 years; previous therapy
in the patients of the third group was absolutely ineffective. The findings showed three types of
changes of lymphoid cells intranuclear protein fractions in patients with localized scleroderma.
The changes probably depend upon the duration of the disease and efficacy of previous therapy.
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Increased adhesion of Epstein-Barr virus-encoded small RNAs-expressing T cells to cultured
endothelial cells
M Nakagawa,1 T Akasaka1 and H Kanno2 1 Dermatology, Iwate Medical University, Iwate,
Japan and 2 Shinshuu University, Nagano, Japan
Epstein-Barr virus (EBV)-positive natural killer/T cells detected in the diseases associated with chronic
active EBV infection exhibit affinity to vascular structure. To clarify the role of EBV-encoded small
RNAs (EBERs), which express in all latently infected cells with EBV, the alteration of adhesion capac-
ity of lymphoid cells to endothelial cells with expression of EBERs was examined using a human γδ
T cell line, MOLT14, and EBERs-expressing stable transformants of MOLT14 with the transfection
of EBERs-expressing plasmids. MOLT14 cells exhibited increased adhesion to cytokine-stimulated
endothelial cells with expression of EBERs. EBERs-expressing MOLT14 cells showed increased pro-
tein expression of an adhesion molecule, lymphocyte function-associated antigen-1 (LFA-1), and a
chemokine receptor, CX3CR1, and furthermore, pretreatment of EBERs-expressing MOLT14 cells
with anti-LFA-1 antibody and that of endothelial cells with anti-intercellular adhesion molecule-1
(ICAM-1) inhibited cellular adhesion. Thus, increased expression of LFA-1 in MOLT14 cells with
EBERs-expression, which interacts with its ligand, ICAM-1, on endothelial cells, would cause the
increased cellular adhesion. These results shed light on the role of viral infection in the infiltration
of T cells into connective tissues, which triggers various immune diseases.
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Human amnion membrane as a substrate for indirect immunofluorescence and immunoblot-
ting analysis of auto antibodies, in autoimmune bullous skin diseases
T Sezin,1 E Avitan-Hersh,1 M Indelman,1 R Moscona,2 R Katz,3 S Pollack,3 E Sabo4 and R Bergman1
1 Dept of Dermatology, Rambam Medical Center, Haifa, Israel, 2 Dept of Plastic Surgery,
Rambam Medical Center, Haifa, Israel, 3 Dept of Immunology, Rambam Medical Center,
Haifa, Israel and 4 Dept of Pathology, Rambam Medical Center, Haifa, Israel
We studied human amniotic membrane (HAM) as an antigenic source for detecting auto antibod-
ies (Abs) in autoimmune bullous skin diseases (AIBSDs).Immunomapping demonstrated the fol-
lowing Ags in both the normal human skin and HAM: Desmogleins (Dsgs) 1&3, desmocollin (Dsc)
3, periplakin, envoplakin, desmoplakin, plakoglobin, bullous pemphigoid antigen 2 (BP180), laminin
5, integrin α6β4, collagen 7, laminin 6γ1 and p170. Tandem liquid chromatography mass spec-
trometry demonstrated all of these Ags in both the normal human skin and HAM, except for the
absence of BP230, and low threshold levels of Dsg1, Dsg3 and Dsc 3 in HAM. Indirect immuno-
fluorescence (IIF) using HAM as a substrate demonstrated anti basement membrane zone (BMZ) Abs
in 20 of the 41 (48.7%) bullous pemphigoid (BP) patients, and anti intercellular space (ICS) Abs in
18 of the 25 (72%) pemphigus vulgaris (PV) patients. Immunoblotting (IB) using HAM as the anti-
genic source did not demonstrate BP230 Abs in any of the BP cases, but detected BP180 Abs in 22
of the 41 (53.6%) BP patients. It did not demonstrate anti Dsg1 and/or Dsg3 Abs in any of the 25
studied PV cases. Altogether, the results of IIF & IB using HAM were inferior to IIF using monkey
esophagus, and enzyme linked immunosorbent assay (ELISA) in detecting anti BP180, BP230, and
Dsg1 & Dsg3 Abs. Therefore, HAM does not offer advantages in detecting auto Abs in AIBSDs .This
is most likely due to the low levels or the absence of several Ags in HAM, and the difficulty inher-
ent in an epithelial monolayer as compared to a multilayer epithelium in the immunofluorescence
assay.
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Anti-TNF-α Molecules Establish A More Differentiated Phenotype In Psoriatic Epidermis
L Pescitelli,1 F Prignano,1 L Tripo,1 F Ricceri,1 E Donetti,2 A Gualerzi2 and M Bedoni2 1 University
Unit of Dermatology – Cluster II Section of Clinical, Preventive and Oncologic Dermatology
Dept. of Critical Care Medicine and Surgery, University of florence, Florence, Italy and 2
Dipartimento di Morfologia Umana e Scienze Biomediche – Città Studi, University of milan,
Florence, Italy
Common inflammatory skin disorders such as psoriasis exhibit an alterated barrier function. In par-
ticular, anomalous expression of proteins forming intercellular junctions has been reported in lesional
and non lesional skin of psoriatic patients. The aim of the present study was to investigate if anti-
TNF-α treatment could affect the expression of the main structural proteins in epidermal junctions
and cytoskeleton together with cell proliferation in psoriatic skin. We investigated by immunoflu-
orescence the expression of transmembrane proteins in desmosomes (desmocollin-1, desmoglein-
1), adherens junctions (E-cadherin, β-catenin), and tight junctions (occludin) in normal and psori-
atic skin before and after 4 months of treatment with the anti-TNF-α treatment etanercept.
Differentiation biomarkers (keratin-10, keratin-14, keratin-16, involucrin) and epithelial prolifera-
tion were also evaluated. Our results showed that in psoriatic epidermis the expression of occludin,
K14, K16 and involucrin was altered compared with healthy subjects, while desmocollin-1,
demoglein-1, E-cadherin, β-catenin, and keratin-10 localizations were comparable. The distribu-
tion pattern of all considered biomarkers of intercellular adhesion and terminal differentiation was
reverted to the physiological condition upon treatment with etanercept. Keratinocyte proliferation
was inhibited in anti-TNF-α treated patients, reaching value similar to controls. Our results high-
light that etanercept is effective in restoring an efficient junctional apparatus, a more differentiated
phenotype, and the typical proliferation rate in the epidermis of psoriatic patients.
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Systemically elevated Th1-, Th2- and Th17-associated chemokines in psoriasis
A Ekman,1 G Sigurdardottir,1 M Carlström,1 N Kartul,1 MC Jenmalm2 and C Enerbäck1 1 Ingrid
Asp Psoriasis Research Center, Department of Clinical and Experimental Medicine, Faculty of
Health Sciences, Linköping University, Linköping, Sweden and 2 Division of Clinical
Immunology, Department of Clinical and Experimental Medicine, Faculty of Health Sciences,
Linköping University, Linköping, Sweden
Psoriasis is a Th1/Th17-characterized immune disease. In psoriasis there is an infiltration of T cells
to the skin and a local secretion of cytokines, chemokines and growth factors. While the disease
manifests in the skin, there is also a systemic inflammation that may explain the increased risk for
co-morbidities in psoriasis patients. The study aimed to investigate circulating chemokines in pso-
riasis patients and to study how they are affected by narrowband ultraviolet (UV)B treatment. The
chemokines CXCL8, CXCL9, CXCL10, CXCL11, CCL17, CCL20 and CCL22 were measured in plasma
from 27 patients and matched controls using a Milliplex cytokine/chemokines assay. Fifteen patients
were followed-up and additional plasma samples were obtained after 6 and 12 weeks of narrow-
band UVB treatment. Peripheral blood mononuclear cells (PBMCs) were isolated from the 10 patients
with the highest severity score and stimulated with LPS or anti-CD3, anti-CD28 antibodies to acti-
vate antigen-presenting cells and T cells, respectively, in order to study the systemic cytokine pro-
file up-streams of the chemokine production. Analysis of chemokines levels revealed an increased
expression of the Th1-associated CXCL9 and -10, the Th2-associated CCL17 and CCL22 and the
Th17-associated CCL20 in plasma from psoriasis patients. CCL20 was found to correlate with dis-
ease severity. Narrowband UVB therapy reduced skin symptoms, but did not affect the plasma lev-
els of the investigated chemokines. Anti-CD3, anti-CD28-mediated activation of PBMCs caused a
higher secretion of the Th2 cytokine IL-13 by PBMCs from psoriasis patients than from healthy con-
trols. The cytokine release by activated PBMCs was not affected by narrowband UVB treatment.
These results suggest that the effect of UVB may be more focused on local inflammation than the
systemic.
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Early-stage development of psoriatic lesions associates with increment of T cells and dermal
CD11c+ dendritic cells
MB Teunissen,1 L Zheng,2 M de Groot,1 MA de Rie,1 JS Fine2 and S Chen2 1 Dermatology,
Academic Medical Center, Amsterdam, Netherlands and 2 Merck Research Lab, Kenilworth,
NJ
Information on leukocytes involved in the earliest stage of psoriatic lesion development is limited.
We examined the presence of several leukocyte types in incipient psoriatic point lesions at differ-
ent time points in a timeframe of 14 days. A series of biopsies were collected from a recently-devel-
oped group of point lesions that were simultaneously formed. After specific staining of skin sec-
tions with various leukocyte markers, numbers were assessed and compared with K16 expression
and epidermal thickness, which both are considered as hallmarks for psoriasis. We found that the
K16+ cell increment correlated significantly with the increase in epidermal thickness. The changes
in CD3+, CD4+, and CD8+ T cell numbers in the dermis showed significant associations with K16
expression and epidermal thickness between d7–d14, whereas in the epidermis only CD8+ T cells
demonstrated a significant correlation. Interestingly, CD11c+ dendritic cells (DCs) showed a sig-
nificant correlation with K16 expression and epidermal thickness from the earliest time point onwards.
There was also a numeric correlation of CD11c+ DCs with the CD3+ T-cell shifts between d7–d14.
Dermal CD14+ cells and K16 expression also showed a significant correlation between d7–d14.
We did not observe BDCA-2+ plasmacytoid DCs in non-lesional skin, but found these cells at low
numbers in most lesions. The change in plasmacytoid DC or neutrophil numbers did not correlate
with lesion development. Our data show that T cells, and in particular dermal CD11c+ DCs, may
have a relevant role in the early development of psoriatic lesions.
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Increased Foxp3+ regulatory T cells in psoriatic lesions are related to psoriatic activity
E Nishida, S Kasuya, C Saito, T Furuhashi, A Nishioka, Y Shintani and A Morita Geriatric and
Environmental Dermatology, Nagoya City University Graduate School of Medical Sciences,
Nagoya, Japan
Foxp3+CD4+ T cells (Treg) are a subset of regulatory T cells that have a suppressive capacity to main-
tain immunologic tolerance. An imbalance between Treg and Th17 is presumably an important fac-
tor for psoriasis activity. Recent studies, including ours, investigating circulating Th17/Treg in pso-
riasis patients, revealed that Th17 are elevated and Treg are elevated or remain similar to levels in
healthy controls. The Th17/Treg imbalance was successfully restored by narrowband UVB or bath-
psoralen UVA therapy. The localization of Treg and Th17 cells in psoriatic lesions, however, has not
been analyzed in depth. Here we analyzed Treg and Th17 in skin lesions with the relevant anti-
bodies and examined their relation to other parameters, including severity and circulating Th17
levels. Skin lesions from 10 psoriasis patients (7 men, 3 women) were examined. The Psoriasis Area
Severity Index (PASI) score was positively correlated with the number of Foxp3+ T cells (r=0.577),
but not CD4+T cells (r=-0.095). The Th17 population among CD4 cells in the peripheral blood did
not correlate with the number of Foxp3+ T cells in the lesional skin (r=0.2444) or PASI scores
(r=0.008). We examined the skin lesions of 5 other psoriasis patients (4 men, 1 woman) before and
after bath-PUVA therapy. Bath-PUVA therapy reduced the number of Foxp3+ T cells in the lesions
and increased circulating Treg. The induced Treg had restored function. A recent in vitro study
revealed a cell population that differentiates into helper T cells from Foxp3+ T cells, which develop
after transient Foxp3 expression induced by cytokine signals and environmental factors. Foxp3+ T
cells have inhibitory activity in human psoriatic lesions, and might also develop into helper T cells,
like a double-edged sword. Based on this study, lesional Foxp3+ T cells might be related to psori-
atic activity by differentiating into Th17 and could be decreased in clinical human settings by the
appropriate phototherapy.
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Dysregulated production of IL-23 by Langerhans Cells from psoriasis patients
CM Sweeney, K Adamzik, A Tobin and B Kirby Dermatology, St Vincent’s University Hospital,
Dublin, Ireland
Topical Vitamin D3 analogues are commonly used to treat psoriasis, an inflammatory skin disorder
characterised by epidermal inflammation, hyperproliferation of keratinocytes and dermal infiltra-
tion of leukocytes. In addition to their effects on keratinocyte proliferation, Vitamin D3 analogues
exert various immunomodulatory properties including inhibition of T cell proliferation. It was pre-
viously thought that T helper (Th) 1 cells were exclusively responsible for the pathogenesis of pso-
riasis, however, in recent years, Th17 cells have been shown to play a central role in disease. Cells
of the innate immune system, in particular dendritic cells (DC), play a crucial role in directing T cell
responses through the production of regulatory cytokines. Recently, IL-23 has been shown to pro-
mote the induction of Th17 cells and genetic variations in the IL-23 signalling pathway appear to
predispose to the development of psoriasis. This study examined the effect of 1,25 (OH)2 D3, the
active form of Vitamin D3, on cytokine production by langerhans cells (LC), a specialised DC sub-
set that reside in the epidermis, focusing specifically, on cytokines known to promote the develop-
ment of Th17 cells. Here we demonstrate that 1,25 (OH)2 D3 significantly suppressed zymosan-
induced IL-23 production but enhanced IL-10 by epidermal LC and monocyte derived (Mo)LC
from healthy controls. Neutralization of IL-10 abrogated the suppressive effect of 1,25 (OH)2 D3
on IL-23 production. In contrast, LC derived from psoriasis patients produced significantly more IL-
23 following zymosan stimulation compared with LC from healthy controls and were refractory to
1,25 (OH)2 D3-mediated suppression. Moreover, 1,25 (OH)2 D3 failed to enhance the production
of IL-10 by LC from psoriasis patients. However, 1,25 (OH)2 D3 directly suppressed IL-17 produc-
tion by anti-CD3 activated T cells from both psoriasis patients and healthy controls. This study demon-
strates that Vitamin D3 suppresses IL-23 in normal circumstances via IL-10 and demonstrates dys-
regulated IL-23 production in psoriasis.
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A benzothiphene γ-hidroxibutenolide derivative as inhibitor of NF-κB and STAT3 signalling
in mouse skin
R Andrés,1 J Arasa,1 M Payá,1 M Montesinos,1 P Navalón2 and M Terencio1 1 Department of
Pharmacology, University of Valencia, Valencia, Spain and 2 Department of Urology, General
University Hospital of Valencia, Valencia, Spain
In a previous study, we demonstrated the inhibitory effect of 4-benzo[b]thiophen-2-yl-3-bromo-5-
hydroxy-5H-furan-2-one (BTH) on TNFα and IL-8 release as well as on NF-κB activation in normal
human keratinocytes. In the present work, we characterized the in vivo effect of BTH on NF-κB and
STAT3 signalling pathways in the TPA(12-O-tetradecanoylphorbol 13-acetate)-induced skin hyper-
plasia murine model. For this purpose, BTH (200 or 400 μg/site) was applied to the backs of female
Swiss mice 1 hour prior the application of TPA (2 nmol/site) for three consecutive days. Skin punch
biopsies were homogenized or processed for histological analysis. In these conditions, BTH inhib-
ited lesion formation as well as edema in a dose-dependent manner. H&E staining of skin biopsies
showed the inhibition of epidermal hyperplasia after BTH treatment and a decrease in inflamma-
tory cell infiltrate in skin of BTH-treated mice that correlated with a reduction of MPO activity and
LTB4 levels in skin homogenates. In addition, immune histochemical analysis showed a decrease
of CD3+ T cell infiltrate and cytokeratin 6 staining, determined as indicative of proliferating ker-
atinocytes. In accordance with the anti-inflammatory profile exerted in vitro, BTH dose-depend-
ently reduced the levels of TNFα and CXCL-1 as well as IL-6, IL-1β and PGE2 in skin homogenates.
Finally, BTH inhibited STAT3 Tyr705 and p65 NF-κB phosphorylation in skin biopsies as determined
by Western blotting analysis. Taken all together, the results presented in this study demonstrate that
the interesting in vitro pharmacological profile showed previously by BTH is also exerted when
applied topically to whole skin, providing further evidence of the potential beneficial effect of BTH
in the treatment of inflammatory skin diseases such as psoriasis.
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Non Dermatitis Herpetiformis-Positive IGA Inflammatory Skin Diseases Associated With
Gluten Sensitivity
V Bonciolini, D Bonciani, A Verdelli, I Pierini, B Bianchi, A D’Errico, E Antiga, P Fabbri and
M Caproni University of Florence, Florence, Italy
In recent years clinical evidence suggested a significant increase of the association between celiac
disease (CD) or gluten sensitivity (GS) and inflammatory skin diseases different from dermatitis her-
petiformis (DH), such as psoriasis, alopecia areata, linear immunoglobulin A (IgA9 bullous der-
matosis, urticaria or atopic dermatitis. While the relationship of CD or GS with DH are continu-
ously investigated, to date we have little knowledge about their pathogenetic association with
other inflammatory skin diseases. In collaboration with the Department of Gastroenterology of the
University of Florence, we enrolled 22 celiac patients, including 16 females and 6 males, affected
by different inflammatory skin diseases. Classical CD histologically classified as Marsh 2a, 2b or 3
was present in 10 of the enrolled patients, while the others were affected by GS. By collecting sam-
ples of perilesional skin for direct immunofluorescence study, we investigate the presence and dis-
tribution of IgA and fraction complement 3 (C3) both in patients on gluten-free diet for at least one
year and in patients not yet on diet. The results of our study showed IgA and/or C3 deposits along
the basement membrane in perilesional skin of patients affected by inflammatory skin diseases, in
particular psoriasis, allergic contact dermatitis, pityriasis roseas Gibert and granuloma annulare,
which had not yet started gluten-free diet, while celiac patients on a gluten-free diet for at least one
year showed perivascular IgA and/or C3 deposits and/or IgA and/or C3 and/or fluorescent bodies.
Our findings showed that gluten-induced IgA antibodies can be detected in all skin diseases asso-
ciated with GS; moreover, their disappearance in patient on a gluten-free diet suggests their poten-
tial pathogenetic role in the development of GS- associated skin lesions.
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Systemic inflammation in plaque-type psoriasis: TNF-α production by corresponding cell types
in skin and blood of affected patients
PM Brunner, F Koszik, B Reininger, M Kalb, W Bauer and G Stingl Dpt. of Dermatology, Medical
University of Vienna, Vienna, Austria
The spectrum of tumor necrosis factor (TNF)-α-producing cells in psoriasis as well as their fate dur-
ing treatment with TNF-α-antagonists is not clearly defined. The elucidation of these questions should
allow us to better understand the mode of action, efficacy and, perhaps, also the risks of an anti-
psoriatic treatment with TNF-α-blockers. Using a tyramide signal amplification system for cytokine
labeling in lesional psoriatic skin, we found TNF-α on dermal HLA-DR+ leukocytes co-expressing
either CD11c or CD163, markers consistent with myeloid dendritic cells (mDCs) and macrophages,
respectively. Strikingly, we did not find detectable levels of TNF-α on other cells including ker-
atinocytes or T cells. In peripheral blood, production of TNF-α was limited to slan(6-sulfo LacNAc)
DCs and CD16+ monocytes, and their number increased with disease severity. Up to 16 hours after
the intravenous administration of the TNF-α-antagonist infliximab, we found no overt changes in
the numbers of TNF-α-reactive cells in the skin and in the blood of psoriatic patients, nor could we
detect signs of apoptosis. Yet, we observed a rapid decrease of levels of mRNA encoding the proin-
flammatory molecules IL-12p40, IL-1beta and CCL20 as well as IL12RB1, the common subset of
the IL-12 and the IL-23 receptor, in lesional psoriatic skin. In our study, the expression of TNF-α
was limited to cells of the myeloid lineage. The increase of these cells not only in lesonal skin but
also in the peripheral blood supports the notion of a chronic systemic inflammatory condition in
psoriatic individuals, possibly fuelling comorbidities such as psoriatic arthritis and the metabolic
syndrome, diseases often associated with low-grade tissue inflammation. Our data further suggest
that these myeloid cells are not subject to direct killing by infliximab. Anti-TNF-α treatment rather
results in decreased tissue inflammation as well as in a rapid downregulation of the pathogenic IL-
12-/IL-23-driven immune response.
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P38 MAPK - an important player in the regulation of S100A8 in human keratinocytes
M Mose, K Zhanyuan, L Iversen and C Johansen Department of Dermatology, Aarhus
University, Aarhus, Denmark
The antimicrobial peptide S100A8 is known to be upregulated in lesional psoriatic skin but little is
known about the signalling pathways involved in its expression. The purpose of this study was to
investigate the intracellular signalling pathways involved in the regulation of S100A8 in cultured
human keratinocytes stimulated with TNFα and IL-17A, two cytokines known to be involved in the
pathogenesis of psoriasis. Normal human keratinocytes were cultured to a confluence of 60-70%
before stimulated with either TNFα (10ng/ml), IL-17A (100ng/ml) or TNFα and IL-17A in combina-
tion for 3, 6 and 24 hours. In some experiments cells were preincubated with either SB202190,
PD98059, SP600125 or SC-514 (a p38-, ERK-, JNK- or NF-κB inhibitor, respectively) for 45 min-
utes before stimulation with either TNFα, IL-17A or TNFα and IL-17A in combination. The S100A8
mRNA expression was determined by quantitative PCR using RPLP0 for normalization, whereas
western blotting was used to measure the protein level of S100A8. Student’s t-test was used for sta-
tistical analysis. Our study demonstrates a time dependent increase in S100A8 mRNA expression
with a significant maximum after 24 hours when stimulating with TNFα and IL-17A alone or in com-
bination. Stimulation with IL-17A and TNFα induced the expression of S100A8 mRNA at a higher
level than the additive values of IL-17A and TNFα alone, demonstrating a synergistic induction of
S100A8. The induction of S100A8 mRNA and protein was found to be mediated by a p38 MAPK
dependent mechanism, because preincubation with a p38 MAPK inhibitor significantly reduced the
TNFα and IL-17A induced expression of S100A8. Inhibition with ERK, JNK or the NF-κB inhibitor
did not significantly change the S100A8 mRNA expression or its protein level. We conclude that
the p38 MAPK signalling pathway plays a key role in the TNFα and IL-17A induced expression of
S100A8 in cultured human keratinocytes. The mechanism by which the synergistic effect of stimu-
lating with TNFα and IL-17A in combination is mediated needs further investigation.
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Isothiocyanate treatment protects from IL-23-mediated autoimmune inflammation
J Geisel, J Brück, I Glocova, K Dengler, T Sinnberg, M Röcken and K Ghoreschi Department of
Dermatology, University of Tuebingen, Tuebingen, Germany
Naturally occuring isothiocyanates (ITC) from cruciferous vegetables have been reported to affect
inflammation. To study the possible effects of ITC on innate and adaptive immune responses we
first fed mice with ITC derivatives or a control diet before immunization with autoantigen and com-
plete Freund’s adjuvant. ITC treatment protected mice from severe inflammatory autoimmune dis-
ease. The improvement was associated with reduced expression of interleukin (IL-)17. However, in
vitro ITC had no effect on Th cell differentiation when activating isolated CD4+ T cells with anti-
CD3 and anti-CD28 antibodies. Next, we analyzed the effects of ITC on dendritic cell (DC) matu-
ration and cytokine production. Interestingly, ITC inhibited LPS-mediated IL-23 production by DC
without affecting DC maturation or survival. Since IL-23 production is regulated by NFκB, we fol-
lowed NFκB activation in ITC-treated DC. Surprisingly, IκBα degradation was not affected by ITC.
In contrast, NFκB binding to the IL-23p19 promoter was reduced in ITC-treated DC. Moreover, in
ITC-treated DC no enrichment was observed for histone 3 acetylation within the IL-23p19 locus.
The anti-inflammatory action of ITC treatment was confirmed in vivo demonstrating that ITC-treat-
ment of mice suppressed IL-23p19 expression after immunization. Thus, ITC treatment protects from
IL-23-mediated autoimmune inflammation by inhibiting NκkB binding to the IL-23p19 promoter.
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Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL): a possible pathogenic
role in chronic plaque psoriasis
G Caldarola,1 A Carbone,1 C De Waure,2 C Benedetti,1 G Vianale,3 P Sollena,1 F Perino,1
P Amerio4 and C De Simone1 1 dermatology, catholic university of the sacred heart, rome, Italy,
2 Institute of Hygiene, catholic university of the sacred heart, rome, Italy, 3 Department of
Oncology and Neurosciences, University of Chieti-Pescara, chieti, Italy and 4 dermatology,
University of Chieti-Pescara, chieti, Italy
Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) is a cytokine member of the Tumor
Necrosis Factor (TNF) family known to have an apoptotic and/or a pro-inflammatory role in normal
skin and in several cutaneous diseases. Recently, an involvement of TRAIL in the pathogenesis of
psoriasis has been also hypothesized. Aim of our study was to evaluate the expression and local-
ization of TRAIL and its receptors in psoriatic skin as well as its serum level. Moreover, in order to
better clarify a potential role of TRAIL and its receptors in psoriasis, we performed immunohisto-
chemistry for caspase 8 and NFkB on lesional skin samples. Finally, we looked for any correlation
between laboratory findings and clinical characteristics of the disease. Twenty-four patients affected
with plaque psoriasis and 25 and sex-matched healthy subjects were enrolled. Each of the tech-
niques used permitted to find higher levels of TRAIL in psoriatic lesional skin than in non-lesional
or healthy skin. In addition, RT-PCR confirmed an increased synthesis of all TRAIL receptors in
lesional rather than non-lesional skin. By immunohistochemestry, TRAIL receptors were found to
be more expressed in lesional skin of psoriatic patients than in healthy subjects and to be completely
absent in the dermis of the control samples. Finally, we found also a correlation between dermal
caspase 8 and TRAIL on immunohistochemistry. No correlation was found between TRAIL expres-
sion and global or local disease severity scores. In conclusion our results suggest that TRAIL may
be involved in the pathogenesis of psoriasis, probably acting at the site of the inflammatory infil-
trate and probably through caspase 8 activation.
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Characterization of dendritic cells in pemphigus vulgaris
K Karlmark,1 B Tackenberg,2 M Hertl,1 M Schnare3 and R Eming1 1 Department of Dermatology
& Allergology, Philipps University of Marburg, Marburg, Germany, 2 Department of
Neurology (Clinical Neuroimmunology group), Philipps University of Marburg, Marburg,
Germany and 3 Institute for Immunology, Philipps University of Marburg, Marburg, Germany
Pemphigus vulgaris (PV) is a severe autoimmune blistering skin disease in which autoantibodies
are directed mainly against the desmosomal protein, desmoglein-3 (Dsg3). The contribution of innate
immune cells to this organ-specific autoimmune disease is largely unknown. Aim of this study was
to investigate dendritic cells (DCs), plasmacytoid dendritic cells (pDCs) and the expression of DC
related chemokines-chemokine receptors in PV patients compared with healthy controls. Multiple
sclerosis (MS) patients were used as an autoimmune disease control to validate the specificity of
our observations.Blood from PV, MS patients and healthy donors were collected and PBMC were
isolated by gradient centrifugation. Cells were analyzed by FACS and were also cultured for in vitro
assays. In the sera, we performed ELISA for the chemokine ligands MIP-3α and MIP-3β. Based on
flow cytometry, our preliminary data showed a profound increase in APC especially CD14+ mono-
cytes, CD11c+ dendritic cells in PV patients compared to healthy controls and to MS patients. The
surface expression of HLA-DR and the co-receptor molecule B7.2 were also increased on APC
from PV patients. Furthermore, CD11c+ DC from PV patients showed increased expression levels
of chemokine receptors CCR2 and CCR4. By ELISA, there was a decreased levels of MIP-3α in the
sera of PV patients (7.65pg/mL) compared to healthy controls (14.55pg/mL).Functional analysis of
PBMC from healthy donors and PV patients upon in vitro stimulation with various TLR ligands such
as LPS, R848 and RNA40, showed a significant global increase in IL-6 and IFN-α secretion by PBMC
from PV patients. In summary, these preliminary results suggest that both quantitative and qualita-
tive differences in the APC compartment, especially the DC, may contribute to the pathogenesis of
PV. Our findings warrant further investigations of the role of innate immune stimuli in pemphigus.
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Insulin resistance at the endothelial cell level is a pathogenic link between psoriasis and its
cardiovascular co-morbidities
K Woth, S Diehl, K Hardt, C Buerger and W Boehncke Department of dermatology, Johann
Wolfgang Goethe University, Frankfurt am Main, Germany
Psoriasis, a chronic inflammatory disease, appears mainly on the skin, but is associated with severe
co-morbidities such as diabetes or coronary atherosclerosis. The common denominator of these
co-morbidities is insulin resistance. Given the similarities in the formation of psoriatic plaques (epi-
dermis) and atherosclerotic plaques (endothelium), we hypothesize that a common pathomech-
anism may provide a causal link between psoriasis and its well-known cardiovascular co-morbidi-
ties. Specifically, the underlying mechanism and pathways that are known to play a role in the
development of atherosclerosis also contribute to the pathogenesis of psoriasis and its co-morbidi-
ties. As insulin is both cardio protective and anti-inflammatory, cytokine-induced insulin resistance
may provide this link. By measuring insulin-dependent PKB phosphorylation in primary endothe-
lial cells (HDBEC [human dermal blood endothelial cells]), we could show that a mix of “psoriatic”
cytokines (interleukin (IL)-1beta, IL-17, IL-23) induces insulin resistance. Moreover we could elu-
cidate which signaling components are involved in mediating insulin resistance by using chemical
inhibitors. Furthermore we examined the expression of adhesion molecules such as E-Selectin and
ICAM-1 which are involved in the process of transendothelial migration of T-cells or monocytes.
The expression of these molecules on the cell surface is repressed by insulin and altered under con-
ditions of insulin resistance. Therefore we suggest that under conditions of systemic inflammation
as in psoriasis the disturbed insulin response contributes to the pathogenesis of psoriasis and its co-
morbidities. Therapeutic approaches interfering with the altered insulin response in psoriasis might
by very effective by targeting both the dermal as well as the cardiovascular dimension of psoriasis.
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Several Cytokines Modulate Differentiation-Related Calcium Channels in Keratinocytes
FA Schafer,1 K Leuner2 and WE Muller1 1 Department of Pharmacology, Biocenter, Goethe
University, Frankfurt am Main, Germany and 2 Deparment of Molecular and Clinical
Pharmacy, University of Erlangen, Erlangen, Germany
Cytokines play a pivotal role in the pathogenesis of psoriasis and atopic dermatitis (AD). Both dis-
eases are characterised by disturbed maturation of keratinocytes. The regulation of intracellular cal-
cium concentration during differentiation seems to be defective in AD and psoriasis. However, the
interplay between cytokines and disturbed calcium regulation is not clear. To elucidate the link
between altered cytokine levels and defective differentiation, we investigated the effects of inter-
leukin-4 (IL4), interleukin-13 (IL13), interferon-γ (IFNγ) and tumor necrosis factor-α (TNFα) on dif-
ferentiation and intracellular calcium concentration using HaCaT keratinocytes. We conducted
calcium imaging experiments to investigate cytokine effects on intracellular calcium. Stimulating
HaCaT cells with the respective cytokine, only IFNγ induced a calcium influx. To explore long-term
effects on proliferating and differentiating keratinocytes, HaCaT cells were treated with a cytokine
in the presence of 0.07 mM or 2 mM calcium. Calcium-induced calcium-influx was assessed. IL4
1 ng/ml and IL13 1ng/ml enhanced calcium influx in proliferating cells after 24h whereas IL4 30
ng/ml reduced it. We also tested cytokine effects on TRPC6 channels using hyperforin. After 24h
treatment with IL4 1 ng/ml or IL13 1 ng/ml, hyperforin-induced calcium influx was reduced in dif-
ferentiating cells. IL13 1 ng/ml also decreased calcium influx in proliferating keratinocytes. Data on
mRNA and protein level complete our findings. To confirm cytokine effects on calcium-induced
differentiation, HaCaT cells were treated with cytokines. Transglutaminase 1 (TGM1) mRNA levels
were analysed by polymerase chain reaction. IL4 30 ng/ml and IFNγ 30 ng/ml increased TGM1
mRNA levels after 24h hours. Data from haematoxylin-eosin-staining and crystal violet assay sup-
ported our results. In conclusion, our data indicate a direct cytokine effect on differentiation and
ion channels linked to keratinocyte differentiation.
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Aberrant Expression of Heat Shock Protein 90 in Skin and Blood of Bullous Pemphigoid Patients
S Tukaj,1 K Kleszczynski,1 D Meyersburg,1 P Trzonkowski,2 E Schmidt,1 RJ Ludwig,1 D Zillikens,1
TW Fischer1 and M Kasperkiewicz1 1 Department of Dermatology, University of Lübeck,
Lübeck, Germany and 2 Department of Clinical Immunology and Transplantology, Medical
University of Gdansk, Gdansk, Poland
The cell stress chaperone heat shock protein 90 (Hsp90) has been implicated in inflammatory
responses and its inhibition has proven successful in different mouse models of autoimmune dis-
eases, including epidermolysis bullosa acquisita. Here, we investigated expression levels and secre-
tory responses of Hsp90 in bullous pemphigoid (BP) patients and healthy controls. Compared with
controls (n=32), an increased intracellular accumulation of Hsp90 was detected in perilesional
skin biopsies and extracts of peripheral blood mononuclear cells of BP patients (n=12) by fluores-
cent immunohistochemistry and ELISA, respectively. In contrast, Hsp90 serum levels were lower in
BP patients than in healthy subjects as measured by ELISA. Interestingly, intraindividual serum lev-
els of Hsp90 increased in parallel with both healing of skin lesions and decline in circulating anti-
BP180 NC16A antibodies. To investigate if comparatively higher intracellular and lower serum lev-
els of Hsp90 in BP patients are a result of compromised secretion of this protein into the extracellular
space, peripheral blood mononuclear cells were cultured and stimulated by the proinflammatory
agents TNFα and LPS/CpG. In fact, Hsp90 levels in supernatants from stimulated cell cultures of BP
patients were lower compared to those of controls as measured by ELISA. By immunoblotting, this
effect was not due to discriminative expression of protein kinase A or protein phosphatase 5, both
of which were previously described to be involved in the regulatory mechanism of Hsp90 secre-
tion. In sum, our results reveal an upregulated Hsp90 expression at the site of inflammation and a
differential regulation of the intracellular and extracellular distribution of Hsp90 in BP patients and
healthy subjects, thus suggesting a pathophysiological role of this protein in this autoimmune bul-
lous disease.
171
Oxidative stress markers in psoriatic patients plasma and NADPH oxidase as a source of oxida-
tive stress in fibroblasts
L Tripo,1 V Barajina,2 M Becatti,2 L Pescitelli,1 C Fiorillo,2 N Taddei,2 S Soldi2 and F Prignano1 1
Division of Clinical, Preventive and Oncology Dermatology, Department of Critical Care
Medicine and Surgery, University of Florence, Florence, Italy and 2 Department of
Biochemistry, University of Florence, Florence, Italy
In psoriasis reactive oxygen species (ROS) over-production and their role in disease progression, is
well proved, but there are still poor data about the sources of ROS in this pathological condition.
In the plasma and in peripheral blood mononuclear cells (PBMC) of untreated, treated with bio-
logicals and control psoriatic patients we searched for markers of lipoperoxidation, protein carbonyl
content and total antioxidant capacity. In PBMC we assayed by citofluorimetric analysis, ROS con-
tent and NADPH-oxidase 4 (NOX4) activity. We also established primary cultures of fibroblasts from
non-involved (treated with biologicals) and involved (not treated) skin of four psoriatic patients. In
these cells we searched for signs of oxidative stress with the same markers. On plasma, our results
show a marked and significant increase in all oxidative stress markers in psoriatic patients in com-
parison with healthy controls. Plasma obtained by biological treated patients showed a significant
decrease in oxidative stress markers. The status of antioxidant defences significantly decreased in
psoriatic untreated patients. We found a significant increase in ROS production in PBMC obtained
by untreated psoriatic patients. Fibroblasts from untreated psoriatic patients showed marked increase
of oxidative markers. Moreover western blot analysis revealed notable increase of the NOX4 expres-
sion in untreated fibroblasts. IOur results highlight a new mechanism of ROS formation in the
blood of psoriatic patients, as evidenced by the increase in NOX4 activity found in PBMC. We can
also suppose that up-regulation of NOX4 in skin fibroblasts of patients with psoriasis can be the
reason of superoxide over-production and oxidative stress development in the skin of psoriasis
patients.
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The soluble form of the TL1A cytokine produced by human keratinocytes may contribute to
psoriasis pathogenesis
A Bebes,1 I Németh,1 K Vas,1 Z Bata-Csörgö,1 L Kemény,1 M Széll2 and V Tubak3 1 Department
of Dermatology and Allergology, University of Szeged, Szeged, Hungary, 2 Dermatological
Research Group of the Hungarian Academy of Sciences, University of Szeged, Szeged,
Hungary and 3 Creative Laboratory Ltd., Szeged, Hungary
The tumor necrosis factor alpha (TNF-alpha)-like cytokine (TL1A, TNFSF15) has been reported to
play a crucial role in inflammatory immune responses. Binding of the TL1A ligand to its receptor,
the death receptor 3 (DR3) results in enhanced cytokine production of activated T-cells. We aimed
to investigate the expression of TL1A in cultured normal human keratinocytes (NHK) and to check
the expression of TL1A and DR3 in psoriatic lesional and non-lesional skin. According to our results,
NHKs express TL1A mRNA and its expression is TNF-alpha induced. Notable amounts of TL1A pro-
tein was detected in the supernatant of NHKs. We observed increased TL1A mRNA levels both in
lesional and non-lesional psoriatic epidermis. Immunohistochemical staining revealed that TL1A
protein accumulated in the dermis of both psoriatic lesional and non-lesional skin, but it was unde-
tectable in healthy skin. The expression of the DR3 receptor was demonstrated on several cells in
psoriatic lesional dermis. Our data suggest that epidermal keratinocytes may be a source of increased
TL1A production in the skin of psoriatic patients and that TL1A-DR3 interaction may play a role in
the pathogenesis of the disease.
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IgE levels and immune response in bullous pemphigoid
L Lunardon,1 D Fanoni,1 M Riboldi,2 F Vaira,1 S Muratori1 and E Berti2 1 U.O. Dermatology,
Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy and 2 U.O.
Dermatology, University of Milano-Bicocca, Milan, Italy
Bullous pemphigoid (BP) and mucous membrane pemphigoid (MMP) are autoimmune blistering
diseases. IgG autoantibodies against BP180 and BP230 antigens have been well demonstrated as
pathogenetic antibodies in BP and MMP. Recent studies have also demonstrated the presence of
specific IgE autoantibodies in pemhigoid patients and their potential pathogenic role. We studied
anti-BP specific IgE presence in the serum of bullous pemphigoid (n=36), with high (n=25) or nor-
mal (n=11) total IgE blood level, mucous membrane pemphigoid (n=25), epidermolysis bullosa
acquisita (n=3) and non-pemphigoid associated hyper-IgE status (n=4). Perilesional skin biopsies
from BP patients were further tested by direct immunofluorescence (DIF). Commercial slides with
biochips (BP180) or transfected cells (BP230) were used to confirm the specificity of serum anti-BP
IgE. Clinical features, IgE levels, eosinophilia and ELISA anti BP180 or BP230 were analyzed at the
time of serum collection. Eighteen out of 25 (72%) BP with high IgE level, 11 out of 11 (100%) BP
with normal IgE level and 4 out of 25 (16%) MMP patients demonstrated IgE basal membrane zone
deposits by IIF. No deposits were detected in the tested control sera. By DIF the 76% of BP patients
with high total IgE level demonstrated IgE deposits. In two patients the diagnosis of BP was based
on the isolated detection of specific IgE together with other consistent clinicopathological features.
Patients with circulating or tissue-bound IgE deposits had clinically more significant urticarial lesions
when compared to anti-BP IgE negative patients. BP patients with higher IgE levels showed more
intense linear deposits and atypical clinical course. Our findings indicate that specific IgE autoan-
tibodies provide an additional useful criterion for diagnosis of pemphigoid. Future studies are needed
to better correlate the presence of IgE autoantibodies, their correlation with clinical features and
course and the usefulness of new biological and immunomodulating strategies in BP and MMP.
175
Skin Bioavailability And Activity Of Topical Beta-Glycyrrhetinic Acid In Intact And Impaired
Skin Models
F Crepel, M Galliano, L Duprat, B Guiraud, S Bessou-Touya and H Duplan R & D, Skin
Pharmacology and Pharmacokinetics Laboratory, PIERRE FABRE DERMOCOSMETICS,
Toulouse, France
Atopic dermatitis is a common inflammatory skin disease, associated with a defective epidermal
barrier. In response to the clinical need for nonsteroidal therapy to treat atopic dermatitis, topical
treatments have been developed combining the anti-inflammatory 18-[beta]-glycyrrhetinic-acid
molecule, derived from licorice root with a specific formulation that restores skin barrier. To assess
percutaneous absorption and bioavailability of 18-[beta]-glycyrrhetinic-acid topically applied, we
used the Pig Ear Skin model. To reproduce the in-use conditions (non lesional/lesional skin) we also
investigated the delivery of 18-[beta]-glycyrrhetinic acid on damaged skin barrier by tape-strip-
ping. Skin penetration of beta-glycyrrhetinic-acid on static-diffusion cells was evaluated by apply-
ing 5 mg/cm2 of a cosmetic cream containing 2% of 18-[beta]-glycyrrhetinic-acid during 24 hours
and then quantified in the different compartments of the skin (surface, stratum corneum SC, remain-
ing skin and receptor fluid) using HPLC-MS. We showed that the bioavailability of beta-glycyrrhetinic
acid after 24 hours is low on healthy skin (97.44% on surface/SC, 0.08% bio-available) and is only
slightly increased on damaged skin (99.96% on surface/SC, 0.70% bio-available). Beside, we have
developed a model of inflammation on human reconstructed epidermis whereby barrier function
is disrupted and inflammation is initiated, mimicking the specific features of atopic dermatitis. When
2% of 18-[beta]-glycyrrhetinic acid-containing cream was applied onto the epidermis, we observed
that the tissue morphological alterations due to inflammation were strongly attenuated. These data
suggested that the beta-glycyrrhetinic acid formulation can reinforce the functional integrity of the
epidermis and preserves skin from barrier defect and inflammation injury.
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Differential effects of IL-1β and TNF-α on NF-κB signaling and cytokine expression in SZ95
sebocytes and the impact of L-ascorbyl-2-phosphate
H Ikeno,1 A Mara,2 CC Zouboulis3 and M Böhm2 1 Ikeno Clinic of Dermatology & Dermatologic
Surgery, Tokyo, Japan, 2 Dept. of Dermatology, University of Münster, Münster, Germany and
3 Departments of Dermatology and Immunology, Dessau Medical Center, Dessau, Germany
Interleukin-1 (IL-1) and tumor necrosis factor-alpha (TNF-α) are pivotal mediators in the pathogen-
esis of acne and induce proinflammatory cytokines such as IL-6 or IL-8 via canonical NF-κB sig-
naling. We determined the effects of L-ascorbyl-2-phosphate (APS), a vitamin C derivative, in SZ95
sebocytes, an immortalized human sebocyte cell line derived from primary facial sebocytes of a
patient with acne vulgaris. Application of topical APS has previously been demonstrated to have
beneficial effects on the extent of facial acne (e. g. Woolery-Lloyd H, Baumann L, Ikeno H. J Cos-
met Dermatol. 2010 9: 22-7). Since NF-κB is a redoxsensitive transcription factor we hypothesized
that APS is capable of reducing IL-1β- and tumor necrosis factor-alpha (TNF-α)-induced signaling
and subsequent expression of proinflammatory cytokines and mediators. Stimulation of SZ95 sebo-
cytes with IL-1β and TNF-α resulted in a dose-dependent expression of IL-6 and IL-8 mRNAs but
only IL-1β was capable of inducing secretion of IL-6 and IL-8. NF-κB p65 translocation, IκB phos-
phorylation and degradation was detectable only after treatment of SZ95 sebocytes with IL-1β but
not with TNF-α indicating alternative molecular mechanisms by which both cytokines regulate IL-
6 and IL-8 mRNA expression. APS - at doses used also in vivo - exhibited some inhibitory effects
on NF-κB activation and IL-6/8 mRNA expression in SZ95 sebocytes exposed to IL-1β. In addition,
APS reduced TNF-α-mediated IL-6 and IL-8 mRNA expression. However, APS failed to alter IL-1β-
mediated secretion of IL-6 and IL-8. Moreover, APS did neither reduce IL-1β- nor TNF-α-mediated
expression of cyclooxygenase 2 which controls prostaglandin E2 secretion by SZ95 sebocytes. Our
findings suggest that the beneficial effects of APS in acne may not be due to an anti-inflammatory
action on sebocytes but rather to an alternative mechanism, e. g. reduction of lipid oxidation.
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Effects of retinoic acid and vitamin D on interleukin-1 family members in psoriasis
M Schiattarella, F Ayala, N Balato, M Mattii, S Lembo and A Balato Department of Dermatology,
University of Naples Federico II, Napoli, Italy
Vitamin D, as well as retinoids, are well known to have anti-inflammatory activity and are proven
to be effective as treatment in psoriasis. Interleukin (IL)-1 family comprises 11 members that takes
part in the inflammatory process and recent evidences have showed a possible role in psoriasis.
1,25-dihydroxyvitamin D3 (vitD) has been shown to suppress TNF-α-induced IL-1F1 in human ker-
atinocytes (KCs). In the present study, we investigated the effects of vitD and retinoic acid (RA) on
IL-1 family cytokines. Lesional skin biopsies from 20 psoriatic patients were performed to analyze
IL-1 family members at gene and protein level. Full thickness ex vivo skin organ culture and pri-
mary KCs were exposed to pro-inflammatory stimuli, such as TNF-α, IL-17, and UVB; afterwards
treatment with vitD or RA was executed and IL-1 family members gene expression was analyzed.
Full thickness ex vivo organ culture with psoriatic skin and vitD as well as RA treatment was also
performed. Our study showed that IL-1 family members (IL-1F3, IL-1F5, IL-1F6, IL-F8, IL-1F9, Il-
1F11) were overexpressed in psoriatic plaque skin. We found that the increase of inflammatory
members, (IL-1F6, IL-1F9, Il-1F11) was more evident respect to antagonists (IL-1F3, IL-1F5). Pro-
inflammatory stimuli were able to increase all agonists IL-1 family members, being IL-17 a signifi-
cant more potent inducer of all cytokines, especially IL-1F6. RA revealed to be a stronger inhibitor
than vitD; moreover both RA and vitD were able to suppress IL-1F11 in psoriatic skin at protein
level. In conclusion, our results showed a possible effect of RA as well as vitD on IL-1 family mem-
bers signalling.
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Regulatory T cells and T helper 17 cells in the pathogenesis of dermatitis herpetiformis
E Antiga,1 P Quaglino,2 I Pierini,1 S Osella Abate,2 R Ponti,2 M Papini,3 D Renzi,1 M Bernengo,2
P Fabbri1 and M Caproni1 1 Department of Critical Care, Section of Dermatology, University of
Florence, Florence, Italy, 2 Department of Biomedical Sciences and Human Oncology, 1st
Dermatologic Clinic,, University of Turin, Turin, Italy and 3 Department of Medical and
Surgical Specialities and Public Health, University of Perugia, Perugia, Italy
In the present study we investigated the role of regulatory T cells (Tregs) and T helper 17 cells (Th17)
in the pathogenesis of dermatitis herpetiformis (DH), the specific cutaneous manifestation of celiac
disease (CD). Twelve patients with DH were enrolled and biological samples were collected before
any treatment. Markers of Tregs (CD4, CD25, FOXP3, IL-10, TGF-beta) and of Th17 (ROR-gamma-
t, CD161, CCR6) were investigated in the skin lesions by immunohistochemistry. Furthermore, Tregs
were investigated in the blood of the same patients by cytofluorimetry. As controls, 15 patients with
bullous pemphigoid (BP) and 10 healthy subjects (HS) were included into the study. Only few
FOXP3+ Tregs and ROR-gamma-t+ Th17 were detected in DH lesions, without differences in their
absolute number compared to BP and HS. By contrast, DH and BP patients showed a significantly
reduced FOXP3+/CD4+ and IL-10+/CD4+ cell ratio if compared to HS (DH vs HS: p < 0.001; BP
vs HS: p < 0.001), suggesting a defect of lesional Tregs in these patients. Accordingly, a reduction
in the number of circulating CD4+CD25highFOXP3+ Tregs was detected in DH and BP than in HS
(DH vs HS: p < 0.001; BP vs HS: p = 0.02). In conclusion, Tregs were reduced in the skin lesions
and in the blood of patients with DH, suggesting a defect in T cell regulation that may lead to the
development of autoimmunity. By contrast, Th17, that have been shown to play a major role in the
pathogenesis of several autoimmune diseases including CD, are probably not involved in the induc-
tion of DH skin lesions.
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Analysis of diurnal changes in scratch number and scratch frequency (Hz) during a chronic
oxazolone-induced inflammation in BALB/c mice
GR Elliott,1 R Vanwersch,2 M Soeberdt3 and C Abels3 1 Derphartox, Leiden, Netherlands, 2
PowerRay, Delft, Netherlands and 3 Dr. August Wolff GmbH & Co. KG Arzneimittel, Bielefeld,
Germany
Analysis of oxazolone-induced scratching is often limited to the manual counting of scratches for
the first 30 to 60 min after exposure to oxazolone. The aim of this study was to analyze diurnal
changes in scratch number and scratch frequency (Hz) during a chronic oxazolone-induced inflam-
mation in female BALB/c mice. Mouse ears were sensitized to 1% oxazolone in acetone on day 0
and challenged with a 1% oxazolone solution on days 7, 9, and 11. Mice were treated with ace-
tone (vehicle control) or 0.05% betamethasone dipropionate (Bdp) in acetone from days 11 to 18.
The number of scratch events (SEs) and scratch frequency (Hz) were measured on days 11 and 18
for 22 hours using an automated system. Scratch number: On day 11 scratching peaked soon after
application of oxazolone (early period SEs) and decreased over the next 8 hours. There was then a
second period of late SEs, starting around 19.00 hrs (“night” period from 19.00 to 07.00) and declin-
ing in the morning. Total SEs by the vehicle group had increased slightly (p<0.06) on day 18 com-
pared to day 11. The biphasic pattern was retained and the increase in late period SEs was more
prominent, Treatment with Bdp had little effect on early period SEs on day 11 but significantly
decreased late period SEs. There was no increase in SEs between days 11 and 18 in the Bdp group
and scratching during both the early the late periods was suppressed on day 18. Scratch frequency:
Scratching by vehicle treated mice on day 11 occurred between 15 and 24 Hz, with a peak at 16
Hz. Bdp reduced scratching at all frequencies similarly. On day 18 scratching shifted to higher fre-
quencies in the vehicle control group, with extra peaks at 20 Hz and 23 Hz. Bdp specially inhib-
ited scratching at these higher frequencies. The characteristics of oxazolone-induced scratching
change during the 24 hour cycle and progression of the inflammation. Bdp particularly suppressed
late period and high frequency SEs.
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Phenotypically abnormal T cells are associated with distinct immune dysfunctions of immunose-
nescence in mice
S Koellner,1 T Oreshkova,2 J Scheuermann,1 JM Weiss,1 A Sindrilaru,1 K Scharffetter-Kochanek1
and T Peters1 1 Dermatology, Ulm Univ, Ulm, Germany and 2 Institute of Biology and
Immunology of Reproduction, Sofia, Bulgaria
Immunosenescence is characterized by a pathologic decline in adaptive and innate immunity. This
leads to an onward immunodeficiency with a combined dysfunction in host defense and regulatory
mechanisms. This increases the risk for autoimmune and chronic inflammatory diseases. Particu-
larly, a senescent T cell repertoire, phenotype and function alters immunity in the elderly. Similarly
abnormal T cell subsets occur in immunodeficient individuals and those suffering from systemic
chronic inflammation. We here sought to identify distinct age-related T cell populations in periph-
eral lymphoid organs of young, adult and old (3-6, 9-12 and 18-24 months-old C57BL/6) mice. Six-
channel fluorescence FACS was performed using markers that have been observed on aged and/or
dysfunctional T cells (such as CD5, CD27, CD28, CD45RB, CD71, CD127, p-Gp, V-beta chain
repertoire) in a first step. We found a marked age-dependent shift of CD4 T cells towards uncon-
ventional CD4-CD8- (DN) T cells and CD8 T cells in lymph nodes. The majority of the CD4 T cell
subset showed an age-related reduction of CD27 and the CD28 costimulatory receptors and a down-
regulation of CD5. Only a minority of the CD4 T cell subset showed a CD27(low)CD28(hi)CD5(hi)
phenotype indicating homeostatic expansion occurring due to a reduced thymic T cell output with
age. Also CD8 T cells and DN T cells had this age-related CD27(low)CD28(hi)CD5(hi) phenotype,
suggesting these cells have an age-related increasing potential of self reactivity. Our data reveal a
substantial increase of distinct T cell subsets in a highly detailed phenotypic profile showing strong
characteristics of dysfunction in old mice. This may help clarifying important aspects of an age-asso-
ciated dysfunction of the immune system and also give insight into pathomechanisms that unite or
separate immunosenescence from exhaustion by chronic inflammation and/or immunodeficiency.
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Expression of glucagon-like peptide-1 receptor in psoriasis plaques
A Faurschou,1 J Pedersen,3 M Gyldenløve,2 J Thyssen,2 C Zachariae,2 JJ Holst,3 T Vilsbøll,1 L Skov2
and F Knop1 1 Diabetes Research Division, Department of Internal Medicine, Gentofte
Hospital, Hellerup, Denmark, 2 Department of Dermato-Allergology, Gentofte Hospital,
Hellerup, Denmark and 3 Department of Biomedical Sciences, Panum Institute, Copenhagen,
Denmark
Psoriasis vulgaris is a chronic inflammatory skin disease affecting 2-3% of the Western population.
Recent case reports suggest that treatment with glucagon-like peptide-1 (GLP-1) agonists may
result in clinical improvement of psoriasis. The purpose of this study was to determine whether GLP-
1 receptors (GLP1Rs) are found in the skin of healthy volunteers and patients suffering from psori-
asis and, if so, whether the GLP1Rs are located on keratinocytes or immune cells. From 6 healthy
volunteers, one 3 mm-punch skin biopsy was taken. From 6 psoriasis patients, two 3 mm-punch
skin biopsies were taken; one from unaffected skin and one from a psoriasis plaque. A blood sam-
ple was obtained from all the participants. In addition, cultured human keratinocytes were either
untreated or incubated with TNFα, IFNγ or a combination of TNFα and IFNγ for 48 hours. Total RNA
was extracted from all samples, reverse transcribed and analyzed for the expression of GLP1R
using SYBR Green-based qPCR. Gene expression analysis showed expression of GLP1R in five out
of six skin biopsies from psoriasis plaques whereas only one out of six biopsies from unaffected
skin from psoriasis patients and one out of six biopsies from healthy volunteers expressed GLP1R.
GLP1R expression was found in the blood of both healthy volunteers and psoriasis patients. How-
ever, GLP1R expression was higher in the blood from psoriasis patients although the results did not
reach statistical significance. No GLP1R expression was found in any of the groups of cultured
human keratinocytes. Our results suggest the presence of GLP-1Rs in psoriasis plaques and that this
most likely is due to infiltration with immune cells. This offers a possible explanation for the posi-
tive effect of treatment with GLP-1 analogs in patients with psoriasis.
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Cell biologic and in situ studies for better understanding of blistering mechanisms of unusual
mucosal pemphigus demonstrating no detectable serum anti-desmoglein 3 antibodies by rou-
tine tests
K Kamiya, Y Aoyama, A Ukida, K Noda, T Hamada, K Fujii and K Iwatsuki Department of
Dermatology, Okayama University Graduate School of Medicine, Dentistry and
Pharmaceutical Sciences, Okayama city, Japan
In mucosal pemphigus vulgaris (m-PV), autoantibodies against desmoglein (Dsg) 3 have a critical
role in acantholysis. Two m-PV patients (cases 1 and 2) who suffered from refractory oral mucosal
erosions were treated in our hospital. In these patients, serum-anti-Dsg3 antibodies were not detected
by indirect immunofluorescence (IF) and enzyme-linked immunosorbent assay (ELISA), while
histopathological findings revealed the suprabasal acantholysis. In order to understand the mech-
anisms of their acantholysis, we compared the expression patterns of desmosomal and adherence
junction molecules, i.e., Dsg3, desmocollin (Dsc) 3, desmoplakin (DP) and E-cadherin (E-cad) in
oral mucosal lesions with those of four patients with typical m-PV. In typical m-PV patients, a dot-
ted distribution of Dsg3 was observed at cell-cell junction and cytoplasm, which was abnormal
and typical to anti-Dsg3 antibody effects as previously reported. Moreover, no signals of Dsg3, Dsc3,
DP and E-cad were observed in complete acantholytic lesions. In case 1, IF staining revealed the
same results as early changes observed in typical m-PV. In case 2, a dotted distribution of Dsg3 at
cell-cell junction with clear decreased expression of Dsg3, Dsc3 and DP was observed in the lesions.
The alteration of desmosomal molecules was compatible with that of typical m-PV. We speculated
that anti-Dsg3 antibodies of these two cases had a higher pathogenicity with very low amount of
IgG. We next purified and concentrated IgG of sera from these two cases. In concentrated PV-IgG,
anti-Dsg3 antibodies were detected by Dsg3 ELISA. These results suggest that acantholysis of these
unique m-PV patients is caused by highly pathogenic anti-Dsg3 antibodies even at a low amount
of IgG that are undetectable by routine indirect IF and ELISA without concentration.
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Dermal atrophy in vitro modelling: effects of glucocorticoids Barbara De Servi and Marisa
Meloni VitroScreen, Via Mosè Bianchi, 103 20149 Milan (I)
B De Servi and M Meloni VitroScreen, Milano, Italy
Skin atrophy is a drug’s side effect that can be observed after long term glucorticoids (GCs) treat-
ment and consists in a defective function of dermal matrix component’s production, in skin thin-
ning and impaired tensile function. An experimental in vitro model of dermal atrophy on skin equiv-
alent has been validated with GCs for its applicability to assess side effects at skin level of novel
steroid compounds. Reference GCs (β-methasone valerate and hydrocortisone, max 0,1 μM) have
been selected as inducers of skin atrophy. Tissues have been exposed to a systemic like treatment
by introducing the GCs in the culture medium. Different exposures to GCs have been assessed: 24h,
3 days systemic treatment followed by 3 and 5 days of recovery without GCs in order to reach a
better prediction of atrophy inducing potency. A 7 days continuous systemic treatment without a
recovery period has also been tested, to explore a further experimental window consisting in the
assessment of the efficacy of topically applied products in counteracting the atrophic process.
Complementary information about epidermal and dermal modifications at the end of the different
exposures have been analyzed by histo-morphological analysis and gene expression of biomarkers
responsible for tensile strenght and elasticity, COL1A1, COL7A1, DCN, ELN, HAS2 by qRT-PCR.
The results after 24h and 3 days treatment indicate a first defence reaction of the skin equivalent
inducing the up-regulation of all the genes and no modifications at morphological level. In the recov-
ery periods (3 and 5 days after the end of the GC treatment): it was interesting to observe a delayed
down regulation (damage) that concerns mostly the Collagen I and Elastin genes and on the con-
trary early markers (decorin and Coll.VII) were still regulated even after 6 days suggesting a physi-
ological defence mechanism. Based on the results obtained with hydrocortisone, which have a
well known potency as skin atrophy inducer, it has been possible to conclude about the robustness
and predictive power of the experimental model described.
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Pruritic and Vascular Responses Induced by Serotonin in Patients with Atopic Dermatitis and
in Healthy Controls
A Rasul, K Nordlind and C Wahlgren Dermatology & Venereology Unit, Dept. of Medicine.,
Karolinska Institutet, Karolinska University Hospital, Solna, Stockholm, Sweden
Atopic dermatitis (AD) is a chronic inflammatory skin disease with often severe itch. The aim of this
study was to study the pruritogenic and vascular effect of serotonin (5-hydroxytryptamin; 5-HT) in
patients with AD and in healthy controls. 5-HT was injected intradermally into non-lesional skin of
25 AD patients and 25 healthy control individuals, and the effect compared with histamine as a pos-
itive control, and buffer as a negative control. The pruritus was recorded by the subjects with a
computerized visual analoge scale (VAS), while flare and wheal were recorded by the investigator.
There was no qualitative or quantitative difference in 5-HT- induced itch between the patients and
the control subjects, nor between males and females. However, a reduced flare and wheal for 5-
HT was found in the patient group. There were no correlations between the clinical findings (i.e.
eczema severity, clinical pruritus) and the recorded experimental itch, nor flare or wheal responses
for 5-HT, in the AD patients. In both groups a shorter itch latency was found for 5-HT compared
with histamine. These results confirm a pruritogenic role of 5-HT in both AD patients and healthy
controls and show a lower vascular response to 5-HT in AD patients compared with healthy con-
trols. The short itch latency time might indicate a direct effect of 5-HT on itch receptors.
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Real-time monitoring of the effect of Propionibacterium acnes on the proliferation and via-
bility of keratinocytes
G Tax,1 K Szabó,2 E Urban3 and L Kemény1 1 Department of Dermatology and Allergology,
University of Szeged, Szeged, Hungary, 2 Dermatological Research Group of the Hungarian
Academy of Sciences, University of Szeged, Szeged, Hungary and 3 Institute of Clinical
Microbiology, University of Szeged, Szeged, Hungary
Acne is a common multifactorial inflammatory skin disease of the pilosebaceous unit in which the
Gram-positive Propionibacterium acnes (P. acnes) is an important pathogenic factor. It has been
shown previously that selected P. acnes strains (889 and ATCC11828) belonging to various phylo-
genetic subgroups differentially affected the proliferation and viability of cultured normal human
keratinocytes. To investigate this phenomenon, we performed real-time label free monitoring of the
effect of three P. acnes strains (889, 6609, ATCC 11828) on the proliferation and viability of immor-
talized human keratinocytes (HPV-KER), using a novel, impedance measurement based technol-
ogy. To analyze whether the effect of the microbe on the HPV-KER cells was dose dependent, we
applied the bacterium at different ratios (multiplicity of infection = MOI: 25, 50, 100, 200 and
300). Addition of P. acnes 889 strain at high MOIs (200,300) induced a rapid increase in the meas-
ured impedances compared to the untreated control cells. This effect was due to increased cell pro-
liferation of the HPV-KER cells. The P. acnes 6609 strain had no effect on cell proliferation, whereas
the HPV-KER cells stopped proliferating in response to the ATCC 11828 treatment. At later time-
points (24-36 h after the bacterial treatment) the impedance values showed a rapid decrease in the
P. acnes 889 and ATCC 11828 treated cultures, using high MOIs (200, 300) due to the death of the
HPV-KER cells. These results suggest that assorted P. acnes strains have different effects on the pro-
liferation and viability of keratinocytes, and strain specific differences may also be important for
determining the severity of individual inflammatory skin symptoms.
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Circulating autoantibodies against α6 integrin can be detected in patients with psoriasis and
psoriatic arthritis
M Kiss,1 L Kovács,2 K Vas,1 S Husz,1 L Kemény1 and Z Bata-Csörgö1 1 Department of
Dermatology and Allergology, University of Szeged, Szeged, Hungary and 2 Department of
Rheumatology, University of Szeged, Szeged, Hungary
Psoriasis is a chronic inflammatory disease targeting primarily the skin, but in psoriatic arthritis (PsA)
patients’ joints are also affected. Abnormal laminin expressions have been described in both unin-
volved and lesional psoriatic skin. We hypothesized that abnormal laminin integrity may result in
insufficient binding of α6 integrin to its laminin ligand, resulting in autoantibody production. Because
the α6β4 integrin heterodimer plays a crucial role in the assembly of hemidesmosomes, antibod-
ies against α6 integrin can disturb the dermal-epidermal association, resulting in micro-wounds,
and sustaining the chronic inflammation. We therefore investigated the presence of anti-α6 inte-
grin antibodies in patients with psoriasis and in patients with PsA. The autoantibody profiles of 40
patients with psoriasis, 55 patients with PsA and 20 healthy volunteers were determined. With the
use of PeptideStructure and PlotStructure software, four different antigenic epitopes were predicted
for α6 integrin and their fusion recombinant constructs were prepared in an E. coli recombinant
system. Sera were tested for α6 integrin autoantibodies by an ELISA technique. While in healthy
people we were not able to detect autoantibodies, 25% of psoriatic patients, and 44% of patients
with PsA displayed circulating antibodies against at least one recombinant α6 integrin protein. Five
patients with psoriasis and 16 patients with PsA presented autoantibodies to more than one anti-
genic epitopes of α6 integrin. We provide the first evidence for the presence of anti-α6 integrin
antibodies in psoriasis. The presence of these antibodies may contribute to the chronic inflamma-
tion in psoriasis.
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Expression of CD137 and its Ligand on Mast Cells in Lesional and Non-lesional Psoriatic Skin
M Knosalla,1 K Zachmann,1 MP Schön,1 C Neumann,1 R Mössner,1 CC Zouboulis2 and U Lippert2
1 Department of Dermatology, Georg August University Goettingen, Goettingen, Germany
and 2 Department of Dermatology, Dessau Medical Center, Dessau, Germany
CD137 belongs to the TNF receptor superfamily and acts as a T-cell costimulatory molecule. It is
mainly expressed on activated T-cells and is involved in tumor growth and in autoimmune diseases
such as rheumatoid arthritis. We previously described the expression of CD137 in mast cells of
lesional psoriasis skin in contrast to skin of healthy individuals where CD137 is completely absent.
To extend these studies we now investigated the expression of CD137 in lesional versus non-lesional
skin and also studied the expression of the corresponding CD137 ligand. Using conventional light
microscopy and dual-color confocal fluorescence microscopy, we found that in both lesional and
non-lesional skin, CD137 receptor was expressed at comparable levels in over 65% of skin mast
cells. In addition, we found that CD137 ligand was expressed in nearly 100% of mast cells in lesional
and non-lesional psoriasis skin, but in contrast to CD137 receptor, was also similarly expressed in
skin from healthy individuals. The CD137 receptor/ ligand system is known to function in a bidi-
rectional manner. We have shown that reverse signaling through CD137 ligand induces TNF-alpha
release in isolated skin mast cells and dendritic cells, as well as dendritic cell differentiation. Since
CD137 receptor expression is found only in psoriatic skin mast cells, upregulation of the receptor
during the disease development might constitute a key regulatory event. Here, activated mast cells
expressing CD137 receptor could activate other mast cells in an autocrine fashion as well as den-
dritic cells to release TNF-alpha via CD137 ligand signaling.
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Impact of adjuvant extracorporal photophoresis-treatment on skin fibrosis in patients with
chronic sclerosing skin diseases
O Brandt, H Lee, R Stefaniak and M Worm Department of Dermatology, Venerology, and
Allergy, Charité University Medicine Berlin, Berlin, Germany
Progressive systemic sclerosis (PSS) is an autoimmune connective tissue disease characterized by
thickening and fibrosis of the skin due to abnormal deposition of collagen and vasculopathy involv-
ing the skin and multiple visceral organs, such as the kidneys, heart, lungs, and the gastrointestinal
tract. Treatment with immunosuppressive drugs is considered the gold standard for this challenging
disease in the case of lung or skin involvement. Since extracorporal photophoresis (ECP) has been
shown to be effective in transplant patients and those with Graft-versus-Host-Disease (GvHD), we
were interested in whether long term ECP-treatment in these patients is as effective as treatments
with immunosuppressive drugs. Methods Data from 8 patients suffering from PSS and treated with
ECP were collected and evaluated retrospectively using the modified Rodnan skin score (mRSS).
ECP was administered on 2 consecutive days every 4 to 8 weeks. 18 patients with PSS who were
exclusively treated with immunosuppressive drugs and 3 patients with GvHD receiving a combined
therapy (immunosuppressive drugs and ECP) served as controls. Results In the 8 ECP-treated the
mRSS decreased in 2, was unchanged in 4 and increased in 2 patients. Similar results were obtained
when investigating PSS patients exclusively treated with drugs. While 8 of the 18 patients exhibited
a reduced mRSS over a 5-year-period, of the remaining 10 patients, 5 of which showed no changes,
the other 5 deteriorations. In the group of the GvHD patients one of each exhibited an improve-
ment, no change and a deterioration of the mRSS, respectively. In none of the ECP-treated patients
any adverse effects were observed. Conclusion The clinical efficacy of ECP remains to be eluci-
dated in controlled studies with higher numbers of patients. Besides the skin score, other organ
parameters (e.g. lung and kidney function) as well as quality of life should be considered.
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Hyperhomocysteinemia and vitamins depletion in autoimmune diseases
D Bonciani, V Bonciolini, A Verdelli, I Pierini, A D’Errico, V Volpi, E Antiga, P Fabbri and
M Caproni University of Florence, Florence, Italy
Hyperhomocysteinemia (HHcy), defined by circulating blood levels of homocysteine (Hcy)>13
μmol/L, is associated with several pathologies like cardiovascular disease and stroke. Recent stud-
ies demonstrated new and intriguing ancillary effects for Hcy either in the enhancement of inflam-
matory activation and in the autoimmunity triggering mechanisms, thus suggesting a possible role
for Hcy in the pathogenesis of autoimmune diseases. In this light the role of the depletion in vita-
mins implicated in the Hcy metabolism, i.e.folate,B12 and B6 seems particularly relevant. More-
over, it has been demonstrated that people who are deficient in vitamin D, which comes from both
food sources and sunlight, have an increased autoimmune disease risk. The aims of this study were
to evaluate if patients with autoimmune disease have HHcy and vitamins depletion and to com-
pare Hcy levels of patients with autoimmune disease and healthy subjects. Six patients with cuta-
neous lupus eritematosus (CLE), 5 with systemic LE (SLE), 31 with autoimmune bollous disease (pem-
phigus and bollous pemphigoid) and 5 with psoriasis vulgaris, were enrolled and Hcy, folic acid,
vitamin B12 and vitamin D serum levels were evaluated. As control, 30 healthy subjects, not smok-
ers, without acute or chronic diseases,familial history of autoimmune disease were included. Our
results showed that HHcy was significantly higher in patients with autoimmune disease than in con-
trols (56.25% versus 20%; P < .01); in particular, the highest percentages of HHcy-positive patients
were found in CLE (66%9), SLE (60%) and psoriasis (80%). Moreover, Vitamin B12, folic acid and
Vitamin D were lower than in healthy controls; in more detail, lower levels of Vitamin B12 were
found in 25% of patients, of folic acid in 35% of patients and of Vitamin D in 50% of patients. In
conclusion, we demonstrated an increase of Hcy and a reduction of Vitamin B12, folic acid and
Vitamin D in patients than in healthy controls. Such results suggest that Hcy and vitamins deple-
tion may play a role in the pathogenesis of autoimmune skin diseases.
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Towards dissecting the in situ-effects of endocannabinoids in human skin: Palmi-
toylethanolamide inhibits hair growth, keratinocyte proliferation, and mast cell activation
N Zákány,1 K Sugawara,2 V Di Marzo,4 T Bíró3 and R Paus1 1 Institute of Dermatology, University
of Lübeck, Lübeck, Germany, 2 Institute of Dermatology, Osaka City University Graduate
School of Medicine, Osaka, Japan, 3 Institute of Physiology, University of Debrecen,
Debrecen, Hungary and 4 Institute of Biomolecular Chemistry, Endocannabinoid Research
Group, CNR, Naples, Italy
Palmitoylethanolamide (PEA) is an endogenous lipid with endocannabinoid characteristics. PEA
binds to a nuclear receptor (probably PPAR-α) and may potentiate the action of another key endo-
cannabinoid, anandamide (AEA) on CB1 receptor. While PEA is reported to have anti-inflamma-
tory, analgesic and anti-pruritic properties, its actions on human skin are still poorly understood.
Since AEA inhibits human hair follicle (HF) growth, HF keratinocyte (KC) proliferation and exces-
sive skin mast cell (MC) maturation and activation, we hypothesized that PEA may exert similar prop-
erties. This was probed in organ-cultured human skin and HFs under serum-free conditions. Although
PEA (10-50 μM) did not affect hair shaft elongation, it promoted catagen development and inhib-
ited hair matrix KC proliferation in situ after 6 days of organ culture. Thus, PEA exerts similar,
though weaker hair growth-inhibitory properties as AEA. By Masson-Fontana histochemistry, PEA
did not alter epidermal melanin content, but – again similar to AEA - significantly inhibited epi-
dermal KC proliferation in situ. This was counteracted by co-administration of either the CB1 spe-
cific antagonist, AM251, or the selective PPAR-α antagonist, GW6471, but not by the CB2-specific
antagonist, AM630. Quantitative MC histomorphometry demonstrated that PEA inhibited the sub-
stance P-induced degranulation of human skin MCs in situ. Thus, PEA may exert a both CB1- and
PPAR-αmediated “inhibitory tone” on KC proliferation and MCs degranulation in human skin. There-
fore, this well-tolerated, topically applicable endogenous cannabinomimetic agent deserves full
therapeutic exploration in MC-dependent inflammatory, hyperproliferative and pruritic skin dis-
eases, including atopic dermatitis.
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Modulation of cutaneous inflammasome pathway by the association « Rhealba® oat plantlet
extract with vitamine E »
M Galliano,1 M Aries,1 C Vaissière,1 N Castex-Rizzi,1 H Duplan,1 C Coutanceau2 and S Bessou-
Touya1 1 R&D - Pharmacologie Cellulaire, Pierre Fabre DermoCosmétique, TOULOUSE,
France and 2 Direction Médicale A-DERMA, Pierre Fabre DermoCosmétique, LAVAUR, France
Reactive skin may result from complex interactions between extrinsic and intrinsic factors e.g. pol-
lution, inadequate hygiene and care, stress and tiredness, through danger signals at the cell level
(from dying cells and microbe components, all ligands of Pattern Recognition Receptors (PRRs))
which are involved in innate immunity, inflammatory response, and inflammasome pathway. Inflam-
masomes are caspase-1 containing multi-protein complexes active in the processing of pro-inflam-
matory cytokines IL-1β, IL-18, synthesized as biologically inactive precursors and having key roles
in inflammatory skin and possibly in reactive skin. We explored the mature forms of such inflam-
masome products and inflammatory mediators in an inflammatory model of Reconstructed Human
Epidermis (RHE). Increased extracellular levels of IL-1β (×2), IL18 (×18), IL6 (×101), IL8 (×70), TNF-
α (×55), VEGF-A (×1.5), MIP-1α/CCL3 (×263), and sICAM-1 (×9) were observed after a 48h stimu-
lation by the Toll Like Receptor-3 (TLR-3) polyI:C ligand (Luminex™ analysis). Either systemic or
topical (cream for reactive skin, A-DERMA) administration of the « Rhealba® Oat Plantlet extract
with Vitamine E » association (2h pre-treatment) significantly and respectively blocked poly I:C-
induced up-regulation of inflammasome cytokines and inflammatory mediators : IL18 (-71%***, -
22%), IL6 (-87%***, -82%***), IL8 (-84%***, -75%***), TNF-α (-92%***, -88%***), VEGF-A (-22%*,
-5%), MIP-1α (-44%***, -38%***), sICAM-1 (-63%***, -49%***) (***p<0.001) along with a signif-
icant reduction of IL-1β. Our results demonstrate ⇒that mature IL-1β and IL18 inflammasome prod-
ucts are up-regulated in our RHE model, suggesting activation of the inflammasome pathway ⇒that
the « Rhealba® Oat Plantlet extract with Vitamine E » association effectively blocked release of
inflammasome products in combination with inflammatory mediators, providing with an adapted
resolution for the treatment of reactive skin.
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Potential Anti-Inflammaging Effects of Plant Extract Containing Butrin and Isobutrin
K Isabelle,1 J Olivier,1 A Patrice1 and P Chantal2 1 Life Sciences Department, LVMH recherche,
Saint Jean de Braye, France and 2 CNRS UPR2301, Orleans, France
In ayruvedic medicine, the Butea monosperma flowers are used for its anti-oxidant and anti-inflam-
matory properties. Butrin and Isobutrin were identified by double Centrifugal Partition Chromatog-
raphy technique as the main flavonoid derivatives from an ethanolic Butea monosperma extract.
The Butrin/Isobutrin rich fraction (BIRF) was evaluated for its anti-inflammatory effects and its action
on matrix metalloproteinases (MMPs) secretion. From UVB-irradiated human normal keratinocytes
(NHEK), our results showed an inhibitory effect of BIRF on the PGE2 secretion (-85% at 0.39μg/ml)
similar to that observed with Indomethacin (-91% at 0.37μg/ml). Moreover, the effects of the BIRF
on pro-inflammatory cytokines IL-1b, IL-6 and IL-8 secretion were measured from UVB-irradiated
NHEK (xMAP technology, Millipore). A strong inhibitory effect of the BIRF on IL-1b was observed
(-59%). In contrast, the positive control, Cholecalciferol (1.54 μg/ml) slowly decreased IL-1b (-21%).
For IL-6 and IL-8, the secretion inhibition was closed to -20% for the BIRF and Cholecalciferol. In
the “inflammaging” context, the MMPs play a crucial role in the homeostasis of the skin tissue, this
balance being broken by inflammatory phenomena. Then, the effects of BIRF on the release of MMP-
1, 2, 7, 9, 10 were studied (xMAP technology) on the supernatants previously tested. The results
showed that BIRF strongly inhibited MMP-2, 9 and 10 secretion (-61%, -54% and -60%, respec-
tively). The effects on MMP-1 secretion was moderate (-40%) and MMP-7 was unaffected. Based
on the identified anti-inflammatory effects and knowing the anti-oxidant properties of flavonoids,
our results suggest that a plant extract containing Butrin/Isobutrin could have a potential action in
the “inflammaging” field.
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Idebenone-ester, Arazine™ and Ergothioneine protect against UV-induced inflammation and
photo damage
L Popescu,1 JR Fernandez,2 JB Stock,3 M Stock,2 A Felix,1 A Pellegrino1 and E Perez2 1 Elizabeth
Arden, New York, NY, 2 Argyle Therapeutics, Inc., Monmouth Junction, NJ and 3 Molecular
Biology, Princeton University, Princeton, NJ
The skin is under constant attack from a variety of environmental stressors such as ultraviolet (UV)
radiation from the sun. Damage to the skin accumulates with age resulting in chronic inflamma-
tion, DNA damage and oxidative stress. Idebenone and idebenone-ester, the main cosmetic func-
tional ingredient in Prevage® facial serum has previously been shown to be a powerful anti-oxi-
dant protecting against skin aging. Similarly, ergothioneine demonstrates excellent free radical
scavenging capacity. Arazine™ (N-acetyl-S-farnesyl-L-cysteine) has been shown to exhibit anti-
inflammatory properties inhibiting the release of pro-inflammatory mediators, and the migration
and activation of inflammatory cells. In this study we investigated if idebenone-ester, Arazine™, and
ergothioneine can inhibit UV induction of pro-inflammatory cytokines. Cultured primary normal
human keratinocytes (NHEKs) and human dermal fibroblasts (HDFs) exposed to UVA and UVB
upregulated the production of IL-6 and TNF-α, two important pro-inflammatory mediators of chronic
inflammation. Results demonstrate all three ingredients mitigate UV induction of IL-6 and TNF-α.
Furthermore, topical application of idebenone-ester, Arazine™, and ergothioneine to 3D human
skin equivalents exposed to UV reduced pro-inflammatory cytokines thymine dimer formation and
provided photo-protection by reducing sun burn cell formation. Taken together, these results demon-
strate that topical application of idebenone-ester, Arazine™, and ergothioneine mitigate UV induced
skin inflammation and photo damage. Given their strong anti-inflammatory and anti-oxidant prop-
erties, these molecules may protect the skin from chronic inflammation and reduce the damage to
UV-induced oxidatively stressed skin.
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Reappraisal of Cutaneous Vasculitis in Behcet’s disease with Erythema Nodosum-like Lesions
K Chen Dermatology, Saiseikai Central Hospital, Tokyo, Japan
We have previously demonstrated that near half of the Behçet’s disease (BD) (19/40) with either
erythema nodosum-like lesions or infiltrated erythema had cutaneous vasculitis characterized by
superficial thrombophlebitis and /or dermal venulitis. Objective: To reevaluate cutaneous vasculi-
tis in BD patients with nodosum-like lesions histopathologically. Eleven recent cases of BD with
histopathologically proven vasculitis were clinicopathologically evaluated. Four cases were con-
firmed to have deep dermal venulitis with underlying moderate to severe lobular neutrophilic pan-
niculitis in 2 cases and subcutaneous necrotizing venulitis in one case. Seven cases with subcuta-
neous phlebitis were confirmed to have overlying deep dermal necrotizing venulitis in 6 cases and
revealed a continuum of venous vasculitis from subcutis to its deep dermal venous branch. Pres-
ence of subcutaneous phlebitis can be identified on serial section, when initial section appeared as
dermal venulitis with panniculitis, however without evidence of subcutaneous phlebitis. Erythema
nodosum-like lesions in BD are venous vasculitis-associated skin lesions. Both the histopathologi-
cal features of subcutaneous phlebitis with overlying deep dermal venulitis and dermal venulitis
with underlying lobular neutrophilic panniculitis are diagnostic clues to BD.
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Trace Elements And Urticaria Activity Score In Chronic Idiopathic Urticaria
L Dinu,1 CD Nicolae,2 DJ Diaconu,3 I Nicolae4 and SR Georgescu3 1 Dermatology, MedLife
Clinic, Bucharest, Romania, 2 UMF “Carol Davila”, Bucharest, Romania, 3 Dermatology, “Dr.
Victor Babes” Hospital for Infectious and Tropical Diseases, Bucharest, Romania and 4
Research, “Dr. Victor Babes” Hospital for Infectious and Tropical Diseases, Bucharest,
Romania
Introduction. Objective.Trace elements may play a role in the pathophysiology of chronic idiopathic
urticaria (CIU) by virtue of their role in oxidative stress. The aim of this study was to determine
whether disease activity in CIU patients is correlated with quantitative variations of some trace ele-
ments in serum of patients with urticaria. Materials. Methods. We tested 37 CIU patients. Disease
activity was assessed using the urticaria activity score (UAS), which combines daily wheal numbers
and pruritus intensity. The results were compared with a control group comprising 30 healthy vol-
unteers. We determined the serum levels of zinc, copper, magnesium, iron, total iron-binding capac-
ity, transferrin, transferrin saturation, using standard photometric and turbidimetric methods (HumaS-
tar 300, GmbH Germany). Results. Compared with the control group, we obtained elevated serum
copper and iron levels and low serum magnesium and zinc levels in CIU patients. Parameters that
define the iron status showed no significant variations between groups, except transferrin satura-
tion coefficient. We obtained a statistically significant positive correlation between serum copper
level and UAS and statistically significant negative correlations between serum concentrations of
magnesium, respectively zinc and UAS in CIU patients. Disruption of trace elements metabolism
could be a risk factor for increased oxidative stress in CIU patients. Based on these observations,
the authors have initiated a systematic study which assess oxidative capacity (8-Hydroxy-
deoxyguanosine, malondialdehyde, advanced oxidation protein products) and antioxidant capac-
ity, correlated with UAS in CIU patients.
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Exploring Valrubicin’s Potential Role in Treating Acne
L Rottbøll,1 K Thomsen,2 E de Darkó,3 TN Dam,4 C Rosada1 and K Stenderup1 1 Department of
Dermatology, Aarhus University Hospital, Aarhus, Denmark, 2 Department of Biomedicine,
Aarhus University, Aarhus, Denmark, 3 Valderm ApS, Lyngby, Denmark and 4 Department of
Dermatology, Roskilde Hospital, Roskilde, Denmark
Valrubicin is an anthracycline without skin toxicity upon skin contact in opposition to other anthra-
cyclines. Currently, it is approved for bladder instillation for the treatment of bladder cancer. In
mouse models, we have demonstrated that topical application of valrubicin inhibits keratinocyte
hyperproliferation in psoriatic skin and developing skin tumors and inhibits skin inflammation in
contact dermatitis. In these skin diseases hyperproliferation and inflammation are common traits.
Acne vulgaris is the most common skin disorder. The disease manifests as comedones and pustules.
Development of the acne lesions includes hyperproliferation of the ductal keratinocytes and a micro
milieu where P. acnes causes inflammation. Considering its mode of action, topical valrubicin
treatment may thus ameliorate acne. The aim of the present study is to investigate valrubicin’s poten-
tial to treat acne by investigating its anti-bacterial and anti-inflammatory effects in vitro and in vivo.
In vitro, the anti-bacterial effect of different valrubicin formulations was tested on three different P.
acnes strains. Valrubicin was shown to lack anti-bacterial effect. However, the mRNA expression
levels of the inflammatory cytokines IL-1β, IL-8, and TNF-α that play important roles in acne were
significantly reduced in TPA stimulated HaCaT cells treated with valrubicin. Importantly, P.acnes
was observed to induce these cytokines in HaCaT cells. In vivo, we employed the acne mouse model
where P. acnes was intradermally injected into the ears to induce inflammation. A single treatment
with valrubicin was not sufficient to reduce inflammation 24 h post treatment. At this point, in
vitro, valrubicin did not demonstrate an anti-bacterial effect but showed anti-inflammatory effects
and in vivo, we are currently investigating whether repeated applications may be effective in treat-
ing mild to moderate acne.
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Does “autoreactivity” play a role in atopic dermatitis?
T Tang,1 T Bieber2 and H Williams1 1 Centre of Evidence-Based Dermatology, University of
Nottingham, Nottingham, United Kingdom and 2 Department of Dermatology and Allergy,
Friedrich-Wilhelms-University, Bonn, Germany
The role of autoimmunity in atopic dermatitis (AD) is unclear. We sought to critically examine the
occurrence, correlation with severity, and possible causative role of autoreactivity in AD. Our sys-
tematic review of studies identified from Medline included thirty-one experiments that described
autoreactivity in AD patients. We defined autoreactivity as in vitro or in vivo evidence of immune
response to autologous human, generic human or recombinant human proteins or other tissue/cel-
lular components. Autoreactivity prevalence in AD ranged from 23-91% in fourteen studies involv-
ing 2644 participants ) although it not appear to vary with age, gender or disease duration. In con-
trast to studies of AD, IgE autoreactivity was not found in healthy people or in those with allergic
rhinoconjunctivitis, psoriasis, SLE or other inflammatory diseases (8 studies of 816 participants). Two
reports found a positive correlation between autoreactivity and AD severity. Autoimmunity has been
consistently demonstrated in patients with atopic dermatitis. We suggest that autoreactivity may be
playing a causative role in AD based on the magnitude and specificity of the associations found,
plausible mechanisms through IgE, IgG autoantibodies and Th1 autoreactivity, and experimental
elicitation of eczematous lesions following provocation. Whether autoantibodies contribute to AD
chronicity now needs to be examined in longitudinal studies.
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Acitretin-refractory oral, esophageal and cutaneous lichen ruber planus controlled with
alitretinoin
A Kolios,1 E Marques Maggio,2 C Gubler,3 A Cozzio,1 R Dummer,1 L French1 and A Navarini1 1
Department of Dermatology, University Hospital Zurich, Zurich, Switzerland, 2 Department
of Pathology, University Hospital Zurich, Zurich, Switzerland and 3 Clinic of Gastroenterology
and Hepatology, University Hospital Zurich, Zurich, Switzerland
Therapy-refractory to classical treatment options of Lichen planus (LP) could be a challenging
approach for dermatologists. There are some case reports about successful treatments of cutaneous
and oral LP but not in esophageal. We present an unique case of a patient with cutaneous, oral and
esophageal Lichen planus which was refractory to classical treatment options (topical clobetasol
propionate and pimecrolimus, intramuscular triamcinolone acetonide) and could not tolerate sys-
temic acitretin dosed up to 25mg daily because of systemic side effects. Alitretinoin was started at
a dose of 30mg daily. Both oral and skin changes and dysphagia completely resolved in 4 weeks
without any side effects and used the drug for 6 months. No papules, enoral striae or dysphagia
recurred over the time of treatment. Further studies are needed to better understand the impact of
Alitretinoin in LP. Our observation suggests as a new, well-tolerating treatment option for esophageal
LP after failed response to previous standard treatments.
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Is Pemphigus Erythematosus (Senear Usher Syndrome) a rare variant of Pemphigus or Crossover
syndrome?
E Ergün,1 C Bassorgun,2 A Akman-Karakas,1 S Uzun1 and E Alpsoy1 1 Dermatology and
Venerology, Akdeniz University School of Medicine, Antalya, Turkey and 2 Pathology, Akdeniz
University School of Medicine, Antalya, Turkey
Pemphigus Erythematosus is simply the localized form of Pemphigus Foliaceous. Typical scaly and
crusted lesions, occur across the malar area of the face in a butterfly distribution that resembles
lupus erythematosus. Lesions can be in other seborrheic areas too. Pemphigus erythematosus, has
features of lupus erythematosus and pemphigus foliaceus. The lupus component of pemphigus ery-
thematosus is demonstrated by circulating antinuclear antibodies and sometimes by immunoglob-
ulin and complement deposits at the dermoepidermal junction. Here we present a case that has
both features of discoid lupus erythmatosus and pemphigus foliaceous. A 54 years old man admit-
ted to our clinic for wounds on face and scalp, that has been present in 5 years. And there have
been new lesions on chest and back of the patient in 5 months. His clinical examinatoin revealed,
a scaly plaque in an erythematous ground on scalp, crusted plaques that have atrophy in the cen-
ter of lesions on nose and malar area, bullous lesions on trunk and back, and scaly, lichenified
plaques in violescent color on right forearm. His serologic tests for lupus erythematosus were neg-
ative. ELISA tests for desmoglein antibodies showed positive results for anti-desmoglein1 antibody.
In his histopathologic and direct immunofluorescence studies from several areas, revealed findings
that compatible with discoid lupus erythmatosus and pemphigus foliaceous. Topical corticosteroid
and oral hydroxychloroquine were started as a treatment.
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Papuloerythroderma (Ofuji’s Disease) : A report of three cases
R Filippetti1 and A Muzi2 1 Day Service Dermatologia, Ospedale San Camillo-Forlanini, Rome,
Italy and 2 Day Service Dermatologia, Ospedale San Camillo-Forlanini, Rome, Italy
Introduction Ofuji’s Disease is a eosinophilic dermatosis affecting mostly male patients (overall
male/female ratio of 4/1) less rare in East Asian areas.It is characterized by the appearance of ster-
ile pruritic papules that coalesce to form plaques centered in hair follicles and typically found in
the upper body,sparing abdomen and legs.The course is chronic with spontaneous exacerbations
and remissions . Comorbidities :HIV infection and hematologic diseases account for 10% of total
cases. Cases report Patient 1: Male 56 years old with advanced HIV infection, had scalp involve-
ment,partial response to oral and topical corticosteroids administered mainly for relief of itching.
Died 3 months later due to cerebral toxoplasmosis. Patient 2: Male 30 years old,HIV positive with
relatively low CD4+ T cells counts and early antiretroviral therapy for airways Kaposi sarcoma.He
had scalp involvement with good response to dapsone (100 mg/day) Patient 3: Female 51 years
old,uncomplicated hepatic cirrhosis post HCV infection.She had scalp involvement and complete
remission with dapsone and PUVA exposure. Mild eosinophilia,lymphocytopenia and increased
IgE were common findings.Hystopathology showed aspecific inflammation.Blood and cutaneous
coltures for microorganisms and bacteria were negative. Conclusions Unless associated with HIV
infection and hematologic disorders (leukemia,lymphoma,myelofibrosis) Ofuji’s disease has a clin-
ical course positively benign.However patients should be monitored because of frequent relapses.
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